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Abstract 
 
Autophagy is a bulk degradation process characterised by the formation of double 
membrane vesicles called autophagosomes. Autophagosomes derive from a small 
precursor structure called phagophore, which is expanded to enclose a portion of 
cytoplasm or organelle, and finally fuses with the endo-lysosomal system to acquire 
degradative capacity. Autophagy is often studied as a response to starvation, since the 
degraded components can be re-used for biosynthetic pathways. However, in 
multicellular organisms, it has many additional functions in tissue homeostasis, during 
development, in infection and immunity, and in programmed cell death. Regarding 
autophagy many questions remain such as the origin of the autophagosomal membrane, 
the mechanism of phagophore extension and many of the signalling pathways that lead 
to autophagosome assembly. To better understand the membrane trafficking events 
involved in autophagosome formation I did an over-expression screen for Rab GTPase 
activating proteins (RabGAPs) inhibiting this process. RabGAPs act inhibitory on Rab 
GTPases, which are major regulators of intracellular membrane traffic. I have identified 
11 RabGAPs that inhibit autophagosome formation, one of which is TBC1D14, which 
binds to ULK1, an important kinase for initiation of autophagy. TBC1D14 also binds to 
Rab11 and tubulates recycling endosomes when over-expressed. I found that both 
ULK1 and another essential autophagy protein mAtg9 localise to recycling endosomes 
under normal conditions. I propose that recycling endosomes can signal through both 
ULK1 and mAtg9 to initiate autophagosome formation upon starvation and may be 
important in monitory cellular nutrient status, and/or provide membrane to 
autophagosomes. 
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Investigating the role of ULK1 in vivo, I found that ULK1 knock-out mice are able to 
undergo basal autophagy as assessed by LC3 lipidation in various tissues. However, 
ULK1 knock-out mice have less CD4 and CD8-positive mature T cells and their 
response to TCR stimulation is impaired compared to T cells from wild type animals. 
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Chapter 1. Introduction 
 
1.1 Autophagy 
 
Autophagy is a degradative process characterised by the formation of double membrane 
vesicles called autophagosomes. It is highly conserved throughout all eukaryotes and 
genetic studies in yeast first revealed the major protein machinery involved. These 
proteins were called the Atg proteins and many of them are conserved in higher 
eukaryotes [1]. Autophagosomes start out as small membrane structures called 
phagophores or isolation membranes (IMs), which are expanded through an unknown 
mechanism to autophagosomes of various sizes but usually with a diameter of about 
300-900 nm [2]. Note that the terms phagophore and IM will be used interchangeably. 
Autophagosomes fuse with endosomes and lysosomes to form autolysosomes leading to 
the degradation of the inner autophagosomal membrane along with all its contents by 
lysosomal hydrolases (Fig. 1-1). Unlike the proteasome, which degrades single proteins 
one at a time autophagosomes can enclose an entire portion of cytoplasm containing 
organelles or parts of organelles, protein aggregates, invading pathogens, etc. leading to 
their degradation. The resulting broken down components such as amino and fatty acids 
are then released into the cytosol and can be reused for biosynthetic pathways, which is 
why it is often studied as a starvation response (Fig. 1-1). However, in multicellular 
organisms autophagy has many additional roles in development, immunity, ageing, and 
tissue homeostasis. Because autophagy has such diverse functions and because it 
happens in almost every nucleated cell in the body, tight control is necessary and 
malfunctions in the process can lead to a plethora of diseases such as 
Chapter 1. Introduction 
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neurodegeneration, myopathies, autoimmune disease, and cancer depending on which 
tissue is affected [3]. 
The aim of this study was to further elucidate the molecular mechanisms of mammalian 
autophagy in particular the membrane trafficking events involved in autophagosome 
formation. 
 
Three major forms of autophagy exist: Macroautophagy, which I refer to as autophagy 
throughout; microautophagy, which describes the uptake of cytoplasmic material by 
invagination of the lysosomal or vacuolar membrane directly; chaperone mediated 
autophagy (CMA), which is the delivery of cytoplasmic material to the lysosome (and 
probably vacuole [4]) surface directly via protein channels and chaperones; and the 
cytosol to vacuole (Cvt) targeting pathway, which only exists in yeast and serves to 
deliver the yeast proteins aminopeptidase1 and -mannosidase to the vacuolar lumen.  
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Figure 1-1 Autophagy overview 
Autophagy is a degradative process characterised by the formation of double membrane vesicles called 
autophagosomes. These vesicles start out as small membrane structures called phagophores or isolation 
membranes (IMs), which are expanded through an unknown mechanism to autophagosomes of various 
sizes with a diameter normally ranging from 300-900 nm. Autophagosomes fuse with endosomes (not 
depicted) and lysosomes to form autolysosomes leading to the degradation of the inner autophagosomal 
membrane along with all its contents by lysosomal hydrolases. The resulting broken down components 
such as amino and fatty acids are then released into the cytosol through permeases and can be reused for 
biosynthetic pathways. Unlike the proteasome, which degrades single proteins one at a time, 
autophagosomes can enclose an entire portion of cytoplasm containing organelles, protein aggregates, 
invading pathogens, etc. Figure drawn with reference to Mizushima et al., 2008 [3]. 
 
Autophagosomes were first noted by S. Clark in 1957 when he examined the kidneys of 
newborn mice by electron microscopy (EM), but it was Christian De Duve and others 
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who discovered the degradative capacity of these organelles (Fig. 1-2). Interestingly, 
Clarke notes that most of these structures, which he describes as vacuoles or large round 
bodies containing an amorphous material, are abundant in the kidney just after birth but 
mostly disappear in the following weeks [5]. A plethora of biochemical studies over the 
next two decades revealed the connection between autophagy and energy/nutrient 
status, for example, reports showing induction of autophagy by glucagon or amino acid 
deprivation in the liver [6, 7]. More recently, confirming Clark’s observations, it was 
indeed found that there is a burst in autophagic activity just after birth to overcome the 
nutrient deprivation experienced by the foetus after separation from the maternal trans-
placental supply. It was found that autophagy is immediately up-regulated after birth 
returning to basal levels after 1-2 days. Atg7 and Atg5 knock-out mice who cannot 
undergo this autophagy burst do not survive this period and die within 24 hours after 
birth even when force fed [8, 9]. 
 
It was not until the 1990’ies when yeast genetic screens were designed to study 
autophagy that significant progress in understanding the molecular machinery of this 
process was made. Autophagy screens in Saccharomyces cerevisiae revealed essential 
genes involved in starvation induced autophagy in yeast [10-16], and for many of these 
the mammalian homologues have been identified [17], advancing the field enormously 
in the last 15 years. However, in 1967 De Duve noted that “very little is known 
concerning the mechanisms whereby these [autophagosomes] are formed and their 
contents degraded” and this is still largely true today. 
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Figure 1-2 Autophagosomes were first observed in the 1950’ies by EM 
(a,b) First observation of autophagosomes by Sam L. Clark in EM micrographs of proximal tubules of 
mouse kidneys. Pictures taken from [5] (a) He notes that the three vacuoles (V) on the left contain an 
amorphous material. (b) Large round bodies (D) containing varying concentrations of an amorphous 
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material are present throughout the cytoplasm and disappear from the proximal tubules of infant mice 
during the first week after birth. (c) Autophagosomes containing a mitochondrion and other material 
taken from De Duve and Wattiaux, 1965 [18]. 
 
1.1.1 Autophagy proteins and complexes 
 
The exact nature of the IM, called pre-autophagosomal structure (PAS) in yeast, is 
unclear and it is not known whether these structures are pre-existing or form upon 
induction of autophagy. The IM is expanded through an unknown mechanism to form 
immature autophagosomes (AVi), which are closed and can fuse with endosomes and 
lysosomes to become a degradative compartment (AVd) also called autolysosome (Fig. 
1-3). Several proteins and protein complexes localise to the IM and autophagosomes 
successively and although they do not seem to act in a strictly linear order at all times a 
hierarchy of Atg proteins has been established in yeast, which seems to be very similar 
or identical in mammals (Fig. 1-4 and see section 1.1.3). 
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Figure 1-3 Autophagosome formation 
Autophagosome formation is a multi-step process starting with the expansion of a small crescent shaped 
vesicle called isolation membrane (IM) or phagophore. It is unclear whether the IM is pre-existing or 
forms upon induction of autophagy and the mechanism of membrane expansion is not known. Once the 
immature autophagosome (AVi) is closed it can fuse with endosomes (E) and lysosomes (LY) and 
acquired degradative capacity (AVd). AVds are also called autolysosomes. Listed underneath are some of 
the important proteins involved in each step, which can also be used as markers to distinguish IMs from 
AVis or AVds. Figure modified from Longatti and Tooze, 2009 [19]. 
 
In yeast 33 Atg proteins have been identified so far, 18 of which are involved in 
autophagosomes formation (Atg1-10, Atg12-14, Atg16-18, Atg29, and Atg31). The 
most important proteins involved in mammalian autophagy are listed in Table 1-1. 
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Table 1-1 Important proteins in mammalian autophagy 
The nomenclature of autophagy proteins  in yeast has been unified to Atg (formerly Apg, Aut, Cvt, and 
Gsa) [1], however, many mammalian proteins have been assigned different names due to their 
involvement in other processes, or if they lack sequence homology with yeast Atg proteins. 
Protein with alternative names Description 
Atg1 (S. cerevisiae. D. melanogaster, D. 
discoideum) 
ULK1 (H. sapiens, M. musculus) 
Unc51 (C. elegans) 
Serine/threonine kinase important in 
induction of autophagy. There are five 
homologues in mammals ULK1, ULK2, 
ULK3, ULK4, STK36/fused. [20-27] 
Atg2 Involved in Atg9 trafficking. The 
mammalian homologue has not been 
studied well. [28, 29] 
Atg3 E2-like enzyme conjugating Atg8/LC3 to 
PE. [16, 30] 
Atg4 Cysteine protease cleaves the ultimate C-
terminus of Atg8/LC3 to expose a 
glycine. Can also de-conjugate Atg8/LC3 
from PE. In mammalian cells there are at 
least four homologues Atg4A, B, C, and 
D. [31-33] 
Atg5 A protein that is part of the Atg16L 
complex upon autophagy induction. 
Atg12 is constitutively conjugated to 
Atg5 shortly after synthesis. [34, 35] 
Atg6/Vps30 (yeast) 
Beclin1 (mammals) 
Component of the PI3K complex. 
Interacts with Bcl-2. [36, 37] 
Atg7 E1-like enzyme that activates both 
Atg8/LC3 and Atg12 in an ATP 
dependent manner to be conjugated to 
their targets. [38] 
Atg8 (yeast) 
LC3 (mammals) 
Ubiquitin-like protein, which is 
conjugated to PE upon induction of 
autophagy. Localises to autophagosomes 
and is partly degraded in them. LC3A has 
two splice variants B and C. There are 
four other mammalian Atg8 homologues 
GABARAP, GABARAPL1, 
GAPARAPL2/GATE16, and 
GABARAPL3 [33, 39, 40] 
Atg9 (yeast) 
mAtg9 (mammals) 
Transmembrane protein. There are two 
mammalian homologues Atg9A and 
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Atg9B. Atg9A is ubiquitous whereas 
Atg9B is only expressed in the placenta 
and pituitary gland. Mammalian Atg9 has 
6 transmembrane domains and cycles 
between the TGN and endosomes. [13, 
41-43] 
Atg10 An E2-like enzyme that conjugates Atg12 
to Atg5. [34, 44] 
Atg12 Protein conjugated to Atg5 constitutively. 
Part of the Atg16L complex. [34] 
Atg13 Component of the Atg1/ULK1 kinase 
complex [21, 45-48] 
Atg14 (yeast) 
Atg14L/Barkor (mammals) 
Component of the PI3K complex 
necessary for function in autophagy. [37, 
49, 50] 
Atg16 (yeast) 
Atg16L (mammals) 
Component of the Atg16L complex. 
There are two mammalian homologues 
Atg16L1 and Atg16L2. Atg16L 
associates with the Atg5-12 complex 
upon autophagy induction and localises 
to the phagophore. [51, 52] 
Atg17 (yeast) 
FIP200 (mammals) 
Component of the Atg1/ULK1 kinase 
complex. FIP200 is functionally 
homologous to Atg17 but shares no 
sequence homology with it. [53-55] 
Atg18 (yeast) 
WIPI2 (mammals) 
PI3P binding protein. Localises to IMs 
and may prevent LC3 de-conjugation by 
Atg4. Involved in Atg9 traffic. There are 
four mammalian homologues WIPI1-4. 
[11, 56-58] 
Atg21 PI3P binding protein homologous to 
Atg18 but more specific for the Cvt 
pathway in yeast. [59] 
Atg24/Cvt13 (yeast) 
SNX4 (mammals) 
PI3P binding protein. In yeast Atg24 is 
part of the ULK1 kinase complex but 
may be specific to the Cvt pathway 
and/or pexophagy. In mammals SNX4 
regulates TfnR sorting to the ERC but has 
not been linked to autophagy. [60-62] 
Atg101 Atg13 binding protein therefore part of 
the ULK1 kinase complex. Conserved in 
various eukaryotes but not in yeast. [63, 
64] 
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Alfy Targets proteins aggregates in the cytosol 
for autophagic degradation. [65, 66] 
Ambra1 Positive regulator of autophagy. Binds 
Beclin1 and modulates its activity. [67] 
Bif-1/Endophilin B1 Interacts with the Beclin1 complex and is 
required for autophagy. Has a BAR 
domain. [68] 
DFCP1 PI3P binding protein. Localises to 
omegasomes, which may act as cradles 
for autophagosome formation. [69] 
FYCO1 Protein that binds LC3, Rab7 and PI3P to 
move autophagosomes to lysosomes. [70] 
TOR (yeast) 
mTOR (mammalian) 
Serine/threonine kinase that forms two 
complexes called TORC1 and TORC2. 
Autophagy is negatively regulated by 
TORC1. [71] 
Rheb Small GTPase that activates mTOR when 
GTP bound. [25] 
Rubicon Beclin1 interactor. Part of the PI3K 
complex. Negative regulator of 
autophagy. [72, 73] 
TRAPPIII Multimeric GEF that activates the 
GTPase Ypt1p. Functions in autophagy in 
yeast. [74] 
TSC1/2 complex May act as a GAP for Rheb thus 
inhibiting mTOR. [75] 
UVRAG Can be part of the Beclin1/PI3K complex 
positively regulating autophagy. [76] 
Vps34 The class III PI3K in the autophagic 
PI3K complex. There are 3 complexes in 
mammalian cells containing 
Vps34/Vps15/Atg14L/Beclin1 and a 
combination of UVRAG, Ambra1 and/or 
Rubicon. [77] 
p62/Sequestosome1 (SQSTM1) Adaptor protein binding ubiquitinated 
protein aggregates and LC3 leading to 
incorporation of aggregated proteins into 
autophagosomes. [78] 
Jumpy PI3-phosphatase that negatively regulates 
initiation of autophagy. [79] 
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Figure 1-4 Hierarchy of Atg proteins in yeast 
A hierarchy of Atg proteins was established by examining their localisation to the PAS in various yeast 
mutants. The Atg1 kinase complex and the PI3K complex act in parallel and are some of the first proteins 
to be recruited to the PAS, followed by Atg18, Atg5-12-16, and finally Atg8. Numbers indicate Atg 
proteins; V30 is Vps30/Atg6. Figure taken from Suzuki et al., 2007 [80]. 
 
1.1.2 The ULK1 kinase complex 
 
The most upstream event in autophagosome formation is probably activation of the 
ULK1 kinase complex. ULK1 has an N-terminal kinase domain, a serine/proline rich 
middle domain and a C-terminal domain, which interacts with Atg13 and FIP200. The 
kinase domain of ULK2 shares about 78% homology with the kinase domain of ULK1 
(about 50% overall) and the two proteins may be functionally partly redundant. 
Interestingly, ULK1 is essential for autophagy in HEK293A cells whereas ULK2 is not 
but ULK1 knock-out mice are healthy (see Chapter 5 and [81]). ULK3, ULK4, and 
STK36 show high similarity to ULK1 in their kinase domain but the serine/proline rich 
regions and the C-terminus are not conserved. Since it is the C-terminus that interacts 
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with Atg13 and FIP200 the role of the other ULK1 orthologues in autophagy remains 
unclear although ULK3 has been shown to induce autophagy when over-expressed [82]. 
 
ULK1, Atg13, FIP200 and Atg101 together form the ULK1 kinase complex, a stable 
complex in both fed and starved conditions. All four proteins are essential for 
autophagosome formation and associate with the isolation membrane (IM) upon 
autophagy initiation [83]. Activity of the ULK1 kinase complex is directly regulated by 
the mammalian target of rapamycin (mTOR) and autophagy can be induced by 
inhibition of the mTOR complex 1 (mTORC1) by either rapamycin or torin. mTORC1 
binds the ULK1 kinase complex in fed conditions and phosphorylates ULK1 inhibiting 
its kinase activity and preventing Atg protein recruitment to the phagophore. In 
starvation mTORC1 releases ULK1 leading to its dephosphorylation, kinase activation, 
subsequent auto-phosphorylation, and phosphorylation of FIP200, and Atg13. The 
ULK1 complex can then associate with the IM and recruit other Atg proteins (Fig. 1-5). 
The activity of the mTORC1 complex itself is regulated by the small monomeric 
GTPase Rheb and other upstream signals linked to nutrient sensing but the exact 
mechanism of how the cell measures its nutrient status is not known. Rheb activates 
mTORC1 when it is GTP-bound and the activity of Rheb in turn is regulated by the 
tuberous sclerosis complex (TSC) consisting of two proteins TSC1 and TSC2, the latter 
of which contains a GAP domain that acts on Rheb [84-86]. The former is necessary for 
stability of TSC2, which is otherwise degraded by the proteasome and mutation in 
either of those genes leads to the cancerous tuberous sclerosis syndrome [87-89]. 
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Figure 1-5 Proteins localising to the isolation membrane 
The most upstream event in autophagosome formation is activation of the ULK1 kinase complex, which 
consists of ULK1, Atg13, FIP200/Atg17, and Atg101 and is constitutively assembled in both fed and 
starved conditions. In nutrient rich conditions ULK1 is directly phosphorylated by the mTORC1 
complex, inhibiting its kinase activity, and Atg protein recruitment to the IM. mTORC1 activity in turn is 
regulated by cellular nutrient status through the action of various proteins (not depicted for simplicity). 
Upon starvation mTORC1 releases its inhibition on ULK1 whose kinase activity becomes active to 
phosphorylate itself, Atg13, and FIP200 subsequently leading to recruitment of other Atg proteins to the 
IM. The contents of the IM lumen would depend on the origin of the membrane. The Atg16L complex 
seems to localise pre-dominantly to the convex side of the IM whereas the PI3K complex is more on the 
concave side. Numbers indicate Atg proteins except 34, which is vps34; bcn1 is Beclin1; FIP200 is 
represented as Atg17. Figure modified from Longatti and Tooze, 2009 [19].  
 
Although ULK1 clearly has an important function in autophagy it is also involved in 
vesicular trafficking processes not linked to autophagosome formation. It was shown to 
be essential for neurite extension in the developing mouse brain by regulating the GAP 
activity of SynGAP, which can inhibit Rab5 and Ras activity [90] (Fig. 1-6a). Rab5 and 
Ras can subsequently coordinate vesicular traffic necessary for axon extension. 
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Additionally, ULK1 can regulate motor-cargo assembly to transport synaptic vesicles to 
the axon tip in Drosophila [91]. By phosphorylating the kinesin-1 adaptor protein 
Unc76 ULK1 increases Unc76 affinity for Synaptotagmin-1 (Syt-1), which is found on 
synaptic vesicles. This links synaptic vesicles to the kinesin-1 motor protein via Unc76 
leading to anterograde transport of the cargo to the axon tip (Fig. 1-6b). At the axon tip 
of mouse neurons ULK1 was also shown to regulate endocytosis of TrkA, the receptor 
for nerve growth factor (NGF) [92, 93]. It remains to be elucidated whether ULK1 has 
specialised roles in neurons where autophagy rates are low or whether it is a general 
feature of the ULK1 kinase that it can regulate so many different processes. Depending 
on nutrient status and developmental signals ULK1 may be able to form different 
complexes to perform various functions. In spite of this plethora of functions controlled 
by ULK1, mice lacking the protein show no obvious neurological phenotypes and only 
mild impairments of the hematopoietic system suggesting that ULK2 can compensate 
for most functions [81] (see also Chapter 5). 
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Figure 1-6 ULK1 is involved in axonal vesicular traffic 
(a) ULK1 binds to the adaptor protein Syntenin-1 and SynGAP. ULK1 can down-regulate the GAP 
activity of SynGAP, which can act on Rab5 and Ras. This leads to activation of Rab5 and Ras who can 
then regulate axonal vesicular traffic leading to axon extension. (b) In Drosophila Atg1 can 
phosphorylate Unc76, which is a kinesin-1 adaptor protein. Unc76 also binds Synaptotagmin-1 (Syt-1) 
linking the kinesin-1 motor to synaptic vesicles and anterograde transport of the cargo. 
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1.1.3 The phosphatidylinositol-3-phosphate kinase complex 
 
There are two class III phosphatidylinositol-3-phosphate (PI3P) kinase (PI3K) 
complexes in mammalian cells. Complex I (hereafter just referred to as PI3K complex) 
is essential for autophagy and consists of the PI3K Vps34, p150, Beclin1, and 
Barkor/Atg14. Complex II is involved in endocytic trafficking and autophagy and 
consist of Vps34, p150, Beclin1, and ultraviolet irradiation resistance-associated gene 
(UVRAG). Interestingly, UVRAG binds Bif1 which is a BAR domain containing 
protein required for autophagy [68]. BAR domains cause membrane curvature [94] and 
it is tempting to speculate that Bif-1 is needed to regulate autophagosome shape. The 
production of PI3P is essential for autophagy as treatment with the PI3K inhibitor 
Wortmannin completely inhibits autophagosome formation. 
 
Production of PI3P on IMs and autophagosomes leads to recruitment of the PI3P 
binding protein WIPI2 [57]. Interestingly, PI3P seems to be produced preferentially on 
the inner autophagosomal membrane at least in yeast [95, 96]. The function of WIPI2 
remains elusive but it may prevent premature LC3 de-lipidation by Atg4 before the 
autophagosome is closed [56]. Another PI3P binding protein is double FYVE domain 
containing protein 1 (DFCP1) but it is not clear whether it binds to PI3P on the isolation 
membrane directly or to PI3P on the ER, which forms a fold termed omegasome around 
nascent IMs possibly providing structural support or even membrane to the 
autophagosomes [69]. Recently, a PI3-phosphatase called Jumpy or MTMR14 has been 
identified that negatively regulates autophagy by antagonising the action of the PI3K 
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complex [79]. Jumpy controls the localisation of LC3 and mAtg9 and also recruits 
WIPI1, which is a negative regulator of autophagy in some cells [57]. 
 
Recent studies have established a hierarchy among mammalian Atg proteins [97, 98]. 
They showed that ULK1 is the most upstream Atg protein necessary for recruitment of 
Atg14 independently of PI3K activity. Both ULK1 and Atg14 associate with the ER and 
lead to recruitment of PI3K, followed by recruitment of the PI3P binding proteins 
WIPI1 and DFCP1, followed by Atg16L and LC3 localisation to the IM. Interestingly, 
ULK1, Atg14, WIPI1, Atg16L, and LC3 localised to the same structure but DFCP1 was 
found adjacent. 
 
1.1.4 The ubiquitin-like conjugation systems 
 
1.1.4.1 Atg5-12 conjugation 
Two ubiquitin-like conjugation systems are involved in autophagosome formation. The 
first one results in the conjugation of Atg12 to Atg5. The second one leads to the 
conjugation of LC3 (or one of its paralogues) to the lipid phosphatidylethanolamine 
(PE) (Fig. 1-7). The conjugation of Atg12 to Atg5 is essentially constitutive and 
independent of autophagy. It happens shortly after translation of the proteins by the 
action of Atg7 (E1-like activating enzyme) and Atg10 (E2-like conjugating enzyme). 
The C-terminal glycine of the small 140 amino acid protein Atg12 is covalently linked 
to an internal lysine of Atg5. The Atg5-12 complex associates with Atg16L upon 
induction of autophagy and through Atg16L homo-dimerisation forms a complex of 
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800kDa [34, 52, 99]. This complex associates with the IM through an unknown 
recognition mechanism, but subsequently it may act as an E3-like enzyme to determine 
the site of LC3 conjugation to PE [100] and it has been shown that the Atg16L complex 
is required for elongation of the IM [101]. Furthermore, Atg5 as well as Atg7 knock-out 
mice die within 24 hours after birth even though they are normal at birth. They cannot 
undergo autophagy and therefore cannot overcome the period of nutrient deprivation 
encountered after separation from the maternal supply. Interestingly, it was found that 
autophagy is essential for pre-implantation development of mouse embryos as oocytes 
derived from oocyte-specific Atg5 knock-out mice failed to develop past the four and 
eight cells stage when fertilised with Atg5 knock-out sperm [102]. It is thought that 
homozygous Atg5 knock-out mice develop normally due to the presence of maternal 
Atg5 mRNA and protein in the oocyte. 
 
1.1.4.2 LC3-PE conjugation 
The second conjugation system involves the covalent linkage of LC3 orthologues to the 
lipid PE. PE is an abundant lipid but LC3 is specifically conjugated to PE on 
autophagosomes because of the E3-like action of the Atg16L complex, which localises 
to the IM before LC3. Unlike Atg12 where the terminal glycine is exposed, LC3 needs 
to be cleaved by the cysteine protease Atg4, which removes C-terminal amino acids of 
LC3 to expose a terminal glycine. This cleavage is constitutive and happens 
immediately after translation. Upon induction of autophagy LC3 is conjugated to PE in 
the IM via the action of Atg7 and Atg3 (E2-like conjugating enzyme). This lipidated 
form of LC3 is called LC3-II and the unlipidated form is called LC3-I, which runs 
slightly slower on SDS-PAGE. Atg4 can also cleave LC3-II to release it from 
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autophagosomes. Interestingly, over-expression of a catalytically inactive mutant of 
Atg4B, which seems to be the pre-dominant Atg4 homologue, led to a larger percentage 
of open autophagosomes and those that were closed were smaller compared to those in 
control cells [103]. This and recent data investigating siRNA mediated knock downs of 
LC3 homologues suggests that LC3 may have a role in phagophore extension and 
determining autophagosomes size [40]. This is supported by the finding that LC3 has 
fusogenic properties in vitro, which may catalyse the elongation process [104]. 
Interestingly, the study by Weidberg et al. also found that while LC3 acts early during 
expansion of autophagosomes the GATE-16 and GABARAP homologues are essential 
at later stages possibly in sealing the membrane. On the other hand it has been shown 
that mammalian Atg8 family members recognise specific cargo adaptor proteins. Nix, 
for example, binds specifically to GABARAP-L1 recruiting mitochondria into 
autophagosomes [105-107]. 
 
LC3 lipidation or LC3 puncta formation are some of the most reliable assays to measure 
autophagy [108]. It is important to keep in mind, however, that LC3 itself is degraded in 
the autolysosome. Therefore, a reduction in LC3-II or LC3 spots could be due to either 
decreased autophagosome formation or enhanced autophagic turnover or flux leading to 
more LC3-II degradation. To distinguish the two possibilities protease inhibitors such as 
leupeptin or other lysosomal inhibitors such as Bafilomycin1A, which inhibits the H
+
-
ATPase (V-ATPase) preventing lysosomal acidification should be tested for each 
condition. This will prevent LC3-II degradation and lead to an accumulation of 
lipidated LC3 or LC3 spots if flux is enhanced or reveal if autophagosome formation is 
impaired, in which case a reduction will be observed. Another caveat is that GFP 
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fluorescence is quenched in an acidic environment such as the lysosome and 
autolysosome and therefore these late stage autophagic organelles cannot be observed 
using GFP-tagged LC3. Note that leupeptin and other protease inhibitors cannot prevent 
GFP-LC3 quenching whereas Bafilomycin1A can. Using a tandem fluorescent RFP-
GFP-LC3 (tfLC3) both immature (red+green=yellow) and mature (red) 
autophagosomes can be observed because RFP fluorescence can withstand the acidic 
autolysosomal environment [109]. 
 
Until recently it was believed that Atg5 and Atg7 are absolutely essential for 
mammalian autophagy. However, in a recent study using mostly EM and protein 
degradation assays to measure autophagy it was found that there might be Atg5 and 
Atg7 independent autophagy termed alternative autophagy [110]. Vesicles appearing to 
be autophagosomes could be readily induced by etoposide, a topoisomerase II inhibitor, 
staurosporin, an inhibitor of various kinases including PKC and PKA, and starvation but 
not by rapamycin. However, as of yet there are no markers for these alternative 
autophagosomes available and their exact nature remains unclear. Alternative 
autophagy is dependent on ULK1, FIP200, Beclin1, and Vps34 but not Atg7, Atg5, 
Atg12, Atg16, or mAtg9. 
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Figure 1-7 Two ubiquitin-like conjugation systems are essential for 
autophagosome formation 
[1] In the first ubiquitin-like conjugation system the C-terminal glycine of Atg12 is covalently conjugated 
to lysine 130 of Atg5 via the action of Atg7 (E1-like activating enzyme) and Atg10 (E2 like conjugating 
enzyme) [111]. The Atg5-12 complex is formed constitutively just after protein translation. Upon 
activation of autophagy Atg5-12 associates with Atg16L, which can homo-oligomerise all together 
forming an 800kDa complex called the Atg16L complex, which localises to the IM. [2] In the second 
conjugation system LC3 is conjugated to the lipid phosphatidylethanolamine (PE). However, unlike 
Atg12 LC3 first has to be cleaved by the cysteine protease Atg4 to expose a C-terminal glycine, which is 
conjugated by the action of Atg7 and Atg3 (E2 like conjugating enzyme) to PE. It has been suggested that 
the Atg16L complex has E3-like activity determining the site of LC3 conjugation [100]. Autophagy 
induction dependent steps are indicated by red arrows. 
 
1.1.5 mAtg9 and VMP1 transmembrane proteins 
 
1.1.5.1 mAtg9 
The only transmembrane protein found to be essential for autophagy in yeast is Atg9. 
Its function is thought to be the delivery of membrane to the phagophore but definitive 
proof for this is still missing [13, 42]. In mammalian cells there are two homologues 
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mAtg9A and mAtg9B but the latter is only expressed in the placenta and pituitary gland 
[112]. Therefore, I will refer to mAtg9A simply as mAtg9. In mammalian cells mAtg9 
is found on the TGN and a peripheral endosomal pool, which consists to about 30% of 
Rab7 positive late endosomes but a lot of mAtg9 is also found on CI-MPR positive and 
other endosomes [41]. mAtg9 has 6 transmembrane domains with both N, and C-
termini in the cytosol and one of the luminal loops is Asn-glycosylated in the ER and 
modified in the Golgi. Upon starvation mAtg9 disperses to the periphery as the TGN 
pool is significantly reduced (Fig. 1-8). This dispersal is dependent on the ULK1 kinase 
since knock down of ULK1 leads to an accumulation of mAtg9 on the TGN. However, 
the mechanism through which ULK1 controls mAtg9 traffic is poorly understood and it 
is unclear whether ULK1 is essential for anterograde traffic or prevents retrograde 
movement of mAtg9 to the TGN. It is tempting to speculate that this starvation induced 
dispersal of mAtg9 leads to delivery of TGN membranes to the phagophore or that 
endosomal mAtg9 can recruit other Atg proteins to induce phagophore formation and 
expansion. Recent evidence from yeast suggests that mAtg9 is found on vesiculo-
tubular membranes and moves towards the vacuole upon induction of autophagy to 
assemble into the PAS [113]. Data from mammalian cells suggests that mAtg9-positive 
vesicles transiently interact with phagophores (unpublished observations A. Orsi).  
 
Chapter 1. Introduction 
 45 
 
Figure 1-8 mAtg9 traffics between the TGN and a peripheral pool 
In basal conditions mAtg9 is found on the TGN and a peripheral pool, which at least in some part seem to 
be late endosomes (LEs) or multivesicular bodies (MVBs). Upon starvation mAtg9 disperses to the 
periphery partly co-localising with IMs. However, evidence in mammalian cells suggests that mAtg9 may 
be on vesicles close to autophagosomes and endosomes (indicated as small transparent vesicles) but not 
actually share the same membrane or at least only localise transiently to subdomains of said membranes 
(unpublished observation A. Orsi, LRI). ULK1 is involved in trafficking of mAtg9 but the exact 
mechanism is poorly understood. Upon knock down of ULK1 mAtg9 re-localises to the TGN and can no 
longer undergo starvation induced dispersal to the periphery. However, whether this is due to reduced 
transport away from the TGN or enhanced retrograde traffic remains to be elucidated. Also, it is not clear 
whether mAtg9 can move from the TGN to IMs directly or via endosomes or whether indeed mAtg9 is 
able to turn endosomes themselves into IMs by recruitment of other Atg proteins (indicated by question 
marks). 
 
1.1.5.2 VMP1 
The only other transmembrane protein implicated in mammalian autophagy is vacuolar 
membrane protein 1 (VMP1), which has no homologues in yeast [114]. VMP1 is highly 
expressed in acute pancreatitis, a disease, which is associated with morphological 
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changes resembling autophagosome formation but it is debatable whether autophagy in 
this case is beneficial to the patient or not. Like mAtg9 VMP1 is also predicted to have 
6 transmembrane domains and is essential for mammalian autophagy as siRNA 
mediated knock down leads to an inhibition of autophagosome formation [115]. The 
homologue of VMP1 in D. discoideum functions in organelle biogenesis, the secretory 
pathway, and potentially, autophagy as well [116]. Although the topology of VMP1 has 
not been determined, its C-terminus binds Beclin1 suggesting that it is cytosolic. VMP1 
expression is induced by induction of autophagy via rapamycin or starvation and over-
expression of the protein leads to induction of autophagosome formation. Intriguingly, 
unlike mAtg9, VMP1 localises predominantly to the ER raising the possibility of 
multiple membrane sources for autophagosomes if that is the function of these 
transmembrane proteins. 
 
1.1.6 Origins of the autophagosomal membrane 
 
A typical autophagosome of 400nm in diameter has a surface area (SA) of about 
500m2 (SA=4r2), which has to be multiplied by two for the outer and inner 
membranes. In comparison, an average endocytic vesicle has a diameter of around 
100nm and therefore a surface area of around 30m2 illustrating the large amount of 
membrane that has to be re-directed to autophagosome formation within just a few 
minutes upon induction. Luckily, cellular membranes are not static but highly dynamic 
structures as exemplified by the plasma membrane of a macrophage, which is a 
specialised cell that can ingest 25% of its own volume of fluid an hour. This means that 
3% of its plasma membrane per minute or 100% per half an hour is endocytosed [117]. 
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Other cells like fibroblasts may endocytose more slowly at about 1% per minute but this 
is still a remarkable feat. Intracellular membranes may be similarly dynamic concerning 
vesicle budding and fusion providing fast and abundant membrane sources for 
autophagosome formation. Indeed, many origins for the autophagosomal membranes 
have been suggested including the plasma membrane, ER, Golgi and mitochondria, 
which will be introduced briefly below. 
 
A striking feature of autophagosomal membranes is their lack of intramembrane 
particles, which clearly distinguishes them from other intracellular organelles. Freeze-
fracture EM of autophagosomes revealed that the inner membrane is essentially free of 
any intramembrane particles and the outer membrane contained only very few [118]. 
This led to the hypothesis that autophagosomal membranes may be formed de novo and 
are not derived from any pre-existing organelles, which has gained some support [19, 
119](Fig. 1-9). However, to my knowledge there has not been found any evidence for 
this theory such as specific lipid transport or synthesis machinery involved uniquely 
during autophagy.  
 
Smooth ER was suggested to be the source of autophagic membranes by investigation 
of EM pictures of rat livers, which contain numerous autophagosomes or cytolysomes 
as they were also called then [120]. Ribosome depleted rough ER has also been 
suggested based on later studies [121]. This hypothesis has recently gained support by 
electron tomography studies showing close association of the ER around IMs with 
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interconnections between them [122-124]. Furthermore, it was shown that the small 
GTPases Rab1 and Sar1 that control ER to Golgi traffic are needed for autophagy [125]. 
 
The plasma membrane was originally suggested to be the origin of autophagosomal 
membranes based on EM studies during human corpus luteum involution, which is 
accompanied by formation of autophagic vacuoles [126]. Another recent study [127] 
supports this hypothesis as they show that Atg16L co-immunoprecipitates clathrin 
heavy chain (CHC) and AP-2, which are involved in vesicle budding from the plasma 
membrane and early tubular sorting endosomes in a dynamin-II dependent manner. 
Formation of IMs, or even precursors of IMs, was proposed to require scission of the 
Atg16L/clathrin/AP-2 vesicles. Furthermore, IM formation was AP-2 but not AP-1 
dependent suggesting that these clathrin coated vesicles do not originate from the Golgi 
complex. This is an intriguing possibility for IM formation but leaves open the question 
where the membranes for IM extension come from. 
 
Mitochondria were first hypothesised to provide autophagosomal membrane based on 
the observation that Atg9 was often co-localised with mitochondrial markers by 
immunofluorescence in yeast [128]. Even though closer investigation by EM revealed 
that Atg9 is not actually localised on the mitochondrial membrane but in close 
proximity to it [129], another recent study suggests that autophagosomes arise from the 
outer mitochondrial membrane [130]. 
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Finally the Golgi/TGN complex has also been suggested as a membrane source for 
autophagosomes in an EM study where it was found that osmium staining, which pre-
dominantly labels the Golgi also labelled IMs [131]. Recent studies in yeast cells 
support this showing that post Golgi secretory proteins are essential for autophagosome 
formation and may redirect membrane from the Golgi/TGN to the PAS [132-134]. In 
mammalian cells it remains to be determined whether homologous secretory proteins 
are involved and whether mAtg9 delivers membrane to the phagophore.  
 
Four models for phagophore extension are presented in Figure 1-9. The IM expansion 
model as presented in 4) would be supported by ER, mitochondria, and plasma 
membrane origins but other sources such as the Golgi and TGN would favour the 
vesicular transport model 2). However, it is very possible that a mixture of two or more 
models occurs and accumulating evidence suggests that autophagosomes may form 
using several membrane sources. This may depend on the autophagic stimulus, the 
cargo, the cell type, or the organism but it may also be a more general principle 
applying to all autophagosomes, after all, autophagy is mainly a stress response and it 
makes sense for the cell to exploit all possible resources under cytotoxic conditions. 
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Figure 1-9 Models for autophagosome extension 
1) Lipids may be delivered to IMs by lipid binding proteins as single lipids, lipid droplets or micelles. 
This would necessitate the presence of proteins that catalyse lipid insertion into bilayers and flipping, and 
possibly capping proteins for the expanding membrane sheets. Alternatively, close association with the 
lipid synthesis machinery in the ER could provide lipids to autophagosomes. 2) Membrane expansion by 
fusion of small vesicles from one or many different donor membranes. 3) Fusion of multiple pre-existing 
IM-like structures. 4) Membrane remodelling whereby sheets of pre-existing membrane sources are 
sequestered in their entirety to form autophagosomes. Finally, a combination of two or more models may 
be used for phagophore expansion. Figure taken from Longatti and Tooze, 2009 [19]. 
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1.1.7 Autophagy in health and disease 
 
Because autophagy is such an important housekeeping mechanism and stress response 
occurring in practically all nucleated cells it can lead to, or exacerbate a variety of 
diseases when not properly regulated or dysfunctional. 
 
1.1.7.1 Autophagy and cancer 
The role of autophagy in cancer is often described as a double edged sword as it has 
both tumour suppressive and tumour promoting properties. Beclin1 is a haplo-
insufficient tumour suppressor, which is mutated in 40-75% of human breast, ovarian, 
and prostate cancers [135, 136]. Beclin1 null mice die early during embryogenesis due 
to severe developmental defects probably due to abnormal visceral endoderm 
formation, which provides an exchange system responsible for nutrition and waste 
product detoxification in the developing embryo. Heterozygous mice develop normally 
and are fertile [137, 138] but suffer from a high incidence of spontaneous tumours, 
which still express the remaining Beclin1 allele. Other proteins binding to the PI3K 
complex such as Ambra1 (activating molecule in Beclin1-regulated autophagy), 
UVRAG, and Bif1 were also shown to have tumour suppressive properties [67, 68, 76]. 
This seems to be true also for Atg proteins not binding to Beclin1, for instance, mice 
lacking Atg4C show increased susceptibility to develop fibrosarcomas induced by 
chemical carcinogens but only mild defects in autophagy under starvation conditions 
and are otherwise viable and fertile [139].  
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Induction of autophagy usually leads to down-regulation of cell growth and 
proliferation and through this interrelation may exert tumour suppressive properties. In 
turn, many commonly known tumour suppressor genes such as PTEN, p53, and TSC1/2 
stimulate autophagy [3]. Other functions of autophagy including removal of damaged 
mitochondria, reactive oxygen species (ROS), peroxisomes, and other cytotoxic agents 
may ensure genomic stability by preventing DNA damage. However, it seems 
autophagy may have additional, poorly understood, roles in maintaining genomic 
stability such as preventing aneuploidy. 
 
Autophagy has also been described as a non-apoptotic type of programmed cell death. 
Although it is now thought that this only applies to cells unable to undergo apoptosis 
[140] this raises intriguing possibilities for the treatment of cancer, where most cells are 
deficient in apoptosis. Furthermore, it has been shown that blocking autophagy 
increased sensitivity of tumours to chemotherapeutic agents probably either preventing 
direct degradation of chemotherapeutics in autophagosomes or preventing degradation 
of mitochondria and other inducers of caspase mediated apoptosis such as active 
caspase 8 protein [141-143]. 
 
Paradoxically, in normal cells autophagy is mostly a cell survival mechanism, which 
can help cells to overcome periods of nutrient and growth factor deprivation, hypoxia, 
and other stresses often encountered in primary tumours and also during metastasis. 
There are two popular possibilities to explain this paradox. Firstly, autophagy could 
prevent necrosis, which leads to inflammation thereby increasing tumour growth rate. 
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Secondly, it may be that the effects of autophagy are cancer-stage specific: Early on it 
could act mainly as a tumour suppressor preventing formation and early tumour 
progression by prevention of genotoxicity but at later stages it may be advantageous to 
the cancer promoting cell survival and metastasis. Therefore, autophagy should be 
targeted accordingly for therapeutic intervention. 
 
1.1.7.2 Neurodegenerative disease 
Because neurons are post-mitotic basal autophagy is especially important in these cells 
for the removal of damaged mitochondria, protein aggregates, and other cytotoxic 
components. Indeed, many neurodegenerative diseases associated with protein 
aggregates have been linked to autophagy including Huntington’s (HD), Alzheimer’s, 
and Parkinson’s disease. However, studies in mice with neuron specific deletions of 
Atg5 or Atg7 show that even in the absence of disease causing mutant proteins, which 
may aggregate, impaired autophagy can lead to neurodegeneration [144, 145]. 
Interestingly, as shown in Atg5 knock-out neurons it seems that the primary target of 
autophagy are diffuse cytosolic abnormal proteins that form aggregates and not the 
aggregates themselves. 
 
Many neurodegenerative diseases are characterised by the aggregation of mutant 
proteins. In Huntington’s disease an expanded polyglutamine
 
tract in the N terminus of 
the huntingtin protein causes its aggregation accompanied by cell death and induction of 
autophagy [146]. Induction of autophagy by treatment with rapamycin enhances 
autophagic clearance of huntingtin aggregates and reduces neuronal cell death [147]. 
This may be similar in other diseases characterised by aggregation of proteins with a 
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polyglutamine extension such as spinocerebellar ataxia, amyotrophic lateral sclerosis, 
and familial Parkinson’s disease where autophagy has a beneficial effect protecting 
against neurodegeneration [3, 148].  
 
However, the situation is not always that simple as generation of aggregates may be a 
cytoprotective mechanism [149]. Alzheimer’s disease is characterised by aggregation of 
tau protein and deposition of amyloid- (A) peptide. A is generated predominantly by 
cleavage of the A precursor protein (APP) by -secretase. Autophagosomes 
accumulate in dystrophic neurites of Alzheimer’s disease patients probably due to a 
maturation defect. Interestingly, the toxic product A is produced within these 
autophagosomes because both APP and -secretase are present in the ER sequestered by 
the phagophores [150]. Treatment with rapamycin in this case enhanced A production 
suggesting that autophagy can be disease promoting under these circumstances. 
Therefore, it may be therapeutically advantageous for some neurodegenerative diseases 
to block autophagy whereas activation would be beneficial others.  
 
1.1.7.3 Crohn’s disease 
A polymorphism in the Atg16L1 gene (T300A) was found in patients with Crohn’s 
disease an inflammatory bowel disorder of the small intestine. Over 30 loci have been 
identified controlling susceptibility to this autoimmune disease and the Atg16L1 gene is 
one of them [151]. Interestingly, the Atg16L1T300A variant had little effect on 
canonical autophagy when expressed in MEFs lacking wild type Atg16L1 as LC3 and 
Atg16L1T300A puncta formed normally upon starvation [152]. However, Crohn’s 
disease can be induced experimentally in mice with hypomorphic Atg16L1 expression 
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[153]. This may be due to a specialised function of Atg16L1, and maybe autophagy, in 
intestinal paneth cells, which function in the secretion of antimicrobial peptides and 
other proteins that alter the intestinal environment. 
 
1.1.7.4 Myopathies, pancreatitis, diabetes, liver and heart disease 
Although neurodegeneration and cancer are probably the best studied diseases with an 
involvement of autophagy, the process has been shown to be involved in many other 
pathologies. But like in the previous two examples, it is often unclear whether 
autophagy plays mainly a protective or disease causing role. 
 
In myopathies, autophagy can have a general protective role but also contribute to 
muscle wasting and interfere with cellular function. Cardiac-specific Atg5-deficient 
mice develop cardiomyopathy and die earlier than wild type animals [154]. In 
autophagic vacuolar myopathy an accumulation of autophagosomes is seen, which may 
contribute to disease [155]. In many diseases that affect a specific organ such as the 
kidney, liver, or lung it is unclear whether excess autophagy can contribute to organ 
damage or is a sign of failed repair as is well illustrated in cardiovascular heart disease 
with damage caused after ischemia and reperfusion accompanied by autophagy [156]. 
Similar questions remain about the role of autophagy in pancreatic beta-cell 
dysfunction, which is the main cause of diabetes type 2 [157]. 
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In conclusion, there clearly is great interest in understanding the molecular mechanisms 
of autophagy in order to be able to target it therapeutically at different stages or in 
different ways depending on the disease or the disease stage. 
 
1.2 Membrane trafficking 
 
Eukaryotic cells are highly compartmentalised with many different membrane bound 
organelles. Transport between organelles and delivery of specific cargo has to be 
directed and tightly regulated because, for example, mistargeting of growth factors or 
other molecules can lead to a variety of diseases including cancer. Transport between 
compartments is achieved by vesicular trafficking and a plethora of regulatory proteins 
and lipids that coordinate it. It is important to understand how the different trafficking 
routes are intertwined and where autophagy is to be placed in this context and this study 
aimed at further elucidating these questions. 
 
1.2.1 Intracellular trafficking pathways 
 
Small vesicles transport material in between organelles in a controlled and directed 
fashion as was first described by George Palade in the 1960’ies and 1970’ies [158]. 
Some cells such as melanocytes, which secrete melanin in the skin or polarised 
epithelial cells exhibit highly specialised protein trafficking to fulfil their function. 
However, here I will describe some of the best studied major trafficking routes that 
apply to most nucleated cells and are relevant to the cell lines I used as models. 
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Proteins are synthesised in the cytosol or on the ER membrane and are subsequently 
targeted to their site of function. This location may be the cytoplasm itself in which case 
no special sorting may be necessary but most often proteins are targeted to a very 
specific organelle. For instance, lysosomal hydrolases, which function in protein 
degradation, are targeted to the lysosome. Missorting of proteins can lead to a variety of 
diseases as illustrated by various forms of lysosomal storage disease [159]. Generally, 
proteins that are secreted or targeted to intracellular organelles and the plasma 
membrane co-translationally enter the ER where they are folded and delivered to the 
Golgi apparatus for further processing. Transport to the Golgi is mainly regulated by 
vesicles coated with coat protein II (COPII) and coat protein I (COPI) two multimeric 
coatomer complexes. Assembly and trafficking of COPII vesicles is regulated among 
others by the small GTPases Rab1 and Sar1 and goes to the ER Golgi intermediate 
compartment (ERGIC) from where COPI vesicles regulate traffic to the Golgi complex 
[160-163]. Interestingly, Rab1 and Sar1 have recently been shown to be essential for 
autophagosome formation whereas COPI subunits are important for autophagosome 
maturation [125, 164].  
 
Retrograde traffic from the Golgi to the ER and intra Golgi trafficking is mediated by 
vesicles coated by the COPI coatomer regulated by the Arf GTPase [165]. Furthermore, 
COPI vesicles have also been shown to regulate endosomal trafficking and 
autophagosome maturation [164, 166-168]. From the Golgi complex and the trans-
Golgi network (TGN) proteins can be sorted to endosomes or the plasma membrane via 
clathrin coated vesicles. Clathrin coated vesicles are another form of coated carriers and 
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can mediate endocytosis from the plasma membrane to early endosomes but one 
important difference is that while clathrin coated vesicle transport between the TGN and 
endosomes requires the adaptor protein AP-1, endocytosis requires AP-2 [169]. Two 
related adaptors AP-3 and AP-4 have also been found to localise to the TGN and 
endosomes but are not necessarily enriched in clathrin coated vesicles suggesting that 
they can regulate assembly of other vesicles [170]. AP-3-coated vesicles deliver their 
cargo to lysosomes or late endosomes and may be important in lysosome biogenesis. 
AP-4 is the least well studies adaptor complex but a recent study has found that it 
regulates transport of amyloid precursor protein from the TGN to endosomes thereby 
reducing amyloidogenic processing, which contributes to Alzheimer’s disease [171]. 
 
An astonishing number of different endocytic pathways have been described (Fig. 1-10) 
and most of them deliver their cargo to early endosomes.  
 
 
Figure 1-10 Endocytic pathways 
A plethora of endocytic pathways have been described so far. Some share common machinery such as the 
GTPase Dynamin, which mediates pinching or popping off of vesicles. Others use unknown machinery. 
Figure modified from Mercer et al., 2010 [172]. 
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The best studied mechanism of uptake is receptor mediated endocytosis through clathrin 
coated pits/vesicles (CCPs/CCVs). CCPs are small, invaginated membrane structures 
intracellularly coated by a regular lattice formed by the clathrin protein complex [173]. 
First discovered in electron micrographs because of their distinct regular appearance 
seen as spikes emanating from membrane invaginations [174] and even more 
impressively visualised in freeze fracture electron micrographs done by John Heuser 
[175] (Fig. 1-11), there are now countless studies that have helped to elucidate the 
molecular mechanisms of CCP mediated endocytosis [176]. CCPs can be pre-existing 
on the plasma membrane or assemble upon receptor activation. Two important proteins 
in CCV formation are the adaptor protein AP-2 and the GTPase Rab5. AP-2 is 
important for cargo selection through specific recognition signals whereas Rab5 recruits 
necessary effectors for vesicle targeting and transport [177]. Interestingly, both proteins 
have been shown to be involved in autophagosome formation and AP-2 and/or clathrin 
seem to bind Atg16L [127]. Once endocytosed the clathrin coat is disassembled and the 
vesicle can fuse with early endosomes where further sorting takes place. 
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Figure 1-11 Internalisation of a CCP 
Clathrin lattices can be flat or bulging inward forming CCPs. CCPs eventually form round vesicles that 
pinch off the plasma membrane. The clathrin coat is then removed and the vesicle can fuse with an 
early/sorting endosome. Image taken form Heuser, 1980 [175]. 
 
Once the cargo has reached the early endosome, also called sorting endosome, it can 
follow various intracellular routes. The best studied proteins and most relevant to this 
thesis are the cation-independent mannose-6-phosphate receptor (CI-MPR), the 
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epidermal growth factor receptor (EGFR) and ligand (EGF), and the transferrin receptor 
(TfnR) with its ligand transferrin (Tfn). CI-MPR is responsible for the delivery of 
lysosomal enzymes from the Golgi/TGN and cycles rapidly between late endosomes 
and the TGN [178] (Fig. 1-12). Lysosomal enzymes are tagged with a mannose-6-
phosphate (M6P) in the Golgi that is recognised by CI-MPR to deliver them to the 
lysosome. mAtg9 co-localises with CI-MPR both on the TGN and late endosomes but 
the functional significance of this is not known [41].  
 
EGF on the other hand is taken up from the extracellular space via its receptor EGFR. 
Both EGF and EGFR are thought to stay associated with early endosomal membranes 
as they acidify and mature into late endosomes. Invagination of the endosomal 
membrane mediated by the endosomal sorting complex required for transport (ESCRT) 
machinery leads to multivesicular body (MVB) formation and eventually lysosomal 
degradation of EGF and EGFR [179, 180]. Interestingly, the ESCRT complexes have 
been shown to be essential for autophagosome maturation but it is unclear what their 
exact role in this process is [181, 182]. The two likely possibilities are that a block in 
MVB formation leads to impaired fusion of autophagosomes with endosomes or that the 
ESCRT complexes themselves are responsible for autophagosome closure or a 
combination of the two [19, 181]. There are four ESCRT complexes in mammalian 
cells ESCRT-0, ESCRT-I, ESCRT-II, and ESCRT-III, which are multi-protein 
complexes themselves. They are thought to coordinate membrane invagination, closure 
and pinching off of the internal vesicles [179]. Topologically this is very similar to the 
closure of an autophagosome and it is easy to imagine that the ESCRT complexes could 
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act on both vesicles. Rab7 is essential for early to late endosome maturation and also for 
autophagosome endosome fusion [183, 184]. 
 
Unlike EGFR, which stays associated with endosomal membranes as they mature to 
MVBs and lysosomes, Tfn and its receptor TfnR are actively sorted away from the early 
endosomes through the action of the BAR domain containing protein SNX4 and the 
GTPase Rab11. TfnR is sequestered into SNX4 coated tubules from where vesicles bud 
off and are transported in a dynein dependent manner to the pericentriolar endocytic 
recycling compartment (ERC). The ERC is a cluster of vesicles and tubules close to the 
Golgi apparatus involved in protein recycling to the plasma membrane [60]. Tfn 
remains bound to its receptor TfnR at all times but the iron bound by Tfn is released in 
the slightly acidic environment of the early endosome. From the ERC Tfn is recycled 
back to the plasma membrane where it can bind fresh iron. TfnR can also be sorted back 
to the plasma membrane from the early endosome directly in a Rab4 dependent manner. 
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Figure 1-12 Intracellular vesicular trafficking 
Depicted are the vesicular trafficking routes of CI-MPR, EGFR, and TfnR with their ligands M6P, EGF, 
and Tfn respectively. CI-MPR shuttles between the TGN and late endosomes/MVBs to deliver lysosomal 
proteins tagged with M6P. EGFR is internalised from the plasma membrane upon EGF binding. MVB 
formation leads to internalisation of EGFR in vesicles inside the endosome and ultimately to lysosomal 
degradation of the ligand and receptor. Tfn is internalised and delivered to the early endosome from 
where it is sorted in a Rab11 dependent manner to the ERC. From the ERC TfnR can be returned to the 
plasma membrane. TfnR can also be sorted back to the plasma membrane from the early endosome 
directly in a Rab4 dependent manner. 
 
1.2.2 Rab GTPases, RabGAPs, and GEFs 
 
1.2.2.1 Rab GTPases 
Rab GTPases are small monomeric GTP binding proteins related to Ras GTPase. There 
are about 60 Rabs encoded in the human genome and each one is thought to regulate a 
different membrane trafficking step (Fig. 1-13). Rab GTPases are synthesised as 
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cytosolic proteins but are quickly bound by Rab escort protein (REP), which presents 
them to the geranylgeranyl transferase [185]. The geranylgeranyl transferase attaches 
one or in most cases two hydrophobic geranylgeranyl groups to cysteines in the C-
terminus of Rabs. This allows reversible membrane anchoring of the Rab protein. Major 
conformational changes occur between the GDP and GTP bound forms of Rab proteins 
mainly in two regions termed switch I and switch II [186]. In their GDP bound form 
Rabs are cytosolic and can be regarded as inactive. GDP dissociation inhibitor (GDI) 
binds GDP bound Rab GTPases and chaperones them in the cytosol masking the 
hydrophobic lipid tail [187-189]. GDI also ensures that GDP remains bound [190] and 
shuttles Rabs to their cognate membrane and back to the cytosol. How the distinct 
membrane localisation of each Rab is achieved is poorly understood [191]. However, 
there is evidence that membrane-bound GDI displacement factors (GDFs) can target 
Rabs to the correct membrane by recognising specific Rab-GDI complexes and 
displacing the GDI, which will lead to membrane insertion of the Rab [192]. Conserved 
residues in the Rab GTPases are responsible for nucleotide binding. Mutation of the 
conserved glutamine to alanine (QA) leads to preferential binding of GTP rendering the 
Rab constitutively active. Mutation of the conserved asparagine to isoleucine (NI) leads 
to inability of the Rab to bind any nucleotide at all, whereas mutation of the conserved 
serine/threonine to asparagine (S/TN) leads to preferential GDP binding in each case 
leaving the Rab constitutively inactive. 
 
In their active GTP bound state Rabs are on their cognate membrane and recruit various 
effectors to mediate vesicular traffic including motor proteins such as dynein, SNARES 
(soluble N-ethylmaleimide-sensitive factor attachment protein receptor), which catalyse 
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membrane fusion, tethering proteins, and regulators such as PI kinases. In this manner, 
each Rab is thought to direct a specific trafficking step in the cell and localises to those 
membranes accordingly (Fig. 1-13). As depicted in Figure 1-13 many Rab proteins can 
form distinct subdomains on a single organelle. For example recycling endosomes 
contain both Rab11 and Rab4 positive subdomains whereas early endosomes contain 
Rab4 and Rab5 subdomains within the same continuous membrane [193]. This 
compartmentalisation is important for proper protein sorting since different cargo in the 
same organelle has to be transported to different destinations. 
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Figure 1-13 Overview of Rab GTPases in membrane traffic 
Illustrated are the major cellular trafficking routes and the Rab GTPases that regulate them. Figure taken 
from Stenmark, 2009 [194].  
 
1.2.2.2 RabGAPs 
Rab GTPases generally have very low intrinsic GTPase activity. Their activity is 
controlled by a family of proteins termed Rab GTPase activating proteins (RabGAPs), 
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which is a misleading name since they catalyse GTP hydrolysis in the Rab thereby 
inactivating it (Fig. 1-14). The crystal structure of a yeast RabGAP Gyp1p together with 
Rab33 revealed that RabGAPs contribute two catalytic residues an arginine and a 
glutamine in trans that mediate GTP hydrolysis [195]. These two residues also called 
arginine finger and glutamine thumb extend into the GTP binding pocket of the Rab and 
lead to GTP hydrolysis. These residues are highly conserved in all 38 putative human 
RabGAPs and it is thought that this mechanism applies to all GAPs. The GAP domain 
is also called Tre-2/Bub2/Cdc16 (TBC) domain, which was used to identify the 38 
putative human RabGAPs [196, 197]. The TBC domains consist mostly of alpha helical 
folds and seem to be structurally similar between different TBC proteins even though 
there is relatively little sequence homology between them with only the arginine and 
glutamine residues conserved. 
 
This is supported by the crystal structure of two human RabGAPs TBC1D22A and 
TBC1D14 [198]. The structures of the GAP domains were modelled on the Gyp1p 
(similar to TBC1D22) crystal structure. Interestingly, the two catalytic residues of 
TBC1D22A align closely with those of Gyp1p but the conserved arginine and 
glutamine of TBC1D14 do not. Binding of the target Rab, which is not known, to 
TBC1D14 may induce the conformational changes necessary for the residues to align in 
order to catalyse GTP hydrolysis. However, this is not supported by the Rab-bound and 
unbound structures of Gyp1p, which are very similar. Otherwise the alignment could be 
done differently so that the catalytic A and Q and immediately adjacent residues of 
TBC1D14 are aligned with the catalytic residues of Gyp1p while allowing significant 
distortions to the rest of the TBC domain. 
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It is thought that each RabGAP acts on a specific Rab family since there are about 40 of 
those and there is good evidence that supports this hypothesis [196, 197, 199-204]. 
 
1.2.2.3 GEFs and GEF/GAP-cascades 
The antagonists of RabGAPs are the guanine nucleotide exchange factors (GEFs), 
which facilitate the exchange of GDP for GTP. The high cytosolic GTP concentration 
(~1mM) ensures that as soon as the GDP in the Rabs is removed it is replaced by GTP 
leading to Rab activation and effector recruitment. GAPs and GEFs act in cascades and 
can also be recruited by a Rab that is not their target but is immediately upstream or 
downstream, respectively, of their target Rab to regulate Rab conversion of a 
compartment. A well studied Rab conversion is the transition from early to late 
endosomes from a Rab5 to a Rab7 positive compartment [205]. These conversions are 
regulated by GEF cascades and counter-current GAP cascades. For example, Rab5 
recruits the GEF for Rab7 during early to late endosome maturation [206]. Conversely 
GAP cascades exist such as the one described for the yeast GAP Gyp1p, which is 
recruited by Ypt32p (similar to Rab11) and acts on Ypt1p (similar to Rab1) to ensure 
conversion of the compartment from Ypt1p to Ypt32p positive vesicles [207]. 
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Figure 1-14 The Rab cycle 
Rab GTPases cycle between an active GTP bound and an inactive GDP bound state and act like 
molecular switches. In the on state they are membrane bound and can recruit various effector proteins to 
guide and facilitate vesicular trafficking. In the off state they are cytosolic and bound to GDP dissociation 
inhibitor (GDI). Two families of enzymes regulate the activation state of their corresponding Rab 
proteins: the Rab GTPase activating proteins (RabGAPs), which catalyse GTP hydrolysis rendering the 
Rab inactive and the guanine nucleotide exchange factors (GEFs), which facilitate exchange of GDP for 
GTP thereby activating the Rab. GDI displacement factors (GDFs) may facilitate targeting of Rabs to 
their cognate membrane compartment. 
 
Another striking feature of intracellular compartmentalisation is the localisation of 
different lipids and in particular phosphoinositides (PIs) to different membranes (Fig. 
15). This is an important feature contributing to membrane identity as proteins can bind 
specifically to certain PIs. This PI distribution is maintained by the PI kinases (PIKs) 
and PI phosphatases, whose activation is often regulated by Rab GTPases. For example, 
the class III PI3K on endosomes is an effector of Rab5 and Rab7 [208, 209]. However, 
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it is unclear whether a specific Rab protein recruits the autophagic class III PI3K 
complex to IMs. 
 
 
Figure 1-15 Distribution of major PI species 
Different intracellular compartments maintain different PI lipid species, which is important for the 
integrity of each organelle. Autophagosomes and/or omegasomes are enriched in PI(3)P but it is not clear 
how IM localised Atg proteins can distinguish between early endosomes (EE) and the phagophore (IM). 
LE/MVB=late endosome/multi-vesicular body; LY=lysosome; PM=plasma membrane. 
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1.2.3 Rab GTPases in autophagy 
 
Rab GTPases are important regulators of membrane traffic and it is reasonable to 
assume that one or more are involved in autophagosome formation, which involves 
major membrane shaping and/or trafficking events. Some Rab GTPases have already 
been shown to be involved in autophagy and will be introduced here (Fig. 1-16). 
 
Rab1 was recently shown to be involved in autophagy but its exact role remains unclear 
[125]. Rab1 is found on ER exit sites (ERES) and the cis and medial-Golgi cisternae 
where it is thought to regulate ER to Golgi traffic [161]. Over-expressed Rab1b co-
localises with LC3 positive autophagosomes and staining with lyso-tracker revealed that 
Rab1b associates with acidic compartments, which presumably are autolysosomes since 
there is no co-localisation with lyso-tracker in fed conditions. Furthermore, they could 
show that the small GTPase Sar1, which is also involved in ER to Golgi traffic is 
essential for autophagy. 
 
Rab32 is another ER localised GTPase that was shown to be essential for 
autophagosome formation [210]. Interestingly, Rab32 does not seem to be essential for 
starvation induced autophagy but specifically basal autophagosome formation. 
Inactivation of Rab32 by over-expressing the dominant negative mutants of Rab32 or 
by siRNA mediated knock down led to protein aggregate formation and a block in 
autophagosome formation. This finding may be particularly important in 
neurodegenerative pathologies where a block in basal autophagy seems to contribute to 
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disease. Rab32 is also involved in melanosome formation and transport, which is 
specific to melanocytes [211, 212]. 
 
Rab24 is an atypical Rab GTPase, which is inefficiently geranylgeranylated and 
therefore mostly cytosolic but also localises to the ER, ERGIC and Golgi compartment 
[213]. Rab24 redistributes to autophagic vacuoles upon starvation but seems to be 
associated mainly with degradative autophagosomes suggesting it is involved in 
maturation and not formation [214]. 
 
Rab7 is another GTPase that is involved in autophagosome maturation most likely by 
mediating fusion of autophagosomes with late endosomes and lysosomes [183, 184]. 
The SNARE protein Vti1b seems to catalyse this fusion process since mice deficient in 
it accumulate autophagosomes [215]. Note that fusion of autophagosomes with early 
endosomes is also essential since loss of COPI function which causes disruption of 
early endosomes also led to autophagosome maturation defects [164]. Likewise, Rab11, 
which usually regulates RE traffic was found to be on MVBs in K562 cells and may 
mediate fusion of MVBs with autophagosomes in those cells [216]. 
 
The only Rabs that have been shown to act at early stages of autophagosome formation 
are Rab5 and Rab33. Previous extensive research has shown that Rab5 is found on early 
endosomes and the plasma membrane regulating traffic between those compartments. 
With regard to autophagosome formation it was found to regulate Atg5-12 conjugation 
and to act in a macromolecular complex with Beclin1 and Vps34 [217]. Interestingly, 
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this autophagic function of Rab5 is independent of its role in endocytosis since blocking 
endocytosis leads to inhibition of autophagosome maturation whereas Rab5 inactivation 
hampers autophagosome formation and leads to impaired clearance of mutant 
huntingtin. In a more recent paper, the same group found that blocking clathrin-
mediated endocytosis leads to impaired IM formation [127] but the exact relation 
between Rab5, clathrin-mediated endocytosis and autophagosomes remains to be 
elucidated.  
 
Rab33b on the other hand is a Golgi located protein involved in retrograde traffic to the 
ER, intra-Golgi traffic, and Golgi homeostasis [218]. Isoform Rab33a is expressed in 
the brain, lymphocytes, and normal melanocytes whereas Rab33b is ubiquitous [219-
221]. Both isoforms of Rab33 were shown to bind Atg16L in a GTP dependent manner 
and when over-expressed are able to recruit the Atg16L complex to the Golgi [222]. 
Expression of a constitutively active Rab33 induces LC3 lipidation even under fed 
conditions but leads to an overall block in autophagy presumably because phagophore 
expansion cannot progress. Their data suggests that Rab33 is responsible for Atg16L 
complex trafficking but additional factors are needed to complete autophagosome 
formation.  
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Figure 1-16 Rab GTPases involved in autophagy 
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Depicted are the Rab GTPases that have been shown to be involved in autophagy and their subcellular 
localisation. Rab33 and Rab5 act at early stages of autophagosome formation whereas Rab1, Rab24, 
Rab11, and Rab7 are involved in autophagosome maturation. Interestingly, Rab32 seems to be involved 
in basal but not starvation induced autophagy. 
 
1.3 Autophagy and the immune system 
 
The vertebrate immune system can mount both an innate and adaptive immune 
response. The innate response is the first line of defence against pathogens and acts 
early recognising conserved patterns of invading organisms. The adaptive immune 
response happens later but is much more specific and dependent on the innate 
responses. The adaptive immune response becomes more and more accurate over the 
course of an infection and is able to retain memory cells that can be activated much 
more quickly in case of re-infection with the same pathogen. The adaptive immune 
response depends on B and T lymphocytes, which recognise specific antigens via their 
B and T cell receptor (TCR), respectively. Whereas B cell receptors can recognise 
soluble antigens TCRs only recognise antigens presented on MHC complexes on the 
plasma membrane of antigen-presenting cells (APCs) [223]. The TCR itself cannot 
transmit intracellular signal and relies on the TCR associated transmembrane protein 
CD3, which activates the TCR responses (Fig. 1-17). In addition to that TCR/CD3 
stimulation is not enough to trigger T cell activation but a co-stimulatory receptor CD28 
has to be bound by its ligand, which can also be provided by APCs. Intracellular 
pathways include PKC activation and Ca
2+
 signalling leading to proliferation, survival, 
and activation of gene transcription in T cells. Another co-stimulatory signal is provided 
by CD4, which recognises MHC class II molecules, or CD8, which recognises MHC 
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class I molecules. Immature T cells in the thymus initially express both CD4 and CD8 
but if their TCR recognises a peptide presented by MHC class II complexes CD8 
expression is down-regulated and vice versa. After activation, CD4 positive T cells will 
act as helper T cells, whereas CD8 positive T cells will act as cytotoxic or killer T cells. 
 
 
Figure 1-17 The TCR recognises antigenic peptides bound to MHC molecules 
A specific peptide bound to an MHC complex is recognised by the TCR leading to downstream signalling 
via CD3. CD8 or CD4 provide co-stimulatory signals for MHC class I or MHC class II complexes, 
respectively. CD28 also provides co-stimulatory signals when bound by its ligand B7. This leads to 
activation of transcription, T cell survival, and proliferation. 
 
Autophagy genes have been shown to be involved in both branches of the immune 
system although it is not always clear whether classical autophagy as described above is 
involved in fighting disease or whether autophagy proteins can have other independent 
functions in the immune system [224]. Figure 1-18 gives an overview of the functions 
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of autophagy or autophagy genes involved in the immune system, which will be 
introduced in more detail below. 
 
 
Figure 1-18 Autophagy in the immune system 
Overview of the major functions of autophagy in the immune system. Clockwise from left: Autophagy 
can deliver endogenously expressed antigens to MHC class II complexes in endosomes. Autophagosomes 
can capture cytosolic antigens and deliver them to endosomes for Toll-like receptor (TLR) activation. 
Mitophagy can reduce production or reactive oxygen species (ROS) to prevent excess production of type 
I interferons (IFNs) in fibroblasts and macrophages. Autophagy can engulf invading pathogens and 
deliver them to the lysosome for degradation. Autophagy is important for lymphocyte development and 
homeostasis. Figure taken from Virgin and Levine, 2009 [224]. 
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1.3.1 Innate immunity 
 
Innate immunity is the first line of defence against infectious agents. Pattern recognition 
receptors (PRRs) such as the Toll-like receptors (TLRs) detect microbial components 
and can activate immune responses. However, these have to be closely controlled since 
excessive activation of the innate immune system can lead to massive inflammation and 
autoimmune disease [225]. 
 
The most straightforward autophagy related innate immune response is direct 
engulfment of invading pathogens by autophagosomes leading to lysosomal 
degradation. Autophagic clearance has been shown for many different infectious agents 
such as Listeria monocytogenes [226], group A Streptococcus [227, 228], and Coxiella 
burnetii [229, 230]. However, other functions of autophagy in the innate immune 
system are more complex and Atg genes may exert immuno-modulatory functions not 
related to classical autophagosome formation. For example, during Toxoplasma gondii 
infection Atg5 is critical for the recruitment of immunity related GTPases but does not 
lead to engulfment of the pathogen by an autophagosome [231, 232]. Furthermore, 
autophagy proteins may be recruited to enhance phagolysosomal maturation, for 
example LC3 and Beclin1 can be recruited to phagosomes without the involvement of 
classical autophagosome formation [233, 234]. Some pathogens have evolved 
mechanisms to avoid autophagic elimination for example Shigella flexneri expresses a 
protein that inhibits Atg5 function [235]. Others have even found ways to exploit 
autophagy as is the case with some RNA viruses such as hepatitis C virus (HCV), which 
depends on at least parts of the autophagic machinery to replicate [236, 237].  
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Another important aspect of autophagy in innate immunity is the delivery of microbial 
components to TLRs. Because some TLRs reside in endosomes cytoplasmic infectious 
agents have to be delivered to them via autophagy. One example is the engulfment of 
cytosolic viral nucleic acid by autophagosomes in plasmacytoid dendritic cells (pDCs), 
which leads to induction of anti-viral type I interferon (IFN) via TLRs signalling [238]. 
Interestingly, in some cases TLR activation in turn leads to induction of autophagy 
[239, 240].  However, it is not clear whether this is a mechanism to increase autophagic 
degradation of pathogens, to enhance delivery of microbial components to TLRs and 
other innate immune receptors, or to enhance autophagic delivery of peptides to MHC 
class II complexes to aid activation of the adaptive immune response. 
 
In pDCs, induction of autophagy leads to the delivery of viral nucleic acid to 
endosomes and subsequent TLR signalling induces activation of type I IFN. Somewhat 
paradoxically, in macrophages and fibroblasts autophagy seems to prevent the 
activation of type I IFN and other inflammatory cytokines [241]. It seems that in these 
cells mitophagy prevents the production of reactive oxygen species (ROS) by damaged 
mitochondria. This, in turn leads to reduced activation of another cytosolic PRR called 
RIG-I-like leading to down-regulation of type I IFN and inflammatory cytokines [242, 
243]. This may be of importance in the pathobiology of Crohn’s disease, which is an 
inflammatory bowel disorder that can be experimentally induced in mice with 
hypomorphic Atg16L1 expression [153]. Enhanced secretion of type I IFN and 
cytokines in these mice may lead to or exacerbate inflammation, which is a hallmark of 
the disease. A polymorphism in the Atg16L1 gene (Atg16L1T300A) was found 
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associated with Crohn’s disease in humans but further studies are necessary to elucidate 
whether similar changes relating to Atg16L activity occur in patients carrying the 
T300A polymorphism [151]. However, it has been shown that canonical autophagy is 
not affected in fibroblasts expressing mutant Atg16L1T300A [152]. 
 
1.3.2 Adaptive immunity 
 
In the adaptive immune system autophagy was shown to play an important role in T cell 
selection in the thymus [244]. T cells mature in the thymus where they undergo positive 
and negative selection. The latter ensures that no autoreactive T cells escape into the 
periphery and the former ensures that T cells do not mature if their TCR does not 
recognise any peptides presented by the MHC complexes. This selection is supervised 
by APCs such as thymic epithelial cells (TECs) present in the thymus, which constantly 
display MHC loaded antigens to immature T cells. If a T cell strongly recognises an 
auto-antigen they are induced to undergo apoptosis to prevent autoimmune reactions. 
Growing evidence suggests that endogenous antigen presentation by MHC class II 
molecules depends on autophagy [245]. The MHC class II complex is loaded with 
antigenic peptides in an endosomal compartment and it seems that TECs use autophagy 
to deliver endogenous antigens there. Indeed, when embryonic thymi from Atg5 knock-
out or wild type mice were transplanted into athymic nude mice these started to show 
signs of autoimmune disease in several organs including the gut [244]. This was shown 
to be due to the inability of Atg5-/- TECs to undergo autophagy, which leads to reduced 
or absent presentation of auto-antigens and maturation of autoreactive T cells. These T 
cells can then escape to the peripheral blood stream and are activated upon auto-antigen 
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encounter in the spleen. In a healthy immuno-competent mouse there are other 
mechanisms to prevent autoimmune disease such as regulatory T cells, which can cause 
apoptosis or anergy in self-reactive T cells but nude mice lack these responses. Impaired 
positive selection of T cells might explain susceptibility to Crohn’s disease in patients 
with an Atg16L1 polymorphism [224] but it remains to be shown whether this 
polymorphism causes any specific autophagy defects as it does not affect canonical 
autophagy [152]. While the physiological role of autophagy during T cell selection is 
clear it remains to be elucidated whether this is a major pathway for it MHC class II 
antigen loading in vivo and the role of autophagy in MHC class I antigen presentation 
remains speculative [246, 247].  
 
Another important function of autophagy is in lymphocyte homeostasis and activation. 
Upon antigen encounter lymphocytes undergo clonal expansion and massive 
rearrangement of the cytoplasm and organelles in order to become effector B and T 
cells. Furthermore, T and B cells regularly encounter lowered growth factor and nutrient 
environment in the blood stream upon leaving the lymphoid organs (spleen, thymus, 
bone marrow, and lymph nodes). Indeed loss of Atg5 or Atg7 has been shown to impair 
survival and proliferation of mature T cells and Atg5 is necessary for B cell 
development and survival [248]. One explanation for this may be impaired clearance of 
damaged mitochondria and accumulation of ROS [249, 250]. However, the question 
remains as to why this would affect lymphocyte survival and proliferation so 
specifically and whether these effects are truly through autophagy or through separate 
functions of the Atg5 and Atg7 proteins.  
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1.4 Aim of study /objective 
 
The core components of the autophagic machinery have been well defined, which has 
opened up countless possibilities to manipulate the autophagy system as a whole in 
order to study its role in various biological processes. However, key questions regarding 
the origin of the autophagosomal membrane and the mechanism of phagophore 
extension remain. Answers to these questions will doubtlessly allow us to not only 
manipulate the autophagic system more precisely but also offer more possibilities to 
target autophagy therapeutically. Autophagosome formation is a complex, multi-step 
process, involving the re-arrangement of large amounts of membrane and/or lipids in a 
short period of time but in a closely controlled fashion. Since Rab GTPases are major 
regulators of membrane traffic I aimed to identify novel Rab GTPases and their 
corresponding RabGAPs involved in autophagosome formation. 
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Chapter 2. Materials and Methods 
 
2.1 Molecular biology 
 
All chemicals and oligonucleotides were purchased from Sigma unless otherwise 
indicated. Cell culture dishes were from Corning. dH2O, PBS, Loria Broth (LB), SOC 
medium, sterile glycerol, and EBSS (123.2mM NaCl, 5.366mM KCl, 2.388mM 
CaCl2,1.662mM MgSO4, 5.551mM D-glucose, 13.094mM NaHCO3) were provided by 
LRI services. 
 
2.1.1 PCR 
 
Polymerase chain reactions (PCRs) were performed using for each reaction (1X): 
0.4l Accuprime Pfx DNA polymerase (Invitrogen) 
5l Accuprime buffer (10X; Invitrogen) 
1.5l forward primer [10M] 
1.5l reverse primer [10M] 
50ng template DNA 
ad 50l dH2O 
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Cycling parameters were done in a thermal cycler and are outlined in Table 2-1. PCR 
reactions were purified using a QIAquick PCR purification kit (QIAGEN). 
Table 2-1 PCR parameters 
Segment Cycles Temperature (ºC) Time (min) 
1 1 94 3 
94 0.5 
55 0.5 
2 30 
68 1/kb of plasmid 
length 
 
2.1.2 Sequencing 
 
Plasmids were sequence verified using the following sequencing reaction (1X): 
8l big dye terminator (BDT, LRI) 
0.32l primer [10M] 
500ng DNA 
ad 20l dH2O 
 
The cycling parameters used for the sequencing reaction are outlined in Table 2-2. 
Sequencing reactions were purified using a DyeEx 2.0 spin kit (QIAGEN) according to 
the manufacturer’s instructions, followed by drying in a vacuum centrifuge for 20min at 
45ºC. Samples were loaded onto the ABI Prism 377 DNA sequencer (Applied 
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biosystems) by LRI sequencing services. Sequencing analysis and alignments were 
carried out using Lasergene (DNASTAR) software. 
 
Table 2-2 Sequencing PCR parameters 
Segment Cycles Temperature (ºC) Time (min) 
1 1 96 2 
96 0.5 2 24 
60 4 
 
2.1.3 Restriction enzyme digest 
 
DNA plasmids and PCR products were digested using the following reaction (1X) for 
1h at 37ºC: 
10l/2g PCR product/vector, respectively 
4l BSA in dH2O 
4l restriction enzyme buffer (10X, NEB) 
1l restriction enzyme 1 (NEB) 
1l restriction enzyme 2 (NEB) 
ad 40l dH2O 
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2.1.4 Ligation  
 
DNA constructs were fused using the following ligation reaction (1X) for 5h but 
usually over night at 16ºC: 
1/2l vector 
9/8l PCR product 
2l T4 DNA ligase buffer (10X, NEB) 
1l T4 DNA ligase (NEB) 
ad 20l dH2O 
 
2.1.5 Bacterial transformation 
 
For bacterial transformations to amplify plasmid constructs, 50l of chemically 
competent DH5 bacteria stored at -80ºC were thawed for 20min on ice. Then, 5l of 
the ligation reaction or 0.1l of plasmid were added to the bacteria, which were put first 
for 10min back on ice, then for 40sec at 37ºC followed by 30sec on ice and finally 
addition of 1ml SOC growth medium (0.5% yeast extract, 2% tryptone, 10mM NaCl, 
2.5mM KCl, 10mM MgCl2, 10mM MgSO4, 20mM glucose; LRI). Bacteria in SOC 
medium were allowed to reconstitute for 1h at 37ºC on a shaker before they were plated 
on LB-agar plates (0.5% yeast extract, 2% tryptone, 1.5% agar; LRI) containing the 
appropriate antibiotic (50g/ml) followed by over night incubation at 37ºC. 
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If ligation reactions were transformed, cells were spun down at 5000rpm for 2min after 
reconstitution and 750l of supernatant medium was removed to concentrate bacteria 
before plating on agar. 
Transformed bacteria were stored at -80ºC in 15% glycerol for re-plating. 
 
2.1.6 DNA agarose gel electrophoresis 
 
Typically 0.8% agarose (Invitrogen) was dissolved in 1X TAE buffer (40mM Tris, 
20mM acetic acid, 1mM EDTA) by heating for 7-9min at ~700W in a microwave 
(Panasonic) with occasional swirling and one drop of ethidiumbromide (0.625mg/ml; 
Amresco) was added per 100ml of TAE/agarose. Liquid agarose was added to the gel 
holder and left to cool down until solid. DNA was resuspended in 5X sample buffer 
(Bioline) and run at a constant 100V in 1X TAE buffer together with a DNA ladder 
(Hyperladder I, Bioline). DNA was visualised by placing the gel on a UV irradiator. If 
applicable, the DNA band was cut out with a sterile scalpel and purified using a 
QIAquick gel extraction kit (QIAGEN), according to the manufacturer’s instructions. 
DNA bound to the QIAquick column was eluted with sterile deionised water (dH2O). 
 
2.1.7 Preparation of plasmid DNA 
 
For initial testing and verification of constructs DNA minipreps were done by the LRI 
equipment park miniprep service. To obtain larger amounts and transfection quality 
plasmids DNA was purified using an Endo-free Plasmid DNA maxi kit (QIAGEN) 
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following the manufacturer’s instructions. DH5 bacteria containing the plasmid of 
interest were grown in 2.5ml (miniprep) or 200ml (maxiprep) LB medium (0.5% yeast 
extract, 2% tryptone, 10mM NaCl; LRI) containing the appropriate selective antibiotic 
(50g/ml). From maxipreps DNA was eluted with endotoxin free dH2O (QIAGEN) and 
the concentration was measured using a NanoDrop spectrophotometer (Thermo 
scientific). DNA stocks were stored as 1mg/ml aliquots at -20ºC. 
 
2.1.8 Constructs 
 
Expression plasmids for myc-ULK1C, myc-ULK1VYA, and myc-ULK1K46I were 
cloned by E. Chan (Strathclyde University and LRI) and have been described [21]. 
All 3x-myc-tagged RabGAP constructs were kindly provided by F. Barr (University of 
Liverpool, UK) and have been described previously [197, 199, 251]. 
GFP-tagged constructs, including GFP-TBC1D14 and its truncation mutants, as well as 
all GFP-tagged Rab constructs and their mutants, were also provided by F. Barr and 
were made in pEGFP-C2 vector (CLONTECH Laboratories, Inc.). 
Point mutations were introduced using the QuikChange method (Stratagene) as 
described [197, 199, 251]. 
HA-Sytnenin1 was kindly provided by J. Henley (University of Bristol) and has been 
described [252]. 
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2.1.8.1 HA-ULK1 
HA-tagged ULK1 was generated amplifying human ULK1 wild type protein by PCR 
from a full length IMAGE clone (IMAGE40080552) containing human ULK1 as 
template using the following primers:  
5’- 
GGCCAAGCTTGCCACCATGGAGTACCCATACGACGTACCAGATTACGCTG
GCGCCATGGAGCCCGGCCGCGGCGGC-3’ 
and 
5’-GGCCGAATTCTCAGGCACAGATGCCAGTCAGC-3’ 
 
The forward primer contains the sequence for the HA-tag (underlined), which was 
added to the N-terminus of ULK1. The PCR product was fused into pcDNA3.1+ vector 
(Invitrogen) using HindIII and EcoRI restriction enzymes (New England Biolabs, NEB) 
and T4 DNA ligase (NEB). 
 
2.1.8.2 ULK1 in pFBT9 
For yeast-2-hybrid assays human ULK1 was cloned into pFBT9 vector, which is a 
modified version of pGBT9 (CLONTECH Laboratories, Inc.) carrying kanamycin 
resistance. myc-ULK1 was used as the PCR template with the following primers: 
 
5’-GCAAGAATTCATGGAGCCGGGCCGCGGCGGCGTC-3’ 
and 
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5’-GCTT GTC GAC TCA GGC ATA GAC ACC ACT CAG-3’ 
 
The PCR product was fused into pFBT9 vector using EcoRI and SalI restriction 
enzymes and T4 DNA ligase (both NEB). 
 
2.1.8.3 HA-ULK2 
HA-tagged ULK2 was generated amplifying human ULK2 wild type protein by PCR 
from a full length IMAGE clone (IMAGE5268025) containing human ULK2 as 
template using the following primers:  
 
5’-GGCCAAGCTTGCCACCATGGAGTACCCATACGACGTACCAGATTAC 
GCTGGCGCCATGGAGGTGGTGGGTGACTTCG-3’ 
and 
5’-GGCCTCTAGATCACACGGTTGCGGTGCTATGG-3’ 
 
The forward primer contains the sequence for the HA-tag (underlined), which was 
added to the N-terminus of ULK2. The PCR product was fused into pcDNA3.1+ vector 
(Invitrogen) using HindIII and XbaI restriction enzymes and T4 DNA ligase (both 
NEB). 
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2.1.8.4 FLAG-Syntenin1 
FLAG-tagged Syntenin1 was generated amplifying human Syntenin1 wild type protein 
by PCR from a full length IMAGE clone (IMAGE6979797) containing human 
Syntenin1 as template using the following primers:  
 
5’-GGCCGCGGCCGCATGTCTCTCTATCCATCTCTC-3’ 
and 
5’-GGCCGGATCCTTAAACCTCAGGAATGGTGTG-3’ 
 
The PCR product was fused into pFLAG-CMV-6c vector (Sigma) using NotI and 
BamHI restriction enzymes and T4 DNA ligase (both NEB). 
 
2.1.8.5 Syntenin1 in pACT2 
For yeast-2-hybrid assays Syntenin1 was cloned into pACT2 (CLONTECH 
Laboratories, Inc.) using HA-Syntenin1 as a PCR template with the following primers: 
 
5’-GCAAGGATCCTGATGTCTCTCTATCCATCTCTC-3’ 
and 
5’-GCTTCTCGAGTTAAACCTCAGGAATGGTGTG-3’ 
 
The PCR product was fused into pACT2 (CLONTECH Laboratories, Inc.) using 
BamHI and XhoI restriction enzymes and T4 DNA ligase (both NEB). 
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2.1.8.6 GST-TBC1D14 
For expression in insect cells using the baculovirus system GST-TBC1D14 was cloned 
into pBacPAKGST (LRI) using myc-TBC1D14 as a PCR template with the following 
primers 
 
5’-ACAAGCTTTATGACTGATGGAAAACTCTCC-3’ 
and 
5’-GCGATTGAATTCTCATCAGTGTCGGAGGGACGGACTTCC-3’ 
 
The PCR product was fused into pBacPAKGST using HindIII and EcoRI restriction 
enzymes and T4 DNA ligase (both NEB). pBacPAKGST encodes GST followed by a 
3C protease cleavage site, which is added N-terminally of TBC1D14. 
 
2.1.8.7 Myc-TBC1D14RA/QA mutagenesis 
Mutant myc-TBC1D14QA and myc-TBC1D14RAQA constructs were generated with a 
QuikChange multi site-directed mutagenesis kit (Stratagene) using either the wild type 
or RA-mutant vector DNA as template with the following primer:  
 
5’-CCAGATGTGGGTTATGTCGCGGGCATGTCCTTCATAGCAGC-3’ 
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All steps were carried out according to the manufacturer’s instructions. Briefly, the 
primer was designed mutating the first two base pairs of the glutamine (CAG) codon to 
an alanine (GCG; underlined). Cycling parameters are outlined in Table 2-3. The 
cycling reaction creates a single stranded DNA plasmid. The double stranded parent 
(methylated) DNA plasmid was digested by the addition of 10U DpnI and incubation at 
37ºC for 1h. The single stranded unmethylated DNA strand was then transformed into 
XL10-Gold Ultracompetent bacteria (Stratagene). 
 
Table 2-3 PCR parameters for site-directed mutagenesis 
Segment Cycles Temperature (ºC) Time (min) 
1 1 95 1 
95 1 
55 1 
2 30 
65 16 (2min/kb) 
 
2.2 Cell biology and biochemistry 
 
2.2.1 Cell culture and maintenance 
 
Human embryonic kidney 293A (HEK293A) cells were provided by LRI services. 
Their derivative cell line stably expressing EGFP-rat-LC3 (2GL9) were created by E. 
Chan and have been described [20]. HEK293A cells stably expressing GPF-DFCP1 
(201 cells) were kindly given by N. Ktistakis and have been described [69]. Cells were 
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cultured in DMEM (Gibco and LRI) supplemented with 10% FBS (Sigma), 4.8mM L-
Glutamine (LRI), and 1% penicillin/streptomycin (pen/strep; LRI) under humidified 
conditions at 37ºC in 10% CO2. 201 cells were grown under selection in the presence of 
geneticin (400g/ml; Gibco). Where cells are indicated as fed they were grown in this 
medium. Starvation medium consisted of Earle’s balanced saline solution (EBSS; LRI) 
containing 0.25 mg/ml (0.5mM) leupeptin (Roche) where indicated. All cells were used 
for experiments between passage 1 and 30 and split for maintenance when 80-100% 
confluent (every 3-4 days) to plate at 1:15 in 20ml medium in 75cm
2
 flasks. To passage 
cells they were washed once with versene (0.02% EDTA (w/v), 1% phenol red in PBS), 
washed once with 0.05% trypsin in versene and incubated in the remaining trypsin for 
5min until they detached. Cells were resuspended in 10ml growth medium initially and 
further diluted to plate according to the experiment (see below). 
 
Cells were stored frozen in liquid nitrogen. To freeze down, 80% confluent cells from a 
10cm dish were trypsinised and centrifuged for 5min at 1000rpm. Cell pellets were 
resuspended in 1ml ice cold DMEM with 20% FBS and 5% DMSO. Aliquots were 
frozen at -80ºC in a styrofoam rack for one week and then transferred to liquid N2. To 
thaw cells aliquots were warmed to 37ºC rapidly (water bath) and diluted into fresh 
warm growth medium in a 10cm dish. To ensure even distribution of cells plates were 
mixes performing figures of 8. 
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For autophagy assays cells were starved by washing once with EBSS (LRI) followed by 
incubation in EBSS±leupeptin (0.5mM) for 2h. Cells indicated as fed were left in 
normal growth medium (not replaced) unless otherwise indicated. 
 
2.2.2 Transfections 
 
For biochemical analyses, cells were transfected using Lipofectamine2000 (Invitrogen), 
for immunofluorescence imaging cells were transfected using FuGene6 (Roche), for 
siRNA transfection Oligofectamine (Invitrogen) was used, all according to the 
manufacturers instructions. 
 
2.2.2.1 Lipofectamine2000 
All values described here are for 12-well plate format but were adjusted accordingly for 
6cm, and 10cm dishes, or 24, and 6-well plates.  
Plates were coated for 15min with poly-D-lysine (1mg/ml; Sigma), washed once with 
3ml PBS and 80’000 cells in 1ml medium without pen/strep were added to each well. 
To ensure even distribution of cells plates were mixes performing figures of 8. Cells 
were left to settle over night and the next day the medium was replaced by 500l 
transfection mix. 1ml transfection mix was prepared as follows: 160l optiMEM 
(Gibco) were mixed with 3.2l Lipofectamine2000 reagent by gentle tapping and left at 
room temperature (RT) for 5min. During those 5min 0.5g DNA construct (0.8g myc-
TBC construct for the GAP screen) was added to 200l optiMEM. The 
Lipofectamine2000 solution was then added to the DNA solution and mixed by gentle 
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tapping 8 times. This transfection mix was incubated for 20min (but no longer than an 
hour) at RT. After this 640l of optiMEM were added to obtain 1ml transfection mix. 
Transfection mix was left on cells for 3h (exactly) and then replaced by full medium. 
Cells were harvested for biochemical analyses the next day. 
Note that cells have to be 80% confluent when transfection mix is added otherwise 
Lipofectamine2000 is toxic. 
 
2.2.2.2 FuGene6 
For immunofluorescence experiments round coverslips were placed in 12-well plates 
and coated with poly-D-lysine for 15min. 80’000 cells in pen/strep-free growth 
medium were added to each well, mixed performing figures of 8, and left over night to 
settle. Next morning for each well the following transfection mix was prepared: 50ml 
optiMEM, with 1.5l FuGene6 reagent, and 0.5g DNA construct. This was mixed by 
gentle tapping 8 times and incubated at RT for 20min. During this incubation the 
growth medium on the cells was replaced by 450l optiMEM. The transfection mix was 
added to cells in optiMEM by drop-wise slow pipetting and left for >5h before it was 
replaced by pen/strep-free growth medium. 
 
2.2.2.3 Oligofectamine 
For siRNA mediated knock down 40’000 cells in pen/strep-free medium were plated 
per well of a 6-well plate. Note that plates should not be coated with poly-D-lysine as 
this reduces transfection efficiency. Transfection mix was prepared as follows: 40l of 
optiMEM was mixed with 3l Oligofectamine by gentle tapping 8 times and incubated 
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at RT for 5min. Meanwhile, 25nM (for Rab11) or 50nM (for TBC1D14, and ULK1) 
siRNA duplexes were added to 140l optiMEM. DNA and Oligofectamine mixes were 
joined, mixed by gentle tapping 8 times and incubated at RT for 20min. The medium of 
cells was replaced by 815l optiMEM and then the transfection mix was added drop-
wise. After 5h 1ml of growth medium containing 20% FBS was added carefully to the 
cells. The next day this procedure was repeated exactly the same way. On the 3
rd
 day 
the transfection medium was replaced by fresh growth medium and cells were harvested 
on day 4 after 72h of knock down. 
 
2.2.3 RNA interference 
 
All siRNAs were purchased from Dharmacon and cells were transfected using 
Oligofectamine as described above.  
 
TBC1D14 silencing was performed using a siRNA duplex (J-014032-1230010) 
targeting the following sequence: 5’-UCACAGAAAUGAACCGUUU-3’.  
ULK1 was silenced with a siRNA duplex (D-005049-04-0010) targeting the following 
sequence: 5’-UGUAGGUGUUUAAGAAUUG-3’.  
Rab11a was targeted with a siRNA duplex (D-004726-01) with the following sequence: 
5’-GUAGGUGCCUUAUUGGUUU-3’.  
Rab11b was targeted with a siRNA duplex (D-004727-03-0005) with the following 
sequence: 5’-GACAGAAGCCCAACAAGCU-3’. 
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2.2.4 Antibodies  
 
Anti-TBC1D14 antibody was generated by LRI polyclonal antisera services injecting 
rabbits with a C-terminal peptide consisting of the amino acids 671-691 of TBC1D14 
with the sequence: CLTALQKDSREMEKGSPSLR 
Rabbit sera were tested by western blot for specificity. Serum from rabbit STO291 was 
affinity purified using a SulfoLink kit (Pierce) with the original peptide used for 
STO291. All other antibodies used are listed in Table 2-4. Secondary antibodies are 
listed in Table 2-5. 
 
Table 2-4 Primary antibodies 
Antibody Antigen Species Application, dilution and 
blocking solution 
Supplier 
anti-mAtg9 mAtg9 Hamster IF 1:1000 (PFA) LRI [253] 
STO219 mAtg9 Rabbit WB 1:500 (milk), IF 
1:1000 (PFA), IP 
LRI 
9E10 myc Mouse WB 1:500 (LI-COR), IF 
1:500 (PFA), IP 
LRI 
anti-LC3 LC3 Rabbit 1:2000 Abcam (UK) 
5F10 LC3 Mouse WB 1:250 (LI-COR), IF 
1:100 (MeOH) 
NanoTools 
(Germany) 
Anti--actin actin Rabbit WB 1:1000 (LI-COR) Abcam (UK) 
AC40 actin Mouse WB 1:1000 (LI-COR) Sigma (USA) 
12CA5 haemagglutinin Mouse WB 1:500 (LI-COR), IP LRI 
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anti-HA HA-tag Rat IF 1:1000 (PFA) Roche (UK) 
anti-HA HA-tag Mouse WB 1:500 (LI-COR), IP Covance (UK) 
4E12/8 GFP Mouse IP LRI (T. Hunt) 
SGE5/6 GFP Rabbit WB 1:500 (LI-COR) LRI 
STO291 TBC1D14 Rabbit WB 1:250 (Milk), IF 1:250 
(PFA) 
LRI 
STO289 TBC1D14 Rabbit WB 1:100 (Milk) LRI 
STO255 mouse ULK1 Rabbit WB 1:250 (milk), IP LRI 
anti-ULK1 human ULK1 Rabbit WB 1:250 (milk), IF 1:250 
(PFA) 
Santa Cruz (USA) 
anti-ULK2 ULK2 Goat WB 1:250 (milk) Santa Cruz (USA) 
STO280 WIPI2 Rabbit IF 1:500 (PFA) LRI [57] 
anti-WIPI2 WIPI2 Mouse IF 1:50 (PFA) LRI [57] 
anti-GM130 GM130 Mouse IF 1:500 (PFA) BD Transduction 
Labs (USA) 
anti-TGN46 TGN46 Sheep IF 1:500 (PFA) AbD Serotec (UK) 
anti-Rab11 Rab11 Mouse IF 1:500 (PFA) BD Transduction 
Labs (USA) 
anti-Rab11a (121-
1) 
Rab11a Rabbit IF 1:500 (PFA) with 
saponin 
M. Zerial 
anti-Rab11b Rab11b Rabbit IF 1:500 (PFA) with 
saponin 
Cell Signalling 
(USA) 
13E4 TfnR Mouse IF 1:500 (PFA) Abcam (UK) 
STO52 CI-MPR Rabbit IF 1:500 (PFA) LRI [254] 
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anti-EEA1 EEA1 Mouse IF 1:500 (PFA) BD Transduction 
Labs (USA) 
anti-LAMP2 LAMP2 Mouse IF 1:500 (PFA) BD PharMingen 
(USA) 
anti-calreticulin calreticulin Rabbit IF 1:500 (PFA) Stressgen (UK) 
108 EGFR Mouse  C. Futter 
anti-Rab7 Rab7 Rabbit IF 1:500 (PFA) Cell Signalling 
(USA) 
M2 FLAG-tag Mouse WB 1:2000 (LI-COR), IF 
1:4000 (PFA), IP 
Sigma (USA) 
anti-p62 p62 Guinea pig IF 1:500 (PFA) Progen (UK) 
anti-p62/lck-
ligand 
p62 Mouse WB 1:500 (LI-COR)IF 
1:500 (PFA) 
BD Transduction 
Labs (USA) 
anti-CD4 (RM4-5) CD4 Rat FACS 1:100 
Fluorescently labelled 
BD PharMingen 
(USA) 
anti-CD8 (53-6.7) CD8 Rat FACS 1:100 
Fluorescently labelled 
BD PharMingen 
(USA) 
anti-CD19 CD19 Rat FACS 1:100 
Fluorescently labelled 
BD PharMingen 
(USA) 
anti-CD3 (145-
2C11) 
CD3 Hamster T cell activation, plate 
bound in PBS 
BD PharMingen 
(USA) 
anti-CD28 CD28 Hamster T cell activation, plate 
bound in PBS 
BD PharMingen 
(USA) 
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Table 2-5 Secondary antibodies 
Antibody tag Antigen Species Application and 
dilution  
Supplier 
Alexa Fluor 488 Mouse, Rat or 
Rabbit IgG 
Goat IF 1:1000 Molecular Probes, 
Invitrogen (USA) 
Alexa Fluor 555 Mouse, Rat or 
Rabbit IgG 
Goat IF 1:1000 Molecular Probes, 
Invitrogen (USA) 
Alexa Fluor 647 Mouse, Rat or 
Rabbit IgG 
Goat IF 1:1000 Molecular Probes, 
Invitrogen (USA) 
Alexa Fluor 647 Sheep IgG Donkey IF 1:1000 Molecular Probes, 
Invitrogen (USA) 
Cy3 Armenian hamster 
IgG 
Goat IF 1:1000 Jackson 
Immunoresearch 
(USA) 
IRdye680 Mouse IgG Goat WB 1:4000 Invitrogen (USA) 
IRdye800 Rabbit IgG Goat WB 1:4000 Rockland (USA) 
HRP Goat IgG Chicken WB 1:2000 Amersham (UK) 
HRP Mouse or Rabbit 
IgG 
Sheep WB 1:2000 Amersham (UK) 
 
2.2.5 Bradford assay 
 
Protein concentration was determined by Bradford assay using serial dilutions of an IgG 
standard (Biorad). Protein was added to 800l of dH2O and mixed with 200l of Biorad 
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dye solution. Samples were vortexed, incubated for 15-60min at RT and the absorbance 
at 595nm was measured using a spectrophotometer. 
 
2.2.6 SDS-PAGE and protein transfer 
 
2.2.6.1 Standard SDS-PAGE 
For all experiments except GFP-LC3-blotting (see section 1.2.6.3) SDS-PAGE was 
performed using precast NuPAGE 4-12% Bis-Tris mini or midi gels (Invitrogen). Gels 
were run at 200V for ~1h in MOPS SDS running buffer (20X stock: 50mM MOPS, 
50mM Tris base, 0.1% SDS, 1mM EDTA, pH7.7; Invitrogen) to resolve big proteins or 
MES SDS running buffer (20X stock: 50mM MES, 50mM Tris base, 0.1% SDS, 1mM 
EDTA, pH7.3; Invitrogen) to resolve small proteins such as LC3.  
 
HEK293A cells were lysed in ice cold TNTE (20mM Tris pH7.5, 150mM NaCl, 0.3% 
v/v Triton-X-100, 5mM EDTA) containing Complete EDTA-free protease inhibitor 
cocktail (dilution was 1 tablet in 25ml of TNTE) and PhosStop phosphatase inhibitors 
(dilution was one tablet in 10ml of TNTE; both Roche) on ice. Immediately after TNTE 
addition, lysates were transferred to 1.5ml eppendorf tubes on ice by pipetting up and 
down 3-4 times to maximise cell lysis. Cell debris and nuclei were pelleted at 2500g 
(5000rpm in a conventional bench top centrifuge) for 5 min at 4ºC. Lysates were 
resuspended in 5xSDS sample buffer (15% SDS (w/v), 312.5mM Tris-HCL (v/v) 
pH6.8, 50% glycerol (w/v), 16% -mercaptoethanol (v/v), some bromophenol blue; all 
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Sigma), heated to 65ºC for 15 min and then loaded onto 4-12% Bis-Tris NuPAGE gels 
(Invitrogen) together with Rainbow marker (Amersham GE healthcare). 
 
2.2.6.2 Protein transfer 
Proteins were transferred onto Immobilon-P polyvinylidene (PVDF) or PVDF-FL 
membrane (Millipore), which was previously wetted in Methanol (MeOH; analytical 
grade; Fisher scientific) for 30sec, and soaked in NuPAGE transfer buffer (20X; 
Invitrogen diluted in 20% MeOH and water) for 5min. Extra thick blot paper (Biorad) 
was also soaked in transfer buffer and proteins were transferred onto membrane at 6V 
constant for 9.5h at 4ºC in a trans blot SD semi-dry transfer cell (Biorad). Next the 
membrane was again wetted in MeOH for 30sec and left to dry at RT for 15min to fix 
proteins. For ponceau staining the membranes were re-wetted in MeOH for 30sec and 
directly transferred into ponceau solution (Sigma) for 5min on a shaker. To remove 
excess staining membranes were washed twice with dH2O for 5 to 10min. To 
completely remove ponceau staining, membranes were washed twice with PBS for 
10min before being transferred into blocking solution. 
 
2.2.6.3 SDS-PAGE for GFP-LC3 blotting 
2GL9 cells on ice were lysed in (150l per well of a 24-well plate) RT 1xSDS Laemmli 
sample buffer (3% SDS (w/v), 62.5mM Tris-HCl (v/v) pH6.8, 10% glycerol (w/v), 
3.33% -mercaptoethanol (v/v), some bromophenol blue), immediately transferred to 
1.5ml eppendorf tubes on ice, and then heated to 65ºC for 10 min. To reduce viscosity 
samples were passed through a 27G needle 8 times before analysis on 10% Laemmli 
SDS-PAGE. The gel composition is listed in Table 2-6. The separating gel was covered 
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with isopropanol to even out the surface until polymerisation was complete and the 
stacking gel could be poured on top. Gels were electrophoresed at 120V constant for 
approximately 1h in running buffer (10X stock: 1.9M glycine, 250mM Tris-HCl, 1% 
SDS, pH8.8) and transferred onto PVDF membrane as described above. 
 
Table 2-6 Separating and stacking gel composition 
Acrylamide, upper, and lower gel buffers were purchased from National Diagnostics. TEMED 
(N,N,N,N-Tetramethylethylenediamine) and APS (ammoniumpersulfate) were purchased from Sigma. 
The indicated volumes are enough for two large 1mm thick gels. 
Separating gel 7.5% 10% 12% Stacking gel 4% 
Lower gel buffer (ml) 8.75 8.75 8.75 Upper gel buffer (ml) 3.75 
30% acrylamide (ml) 8.75 11.7 14 30% acrylamide (ml) 2 
dH2O (ml) 17.5 14.6 12.25 dH2O (ml) 9.25 
TEMED (l) 40 40 40 TEMED (l) 15 
APS (l) 120 120 120 APS (l) 150 
 
2.2.7 Immunoblotting/western blotting and detection 
 
2.2.7.1 ECL 
Membranes were blocked in 5% milk made from powder (Marvel) in PBS with 0.05% 
tween20 (PBS/tween) for 1h. Next, membranes were incubated with primary antibody 
in PBS or 5% milk made in PBS/tween for 2h at RT but usually over night at 4ºC. 
Membranes were washed 3 times for 5min in 5% milk made in PBS/tween and then 
incubated with secondary HRP-conjugated antibody in 5% milk made in PBS/tween for 
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1h. Finally, membranes were washed for 15min twice in 5% milk in PBS/tween, once 
in PBS/tween, and once in PBS before adding ECL reagent (Amersham GE healthcare) 
for 1min to detect HRP activity. Lastly, Membranes were exposed to film for various 
time points. To re-probe the same membrane, it was washed in PBS and incubated in 
Restore western blot stripping buffer (Thermo scientific) for 15min prior to restarting 
the blotting procedure. 
 
2.2.7.2 LI-COR 
Membranes were incubated in Odyssey blocking buffer (LI-COR infrared imaging 
system) for 1h directly followed (no wash) by incubation with one or two primary 
antibody(-ies) in PBS for 2h at RT but usually over night at 4ºC. Note that antibodies 
in PBS can be stored at 4ºC to reuse, and that if two antibodies are used one has to have 
been raised in mouse and the other one in rabbit. Next, membranes were washed 3 times 
for 5min in PBS with PBS/tween before incubating with secondary antibody(-ies) 
coupled to infrared chromophores with different excitation/emission wavelengths for 
1h. Membranes were washed 3 times in PBS/tween and once in PBS for 15min before 
scanning using a 2-channel scanner (LI-COR Odyssey). Protein levels revealed by LI-
COR scanning were quantified using Metamorph software by drawing narrow boxes 
around each band and recording the average pixel intensity. 
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2.2.8 Immunofluorescence labelling and confocal microscopy 
 
All steps were performed at room temperature and solutions are room temperature 
unless otherwise indicated. Cells on glass coverslips were washed with PBS warmed to 
37ºC once, if applicable incubated in saponin/pipes (0.05% saponin, 80mM pipes pH7, 
1mM MgCl2, 5mM EGTA in dH2O prepared freshly) for 5min, washed with 37ºC PBS 
once, fixed in 4% paraformaldehyde (agar scientific) in PBS warmed to 37ºC for 20 
min, washed with PBS 2 times, quenched with 50nM NH4Cl/PBS for 10 min, washed 
with PBS 2 times, permeabilised with 0.2% Triton-X-100 in PBS for 3 min, washed 
with PBS 3 times, and blocked with 0.2% gelatin in PBS (PBS-G) for 20 min. 
 
Alternatively, cells were washed with 37ºC PBS once, treated with saponin/pipes for 
5min or not, fixed with -20ºC MeOH for 20min at RT, washed with PBS once, 
permeabilised with 0.2% Triton-X-100 in PBS for 3 min, washed with PBS once, fixed 
again with -20ºC MeOH for 5min at RT, washed with PBS once, quenched with 50nM 
NH4Cl/PBS for 10 min, washed 3 times with PBS, and blocked with PBS-G for 20 min. 
After fixation and blocking, cells were incubated with primary antibodies diluted in 
PBS-G for 20 min, washed 3 times with PBS-G, incubated with secondary antibodies 
diluted in PBS-G for 20 min, washed 3 times with PBS-G, washed 3 times with PBS, 
washed once with sterile water and mounted on microscope slides with Moviol 4-88 
(Calbiochem) mounting medium. 
 
Confocal images with a slice thickness of 0.7m were obtained with a Zeiss Axioplan 2 
LSM510 or LSM710 laser scanning microscope equipped with a 63x, 1.4 NA, oil-
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immersion objective (Carl Zeiss MicroImaging, Inc.) and images were processed using 
LSM510/LSM710 software. 
 
2.2.9 Immunoprecipitation 
 
HEK293A cells were grown to ~80% confluency in 6cm dishes and lysed in 1ml ice 
cold TNTE supplemented with Complete Protease inhibitor cocktail and PhosStop on 
ice. Cells were scraped and transferred to eppendorf tubes on ice and spun down at 
2500g for 5 min to clear the lysates. 25l Protein-G sepharose beads (Sigma) were 
washed twice in TNTE and once in TNTE with protease and phosphatase inhibitors. 2l 
of appropriate antibody was added to the beads and left for 10min to allow binding to 
the protein G followed by addition of 450l of cell extracts but first removing a small 
aliquot of total cleared lysate. This mix was incubated at 4ºC for 4h but usually over 
night on a spinning wheel. Beads were spun down at 5000rpm for 2min, an aliquot of 
unbound supernatant was removed, and beads were washed 3 times in 500ml TNTE 
with protease and phosphatase inhibitors. Finally, beads were resuspended in 25l 3X 
SDS sample buffer (9% SDS (w/v), 187.5mM Tris-HCl (v/v) pH6.8, 30% glycerol 
(w/v), 10% -mercaptoethanol (v/v), some bromophenol blue; all Sigma) as were the 
total lysate and supernatant aliquots. Samples were heated to 65ºC for 15 min, and 
analysed on 4-12% Bis-Tris NuPAGE gels (Invitrogen) as described above. 
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2.2.10 Long-lived protein degradation 
 
Transfected HEK293A cells were incubated with growth medium containing 65M 
valine and 0.2Ci/ml [14C]valine (GE healthcare) over night. Cells were chased with 
full medium containing 2mM valine for 24h and then either incubated with EBSS or full 
medium with 2mM valine for 2h. Next, medium was removed and cells were harvested 
in ice cold PBS containing 1% triton-X-100 (TX100). Proteins from the medium and 
cell lysates were precipitated with trichloroacetic acid (TCA) over-night at 4ºC. TCA 
soluble medium fraction and the TCA insoluble cell lysate fractions were added to 
scintillation fluid and the radioactivity present was counted using a Beckman LS 6500 
multipurpose scintillation counter. The extent of long-lived protein degradation was 
expressed as the percentage of the TCA-soluble counts in the medium compared to the 
total TCA-soluble counts in the medium plus TCA-insoluble counts from the cells. 
 
2.2.11 Yeast-two-hybrid 
 
The yeast-two-hybrid assay has been described before [197]. All TBC and Rab 
constructs were provided by F. Barr (currently University of Liverpool, UK) and 
experiments were performed at the Max Planck Institute of Biochemistry, Martinsried, 
Germany. Briefly, competent PJ694A yeast cells were transfected with ULK1 (in 
pFBT9 vector) and a TBC construct (in pACT2 vector), or Syntenin1 (in pACT2 
vector) and a Rab GTPase (in pFBT9 vector) and grown on plates lacking leucine and 
tryptophan (DDO) to select for double transfected cells (pFBT9 contains the leucine, 
pACT2 the tryptophan cassette). After 3 to 5 days growing at 30ºC medium sized 
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colonies were re-streaked on DDO plates and plates lacking leucine, tryptophan, 
histidine, and adenine (QDO). A medium sized colony was picked with a pipette tip and 
streaked first on the DDO plate and then on the QDO plate and this was done for five 
different colonies from each plate. Plates were then put back at 30ºC to grow for 3 to 5 
days after which plates were analysed for interactions and scanned. 
 
2.2.12 In vitro GAP assay 
 
The in vitro GAP assay has been described [251]. Briefly, recombinant TBC1D14 was 
purified from Sf9 and High5 insect cells (pooled to enhance yield) by the protein 
purification facility at LRI. The GST moiety was cleaved off by 3C protease thanks to 
the presence of a cleavage site between the GST and TBC1D14. TBC1D14 was eluted 
and stored frozen in glycerol containing buffer (50mM Tris pH 7.5, 150mM NaCl, 
1mM EDTA, 1% (v/v) Triton-X-100, 5% (v/v) glycerol, 1mM DTT or TCEP, 10mM 
Benzamidine, 1mM NaF, 10mM b-glycerophosphate) until thawed for the GAP assay. 
5g (100pmol) of each Rab GTPase was incubated with 10l of 10X assay buffer (10X: 
500mM Hepes-NaOH pH6.8, 10mM DTT, 2mg/ml bovine serum albumin), 10l of 
10mM EDTA pH8, 5l of 1mM Mg2+-GTP and 1l of [32P]GTP (GE healthcare 
10mCi/ml; 5mCi/mmol) for 15min at 30ºC. This was then split in half and to one half 
buffer was added, to the other 200ng of TBC1D14 was added followed by 1h 
incubation at 30ºC. 2.5l of the assay mix was scintillation counted to allow calculation 
of the specific activity. Next 5l in duplicates were added to 800l of ice-cold activated 
charcoal slurry in 50mM NaH2PO4 and incubated on ice for 1h. Then samples were 
centrifuged at 16000g for 5min to pellet the charcoal. The supernatant was carefully 
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removed with a pipette and 400l aliquots are scintillation counted in 4ml of Ultima 
Gold scintillation liquid (Perkin-Elmer). 
 
To calculate the amount of GTP in the reaction mix the activity measured in 2.5l of 
assay mix was multiplied by 40 since the total volume was 100l. This value was then 
divided by the total of 5000pmol GTP that was in the reaction mix 
(5l(1mM)GTP/100l => 0.05mM GTP in the reaction mix, which for 100l is 
5000pmol) to obtain the specific activity in [cpm/pmol]. The duplicate values [cpm] of 
the 5l aliquot from each reaction were averaged and multiplied by two because only 
400l out of the 800l charcoal mix were counted. Because 5l out of the 100l 
reaction mix was counted, these values were multiplied by 20. Finally to calculate the 
amount of GTP hydrolysed these values are divided by the specific activity. The 
formulae are indicated below: 
 
(
100μl
5μl
)  (CPM
reaction  2
spec[CPMpmol ]
) =GTPhydrolysed [pmol]
 
 
with spec indicating the specific activity calculated as follows: 
 
CPMmix  100μl
2.5μl
5000pmol
= spec[
CPM
pmol
] 
Chapter 2. Materials and Methods 
 111 
 
2.2.13 Tfn and EGF trafficking 
 
Transfected HEK293 cells plated on Poly-D-Lysine coated coverslips were serum 
starved for 2 hours and then incubated in 37ºC warm serum-free DMEM containing 
alexa-fluor-647 (AF647)-labelled Tfn (5mg/ml stock used 1:500; Invitrogen) and 
AF555-labelled EGF (200g/ml stock used 1:500; Invitrogen) for 15 min at 37ºC, 
washed once with 37ºC warm PBS and then chased for the indicated time in serum free 
medium in cell culture conditions. Cells were then fixed by transferring the coverslip 
into wells containing 4% paraformaldehyde warmed to 37ºC for 20 min. Coverslips 
were washed 3 times with PBS, mounted on microscope slides in Moviol 4-88, and 
analysed by confocal microscopy. 
 
2.2.14 [125I]Tfn uptake assay 
 
Transfected HEK293 cells plated in Poly-D-Lysine coated wells were serum starved for 
2 hours and then incubated with [
125
I]Tfn (0.3μg/ml; Perkin Elmer) in binding medium 
(0.05% BSA in serum free culture medium) for 10 minutes at 37°C. [
125
I]Tfn was 
washed off and cells were surface stripped using 0.1M glycine, 0.9% NaCl pH 3.0 at 
4°C and washed with binding medium. Next cells were incubated in fresh pre-warmed 
binding medium. After each time point the medium was collected and replaced by fresh 
medium for the subsequent time point. Cells were lysed in PBS containing 1% Triton-
X-100 and the amount of radioactivity in the chase medium and the cell lysates was 
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counted using a Beckman LS 6500 multipurpose scintillation counter. Data presented 
includes the stimulation period. The percent recycled [
125
I]Tfn was determined by 
dividing the CPM in the medium (adding all counts from previous time points if 
applicable) by the total CPM (lysate+medium). The formula for the 60min time point is 
indicated below as an example: 
 
(CPMt 0min + CPMt 30min + CPMt 60min )MEDIUM
(CPMt0min + CPMt30min + CPMt60min )MEDIUM + (CPMt 0min + CPMt 30min + CPMt 60min )LYSATES
 
2.3 In vivo and primary mouse cell analyses 
 
2.3.1 Animal maintenance and back-crossing 
 
All mice were maintained and bred at the animal unit at CRUK Clare Hall laboratories. 
Back-crossings for ULK1 gene trapped mice (clone AC0566) were done mating 
heterozygous females with wild type C57BL/6J males obtained from the animal unit. 
Post-mortem analysis was done by Dr. Geza Hrivnak at the Clare Hall animal unit. For 
experiments mice were transferred to the LRI animal unit. Ear snips were sent to LRI 
for genotyping. 
 
2.3.1.1 Genotyping 
Ear snips were incubated over night in 150l DirectPCR lysis reagent (Viagen Biotech) 
with 0.1mg/ml proteinase K at 55ºC on a shaker. Next day the samples were heated to 
85ºC for 45min. Then samples were spun down briefly and 2l were used for PCR. For 
Chapter 2. Materials and Methods 
 113 
PCR 2.5nM of forward and 2.5nM of reverse primer were added to 15l of MegaMix 
blue (Microzone limited) with 2l of the ear snip DNA extract. To identify animals that 
carry the gene trap mutation (KO or HET) the following primers were used (EN80: the 
reverse primer lies within the gene trap cassette) and the PCR parameters are indicated 
in Table 2-7: 
 
5’-ACTCGTGAGATCTCATGGCCAT-3’ 
and 
5’-GCATAAATAGGACCAAGTGGGCACGC-3’ 
 
To identify animals carrying the wild type gene (WT and HET) the following primers 
were used (W4340: the two primers lie on each side of the gene trap insertion site so in 
mutant animals they are too far apart to produce a PCR product) and the PCR 
parameters are indicated in Table 2-8: 
 
5’-ACAACCAGGTCCCAGGTCCCG-3’ 
 
5’-TTCAGGCTGCGCAACTGTTGG-3’ 
 
After the PCR programme has finished the MegaMix blue solution containing the PCR 
product, if amplified, can be directly loaded onto a 0.8% agarose gel. 
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Table 2-7 PCR parameters for genotyping EN80 
Segment Cycles Temperature (ºC) Time (min) 
1 1 94 3 
94 0.5 
60 0.5 
2 35 
72 2
3
 
 
Table 2-8 PCR parameters for genotyping W4340 
Segment Cycles Temperature (ºC) Time (min) 
1 1 94 3 
94 0.5 
60 0.5 
2 35 
72 0.5 
 
2.3.2 Primary T cell preparation and culture 
 
Animals were sacrificed to harvest organs between 1 and 6 months of age. Primary 
splenocytes and thymocytes were cultured in Roswell Park Memorial Institute (RPMI) 
1640 medium supplemented with 10%FBS (Autogen Bioclear), 0.3g/ml L-Glutamine 
(GIBCO), 100U/ml (each) pen/strep, 1mM sodium pyruvate (GIBCO), 0.1mM non-
essential amino acids (NEAAs; GIBCO), 10mM HEPES (GIBCO), and 50M -
mercaptoethanol (GIBCO) (=R10*). Cells and organs were kept on ice in between all 
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steps. Organs and tissues for western blot analysis were shock-frozen in liquid nitrogen 
and stored at -80ºC until lysis and homogenisation in TNTE containing protease and 
phosphatase inhibitors using a polytronic homogeniser.  
 
To obtain primary splenocyte cultures whole spleen was passed through a 70m mesh 
using a plunger of a 1ml syringe and washing the mesh with medium frequently. Cells 
were centrifuged at 1700rpm for 5min and incubated in red blood cell (RBC) lysis 
buffer (Sigma; or make up: 155mM NH4Cl, 10mM KHCO3, 0.1mM EDTA, pH7-7.2 ) 
for 5min at RT, if applicable. Cells were washed with fresh medium once and then 
counted in a Neubaur haemocytometer not counting RBCs (exclusion by size and 
shape) if no RBC lysis buffer was used. Cells were cultured at 37ºC under humified 
conditions and 5% CO2 in R10*. The same procedures and conditions apply for 
thymocytes from whole thymi. For FACS sorting the cell suspension was filtered 
through a 40m mesh to avoid clumps in the sorter. FACS sorting was done by the 
FACS laboratory at LRI. 
 
2.3.3 Flow cytometry 
 
2.3.3.1 Cell surface staining and FACS analysis 
For cell surface staining of primary splenocytes and thymocytes cell suspensions were 
washed once in ice-cold FACS buffer (5mM EDTA, 1% FCS (Autogen bioclear), 
0.02% NaN3 in PBS) and stained with surface staining antibodies (1:100) for 20 min at 
4ºC in the dark. Data were acquired on a FACSCalibur (BD Biosciences) or LSRII (BD 
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Biosciences) and analyzed using FlowJo software (Treestar). An example of cell gates 
(Fig. 2-1a, excluding debris) is shown in Figure 2-1. Cell clusters were excluded by 
(Fig. 2-1b, gating on single cells). To determine total cell number a known number of 
beads was added as a reference (Fig. 2-1c; to calculate number of cells: (#beads added 
to sample divided by #beads acquired in FACS profile)x(#CD4 acquired)=total CD4+) 
or, alternatively, for cells diluted to equal amounts the FACS profile was acquired for 
the same amount of time. 
 
 
Figure 2-1 Typical FACS analysis 
(a) Forward (~size) and side (~granularity) scatter (FSC and SSC, respectively) heights (H) are used to 
exclude debris, (b) SSC width (W) and area (A) are used to exclude cell clusters, and (c) beads can be 
added and counted to calculate total cell number. 
 
2.3.3.2 AnnexinV, TO-PRO3, and DAPI staining 
For AnnexinV (PharMingen) staining cell suspensions were spun down and 
resuspended in Annexin binding buffer (PharMingen; alternatively to the commercial 
buffer use: 1mM Hepes-NaOH pH7.4, 140mM NaCl, 2.5mM CaCl2). 3l of AnnexinV-
FITC were added and cells were incubated for 20min at RT in the dark. 1nM TO-PRO3 
or 1M DAPI were added to cells shortly before FACS profile acquisition. 
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2.3.4 Cell viability assays 
 
2.3.4.1 Anti-CD3 titration 
For anti-CD3 titration assays, 96-well plates were coated with serial dilutions of anti-
CD3 in PBS over night in a moisture chamber at 4ºC. Splenocytes were processed as 
described above not using RBC lysis buffer. Per well 500’000 splenocytes (not counting 
RBCs) in 100l R10* were added using a multi-well pipette and cultured for 3 days at 
37ºC. Each condition was done in quadruplicates (4 wells). After 3 days in culture 
plates and CellTitre-Glo reagent were equilibrated to RT for 30min. 100l of CellTitre-
Glo reagent was added to each well using a multi-well pipette and plates were incubated 
on an orbital shaker for 2min. Plates were further incubated on the bench at RT for 
10min and luminescence was recorded using an Envision multilabel reader (Perkin 
Elmer). 
 
2.3.4.2 CFSE proliferation assay 
For the CFSE proliferation assay splenocytes were labelled with 5M CFSE (Molecular 
Probes) for 5min at RT in R10* in the dark. Cells were washed once and 10
6 
cells per 
well were
 
added to a 96-well plate. Cells were stimulated by plate-bound anti-CD3 
(5g/ml) with or without plate-bound anti-CD28 (1g/ml), or recombinant IL-2 
(100U/ml; RnD Systems), or 10ng/ml PMA with 300mg/ml ionomycin. Cells were 
stained with anti-CD4 and proliferation was assayed by flow cytometry after 4 days in 
culture. 
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2.4 Statistical analysis 
 
Statistical analysis was done using Prism (GraphPad software). Two-tailed student’s t-
tests were performed unpaired or paired as indicated. Two-way ANOVA test was 
performed two-tailed followed by Bonferroni posttest analysis. Asterisk(s) indicate 
significance, * p0.05, **p0.01, ***p0.001. Data represent mean of indicated 
number of independent experiments. Error bars indicate standard error of the mean. 
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Chapter 3. Identification of RabGAPs and Rabs 
involved in autophagosome formation 
 
3.1 Aim 
 
Many questions remain concerning autophagosome formation as it is still unclear what 
the exact mechanism of autophagosome expansion is and where the donor membrane 
comes from [19]. Upon induction of autophagy large amounts of membrane are 
sequestered very quickly to form multiple autophagosomes throughout the cytoplasm. 
To better understand the mechanisms and the molecular machinery involved in 
phagophore extension I wanted to do a comprehensive analysis of the membrane 
trafficking events involved in autophagosome formation. With Rab GTPases being 
major regulators of membrane traffic in the cell [194], I hypothesised that one or more 
Rabs are involved in autophagosome formation. The activity of Rab GTPases in the cell 
is controlled by a family of enzymes called RabGAPs, which when over-expressed 
inactivate their target Rab. Therefore, my main approach was to do an over-expression 
screen testing all putative human RabGAP proteins for their ability to inhibit 
autophagosome formation.  
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3.2 A RabGAP over-expression screen to identify negative 
regulators of autophagosome formation 
 
I screened a library of 38 human Tre-2/Bub2/Cdc16 (TBC)-domain containing proteins, 
putative RabGAPs, for their ability to inhibit autophagosome formation when over-
expressed in HEK293A cells stably expressing GFP-LC3 (2GL9 cells). All TBC 
constructs were kindly provided by Prof. F. Barr (University of Liverpool, UK). To 
measure autophagosome formation I assayed lipidation of GFP-LC3 during a two-hour 
starvation period (Fig. 3-1). I added the lysosomal protease inhibitor leupeptin to the 
starvation medium to prevent lysosomal degradation of GFP-LC3-II. This allowed me 
to assess total accumulation of GFP-LC3-II during the two hour starvation period as a 
measurement of the number of autophagosomes formed. The screen will only identify 
RabGAPs that inhibit autophagosome formation and not maturation or turnover for two 
reasons: 1) Autophagosome maturation is affected by disruption of lysosome function, 
which cannot be distinguished from the effect of leupeptin. 2) RabGAPs that increase 
and those that accelerate autophagosome formation would cause enhanced GFP-LC3-II 
degradation in the absence of leupeptin seemingly inhibiting autophagy. However, in 
the presence of leupeptin they will lead to accumulation of GFP-LC3-II ensuring that 
any inhibition of GFP-LC3-II accumulation seen is due to decreased lipidation and not 
enhanced turnover. 
 
2GL9 cells were transfected with one of the 38 myc-tagged RabGAP constructs and 
GFP-LC3 lipidation was assessed by western blot. To avoid gel to gel variations the 
renilla vector control was loaded onto each gel for normalisation. A truncation mutant 
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of ULK1, which is known to inhibit autophagy, was used as a positive control. The 
renilla vector rather than empty vector was used because protein over-expression mildly 
enhances basal autophagy. All conditions were done in duplicates with two wells for fed 
and two for starved with leupeptin. Membranes were probed using the LI-COR system, 
which uses special Odyssey blocking buffer and secondary antibodies tagged with 
infrared fluorophores with an excitation wave length of 700nm or 800nm. Both 
secondaries can be applied at the same time to the membrane and scanned so that there 
is no bleed through from one channel to another. This allowed me to reveal the levels of 
actin (polyclonal 800nm) and LC3 (monoclonal 700nm) simultaneously even though 
GFP-LC3 and actin migrate similarly on SDS-PAGE. Antibodies against LC3 and actin 
were used to quantify protein levels first, followed by anti-myc to detect over-expressed 
myc-tagged TBC proteins. Membranes were scanned using the Odyssey infrared 
imaging system and all quantification was done with Metamorph software by drawing 
individual boxes around each actin and LC3-II band. 
 
A 40% or more reduction in GFP-LC3-II production was detected after expression of 11 
RabGAPs. To test whether GAP activity, and therefore Rab inactivation, was necessary 
for inhibition of autophagosome formation I investigated whether mutation of the 
catalytic arginine residue within the TBC domain (RA mutant, see Introduction section 
1.2.2.2), would rescue this inhibition. The RA mutant was only available for 8 out of the 
11 candidates and I found that seven out of these eight mutant proteins were no longer 
able to inhibit autophagy when over-expressed (Fig. 3-1). 
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Figure 3-1 11 RabGAPs inhibit autophagosome formation 
(a) 38 N-terminally myc-tagged TBC-domain containing proteins were over-expressed in HEK293A cells 
stably expressing GFP-LC3 (2GL9 cells) and accumulation of GFP-LC3-II was measured as a read out 
for autophagic activity. Cells were seeded in 24-well plates and 24 h after transfection cells were starved 
in Earle’s buffered saline solution (EBSS) with 0.25 mg/ml leupeptin (leu) for 2 h or not. In each 
experiment, TBC proteins were done in duplicate for each condition (4 wells per TBC protein in total). 
Membranes were probed using the LI-COR system with antibodies against LC3 and actin for 
quantification, followed by the anti-myc antibody. Black bars show levels of GFP-LC3-II after starvation 
normalised to the renilla vector control, which was present on each gel. In fed conditions no significant 
differences were seen and data is not shown. Each myc-TBC was repeated at least twice (n=2) and if 
inhibition was seen, then three or more times (n3). ULK1C, a C-terminal truncation mutant that is 
known to inhibit autophagy [21] was included in each experiment. (b) Representative western blots for 
TBC proteins that inhibited autophagy by 40% or more are shown. Of the 11 hits, eight GAP-activity 
deficient mutants (RA), TBC1D17R381A, TBC1D10CR141A, TBC1D14R472A, TBC1D9BR559A, 
RUTBC1R848A, TBC1D16R494A, TBC1D10AR160A, TBC1D10BR134A, were tested for rescue of 
the inhibition of autophagy (grey bars). Partial rescue can be seen for 7 of the 8 mutants tested. (c) Shown 
is a representative gel from the screen. All gels contained the renilla vector control, which the other 
samples were normalised to. Triple myc-tagged TBC constructs in pcDNA3.1 vector were kindly 
provided by F. Barr (University of Liverpool, UK). 
 
3.3 Analysis of 11 RabGAP candidates that inhibit 
autophagosome formation 
 
To further characterise the role of the 11 RabGAP hits from the over-expression screen, 
I first investigated whether any of these localise to intermediate and late stage 
autophagosomes marked by GFP-LC3 (Fig. 3-2). 2GL9 cells were transfected with one 
of the hits, starved for 2 hours, fixed, and labelled with anti-myc antibody followed by 
Alexa Fluor 555 tagged anti-mouse secondary antibody. As expected, cells over-
expressing TBC-constructs have generally less autophagosomes, however, only partial 
co-localisation with GFP-LC3 puncta can be observed for some of the GAPs in starved 
2GL9 cells. The size and distribution of the remaining GFP-LC3 spots appears normal 
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in transfected cells, excluding the possibility that one of the TBC-proteins may induce 
ectopic GFP-LC3-II formation or that any of them severely disrupt autophagosome 
transport. TBC1D7 and TBC1D14 vesicles show some degree of juxta-position with 
GFP-LC3 and TBC1D17, TBC1D9B, TBC1D4, and RUTBC1 show partial co-
localisation with GFP-LC3 positive autophagosomes, however, in some cases this may 
be due to engulfment of the over-expressed protein by the autophagosome.  
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Figure 3-2 Screening candidates from the RabGAP screen for co-localisation with 
GFP-LC3-positive autophagosomes 
(a - k) 2GL9 cells were transfected with the indicated TBC-protein. After 24h expression cells were 
labelled with anti-myc antibody and specific fluorescently tagged secondary antibody. Boxes shown in 
merge are enlarged in right panels with GFP-LC3 in green and myc in red. (a) myc-TBC1D7, (b) myc-
TBC1D17, (c) myc-TBC1D10C, (d) myc-TBC1D9 (e) myc-TBC1D14 (f) myc-TBC1D9B, (g) myc-
TBC1D4, (h) myc-RUTBC1, (i) myc-TBC1D16, (j) myc-TBC1D10A, (k) myc-TBC1D10B.  
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Next I wanted to investigate whether any of the 11 candidate TBC proteins co-localise 
with very early phagophores labelled by ULK1 (Fig. 3-3). Catalytically inactive RA 
mutant TBC-constructs were over-expressed where available to allow autophagosomes 
to form. HEK293A cells were starved for 2 hours and cells were fixed and labelled with 
anti-myc and anti-ULK1 antibodies followed by specific fluorescently tagged secondary 
antibodies.  
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Figure 3-3 Screening candidates from the RabGAP screen for co-localisation with 
ULK1 
(a - j) HEK293A cells were transfected with the indicated TBC-protein, wild type or RA mutant as 
indicated. After 24h expression cells were stained with anti-myc and anti-ULK1 antibodies and specific 
fluorescently tagged secondary antibodies. Inserts shown in merge panel on left are shown in right panels. 
(a) myc-TBC1D7, (b) myc-TBC1D17R381A, (c) myc-TBC1D10CR141A, (d) myc-TBC1D9 (e) myc-
TBC1D9BR559A, (f) myc-TBC1D4, (g) RUTBC1R848A, (h) TBC1D16R494A, (i) TBC1D10AR160A, 
(j) TBC1D10BR134A. Scale bars are equal to 10m. 
 
Out of the 11 candidate proteins only TBC1D14 showed substantial co-localisation with 
ULK1 (Fig. 3-4a). In transfected HEK293A cells myc-TBC1D14 forms tubular 
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structures throughout the cytosol and ULK1 is found concentrated on subdomains of 
these tubules. In some cases tubular structures are observed in a juxta-nuclear position 
(Fig. 3-4b). The length of the TBC1D14 tubules varies and may depend on the level of 
over-expression (Fig. 3-4c). Shown in Figure 3-4c is a starved 2GL9 cell expressing 
high levels of myc-TBC1D14 demonstrating that the tubules can get very long. 
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Figure 3-4 Over-expressed TBC1D14 forms tubules in the cytosol and sequesters 
ULK1 
(a,b) HEK293A cells were transfected with myc-TBC1D14R472A (myc-TBC1D14RA), fixed, and 
stained 24h later with antibodies against myc (red) and ULK1 (green) followed by specific fluorescently 
tagged secondary antibodies. (a) A representative cell with tubules throughout the cytosol. (b) A 
representative cells with tubules concentrated in a juxta-nuclear position and throughout the cytosol. (c) A 
2GL9 cell transfected with myc-TBC1D14 and starved for 2h in EBSS showing long tubules. 
 
3.4 RabGAPs interacting with ULK1 
 
ULK1 was shown to form a complex with Rab5, the adaptor protein Syntenin1 and 
SynGAP, a GAP for Rab5 [90]. This complex seems to be neuronal specific and 
regulates vesicular traffic during axon extension. However, I hypothesised that ULK1 
could form a similar complex to regulate autophagosome formation since I could 
confirm that Syntenin1 binds ULK1 in HEK293A cells via a co-immunoprecipitation 
assay (Fig. 3-5). Syntenin1 is a PDZ-domain containing protein and ULK1 has a 
classical PDZ binding motif consisting of the last three C-terminal amino acids 
valine/tyrosine/alanine (VYA) in mouse and isoleucine/cysteine/alanine (ICA) in 
human ULK1 [255]. Consistent with the notion that ULK1 and Syntenin1 interact via 
these two domains, deletion of these last three amino acids in ULK1 abolishes binding 
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to Syntenin1. For the co-immunoprecipitation experiment HEK293A cells were 
transfected with HA-Syntenin1 and myc-ULK1 or myc-ULK1VYA or with either 
construct alone. Cell lysates were then immunoprecipitated using anti-HA or anti-myc 
antibodies. 
 
 
Figure 3-5 ULK1 binds Syntenin1 in HEK293A cells via its PDZ binding motif 
HEK293A cells were transfected with the indicated construct(s) and allowed to express the proteins for 
24 hours. Cell lysates were then incubated with protein-G-sepharose bound anti-HA or anti-myc over-
night at 4ºC on a spinning wheel. Membranes were cut and the top part was labelled with anti-myc to 
detect myc-ULK1; the bottom part was labelled with anti-HA to detect HA-Syntenin1 using the LI-COR 
system. Red box left: HA-Syntenin1 co-immunoprecipitates with myc-ULK1. Red box middle: HA-
Syntenin1 does not co-immunoprecipitate with myc-ULK1VYA. Red box right: myc-ULK1 co-
immunoprecipitates with HA-Syntenin1. S indicates 5% unbound supernatant; L indicates 5% lysate; IP 
indicates immunoprecipitated proteins. Asterisk indicates a non-specific band, red arrowhead indicates 
HA-Syntenin1. 
 
Next, I undertook a yeast-2-hybrid screen to find RabGAPs interacting with ULK1 (Fig. 
3-6) using full length wild type ULK1 as bait against the GAP library using RA mutants 
where available. A truncation mutant of ULK1 containing only the C-terminus from 
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amino acids 653 to the end (1051) was also tested as this region was reported to contain 
the GAP binding domain of ULK1 but this construct was auto-activating and could not 
be used. RabGAP constructs for yeast-2-hybrid analysis were provided by Prof. F. Barr 
(Max Planck Institute of Biochemistry, Martinsried, Germany and currently University 
of Liverpool, UK). Competent PJ694A yeast cells were transfected with ULK1 and one 
of the RabGAPs. Double transfected cells were selected on plates lacking leucine and 
tryptophan. Five colonies were taken from each plate and re-streaked on both selective 
plates. Protein interaction allows growth of yeast on quadruple drop out (QDO) plates 
lacking leucine, tryptophan, histidine, and adenine. Some constructs are toxic to the 
yeast cells such as EVI5-like, where only one colony grew but this colony is probably 
untransfected and has coincidentally acquired mutations that allow it to grow on 
selective plates. Surprisingly, ULK1 interacts with 17 out of 35 GAPs tested.  
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Figure 3-6 Yeast-2-hybrid screen to identify RabGAP binding partners of ULK1 
Cells were transfected with the indicated inactive (RA) RabGAP constructs (prey, in pACT2 vector) 
where available, and ULK1 (bait, in pFBT9 vector) and selected for double transfected cells on plates 
lacking leucine and tryptophan (-L/-W left). Cells were allowed to grow at 30ºC for 72h. Each box shows 
five colonies with each colony having been streaked on both selective media. Binding of ULK1 to the 
RabGAP allows growth on quadruple drop out medium (QDO) lacking leucine, tryptophan, histidine and 
adenine (right panel). TBC constructs in pACT2 vector were kindly provided by F. Barr (University of 
Liverpool, UK). 
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ULK1 does not bind to a specific branch of TBC-proteins when the full length proteins 
were aligned in a phylogenetic tree (Fig. 3-7a) nor when only the TBC-domains were 
aligned [196] but this could be explained by the fact that TBC domains share little 
amino acid sequence homology but high structural homology so the ULK1 binding fold 
may still look similar even if the amino acid sequence does not.  
 
Furthermore, RabGAPs that inhibit autophagy as found in my screen, do not group into 
a particular family or branch, and ULK1 sequestration alone cannot explain their 
inhibitory effect when over-expressed, since many ULK1 binding partners show no 
reduction of GFP-LC3-II formation (Fig. 3-7b). 
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Figure 3-7 A phylogenetic tree of full length human RabGAPs 
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(a) Full length human TBC-domain proteins were aligned using the ClustalW method. The 11 RabGAPs 
inhibiting autophagy are coloured red and asterisks indicate binding to ULK1 in a yeast-2-hybrid assay. 
(b) Same as in (a) with RabGAPs binding to ULK1 indicated by blue bars.  
 
3.5 A yeast-2-hybrid screen to identify Rab GTPases binding to 
Syntenin1. 
 
Lastly, since I hypothesised that ULK1 can regulate autophagosome formation in a 
complex with a Rab-RabGAP pair bridged by the adaptor protein Syntenin1, I 
investigated which Rabs, if any, Syntenin1 can bind to. Therefore, I undertook a yeast-
2-hybrid screen using full length Syntenin1 as bait against a library of Rab GTPases 
(the Rabome; Fig. 3-8). The yeast-2-hybrid screen was done exactly as described above 
but using Syntenin1 as bait (in pFBT9 vector) and GTP-locked active Rab GTPases as 
prey (in pACT2 vector). All Rab constructs were kindly provided by Prof. F. Barr 
(University of Liverpool, UK). As previously shown by Tomoda et al., Syntenin1 binds 
Rab5a, b, and c but not its most closely related homologues Rab21 or Rab22. It also 
binds Rab37, which is found on secretory granules in mast cells [256], and Rab33a and 
b. Importantly, Rab33b was shown to control localisation of the Atg16L complex [222] 
involved in autophagosome formation, and over-expression of a dominant active mutant 
of Rab33b (Rab33bQ92L) induced autophagy. However, the GAP for Rab33 is thought 
to be TBC1D22B (personal communication F. Barr; University of Liverpool, UK) and 
had no inhibitory effect on GFP-LC3 lipidation (Fig. 3-1). Over-expression of a 
dominant negative mutant Rab33a/bT50N also did not inhibit autophagosome formation 
in my hands (Fig. 3-9). The Rab45-pACT2 construct is auto-activating and does not 
need to interact with a pFBT9 construct to activate transcription. However, it was 
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included as an internal control even though no conclusion can be drawn as to whether 
Rab45 interacts with Syntenin1 or not. 
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Figure 3-8 Syntenin1 binds Rab5, Rab33, and Rab37 
Cells were transfected with the indicated active GTP-locked (QA) Rab construct (prey, in pFBT9 vector) 
and full length Syntenin1 (bait, in pACT2 vector) and selected for double transfected cells on plates 
lacking leucine and tryptophan (-L/-W left). Cells were allowed to grow at 30ºC for 72h. Each box shows 
five colonies with each colony having been streaked on both selective media. Binding of Syntenin1 to the 
Rab GTPase allows growth on quadruple drop out medium (QDO) lacking leucine, tryptophan, histidine 
and adenine (right panel). Syntenin1 binds all 3 isoforms of Rab5 (a, b, and c), Rab37, and Rab33a and 
33b (indicated by red arrows). The Rab45 construct is auto-activating. Rab GTPase constructs in pFBT9 
vector were provided by F. Barr (University of Liverpool, UK). 
 
3.6 Screening putative target Rab GTPases of RabGAPs that 
inhibit autophagy 
 
It is thought that each RabGAP targets a specific family of Rab GTPases and ongoing 
research is aiming to identify such Rab-RabGAP pairs and their role in membrane 
traffic. Of the RabGAPs I have found to inhibit autophagy some target Rabs have been 
discovered and their functions in cellular transport have been described (summarised in 
Table 3-1). These RabGAP targets were tested using mutant Rabs available through a 
collaboration with Francis Barr (University of Liverpool, UK) and the results are 
summarised below. Endogenous LC3 lipidation was chosen as a readout for autophagic 
activity looking at fed, starved, and starved with leupeptin conditions to be able to 
distinguish between defects in autophagosome formation and autophagosome 
maturation (see Introduction section 1.1.4.2). 
 
Rab17 was shown to be the target of TBC1D7 and they are involved in cilia formation 
[251]. Importantly however, TBC1D7 binds and inhibits TSC1 [75], which is upstream 
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of mTOR. It would seem that Rab17 is also involved in this pathway since inactive 
Rab17N132I over-expression inhibits autophagosome formation (Fig. 3-9). 
 
Rab35 is the target of the TBC1D10 family [199, 257] and has been shown to be 
involved in various processes, including Tfn recycling. However, over-expression of 
Rab35N120I did not inhibit LC3 lipidation but slightly activated it. This is unexpected 
since over-expressing the inactive Rab should pheno-copy the effect of over-expression 
of its GAP. 
 
Rab36 may be the target of TBC1D16 and regulate the spatial distribution of late 
endosomes and lysosomes [258]. The constitutively active mutant Rab36Q182A led to a 
slight increase in LC3 lipidation as expected. This could be due to fewer lysosomes 
being available for autophagosomes to fuse with due to aberrant distribution of 
lysosomes. However, as inactivating Rab36 by over-expressing TBC1D16 did not lead 
to a maturation defect leading to accumulation of GFP-LC3-II but to decreased LC3 
lipidation this is unlikely to be the case here and there must be an additional effect 
affecting autophagosome formation. 
 
Rab37 was tested because a yeast-2-hybrid screen revealed that it binds the ULK1 
interactor Syntenin1 (Fig. 3-5). Again the constitutively active mutant Rab37Q82A was 
over-expressed but it had no effect on autophagy. 
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Rab5 was shown to bind TBC1D17 [196] and has been shown to be involved in the 
removal of aggregated mutant huntingtin (htt) by selective autophagy [217]. However, 
when I tested the ability of inactive mutant Rab5N133I to inhibit LC3 lipidation in 
response to starvation it had no effect although there may be slightly less total LC3 in 
Rab5N133I over-expressing cells. This was apparently not due to enhanced degradation 
during the two hour starvation period since addition of leupeptin does not prevent the 
reduction in LC3 observed. Further investigation by RT-PCR or investigating 
proteasomal protein turnover would be necessary to explain this effect. 
 
Lastly, I tested the effect of inactive Rab22aS19N on autophagosome formation because 
it is the target Rab of TBC1D9B and was found by N. McKnight (LRI) in a siRNA 
screen to be involved in autophagy (unpublished). Over-expression of this GDP-locked 
mutant had no effect on LC3 lipidation, but it might be worth investigating a different 
mutant, which cannot bind nucleotides. 
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Figure 3-9 Mutant Rab targets tested in HEK293A cells 
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HEK293A cells were transfected with the indicated Rab constructs: GFP-Rab17N132I (nucleotide 
empty), myc-Rab35N120I (nucleotide empty), GFP-Rab36Q182A (GTP-bound), GFP-Rab37Q82A 
(GTP-bound), GFP-Rab5N133I (nucleotide empty), GFP-Rab22aS19N (GDP-bound), or renilla vector 
control. Cells were starved 24h later in EBSS with (dark grey) or without (light grey) leupeptin (leu). 
Endogenous LC3 conversion was measured by western blot using anti-LC3 antibody. The mean of 3 
independent experiments is shown with the starved and starved with leupeptin samples done in 
duplicates. Asterisks indicate results of unpaired Student’s t-test comparing to the vector control (fed vs. 
fed; starved vs. starved; etc.). Rab17N132I starved with leupeptin p=0.0207; Rab35N120I starved with 
leupeptin p=0.0339; Rab36Q182A starved p=0.0433; Rab36Q182A starved with leupeptin p=0.0429. 
Error bars indicate SEM. A representative western blot done with the LI-COR system is shown using 
anti-GFP and anti-myc antibodies to detect transfected Rab proteins, anti-actin, and anti-LC3 antibodies 
to detect the respective endogenous proteins. Asterisk in western blot indicates irrelevant samples. Only 
Rab33b is shown in the quantification because of space constraints but Rab33a has a very similar effect. 
Note that the effect of Rab11 on autophagy will be described in more detail below. 
 
3.7 Conclusion 
 
In an over-expression screen with all putative human RabGAPs 11 TBC-proteins were 
found to inhibit autophagosome formation when over-expressed in 2GL9 cells (listed in 
Table 3-1). Out of these 11 RabGAPs, TBC1D7 and TBC1D14-positive vesicles show 
some juxta position with GFP-LC3 positive autophagosomes and TBC1D17, 
TBC1D9B, TBC1D4, and RUTBC1 show a partial co-localisation. Only TBC1D14 
shows substantial overlap with early ULK1-positive autophagosomes. A screen for 
RabGAP binding partners of ULK1 revealed 17 RabGAPs that interact with ULK1 and 
TBC1D14 was one of them. The ULK1 complex may transiently form a bigger multi-
protein complex with TBC1D22B, Syntenin1, and Rab33b. Out of these proteins 
Rab33b has already been shown to be involved in autophagy. However, over-expression 
of TBC1D22B does not inhibit autophagosome formation. ULK1 may be able to form 
different Rab-RabGAP complexes in different cells, at different stages of development, 
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or at different nutrient levels since it has been shown to form a complex with Syntenin1, 
Rab5, and SynGAP in developing neurons to regulate neurite extension [90]. SynGAP 
is a neuronal specific GAP with a RasGAP rather than a TBC domain but it seems to be 
able to act as a Rab5 GAP in these cells. Interestingly, Rab5 has been shown to be 
essential for autophagosome formation to remove mutant huntingtin aggregates and it 
would be interesting to investigate whether it does so in a complex with ULK1 as well 
[217]. Investigating target Rab GTPases of RabGAP that inhibit autophagy using 
mutant Rab constructs I found that over-expression of inactive Rab17N132I decreased 
and constitutively active Rab36Q182A increased autophagosome formation. 
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Table 3-1 Summary of RabGAPs found to inhibit autophagy 
Table 3-1 shows a summary of the RabGAPs found to inhibit autophagy indicating their putative target 
Rab and demonstrated function(s). 
Rab-GAP 
and 
alternative 
names 
Possible 
target 
Rab 
Demonstrated function(s) 
TBC1D7 
PIG51 
Rab17 Inhibits TSC1, which in turn inhibits mTOR 
[75] 
Cilia formation [251] 
Expressed in a majority of lung cancers [259] 
TBC1D17 Rab21 
Rab5a/b/c 
Shiga toxin uptake [199] 
Binds Rab5 [196] 
TBC1D10C 
Carabin 
EPI64C 
Rab35 Inhibits Ras and Calcineurin [260]  
Shiga toxin uptake [199] 
Tfn recycling and immunological synapse 
formation [202] 
Exosome secretion [261] 
Regulates Ca
2+
-activated K
+
 channel KCa2.3 
recycling involved in endothelial function [202, 
257] 
TBC1D9 
KIAA0882 
 Contains two GRAM domains, which are 
similar to plekstrin homology (PH) domains 
involved in PI lipid binding. 
TBC1D14 
KIAA1322 
 Yeast homologue Sbe22p binds Atg18p [262] 
3D crystal structure of the TBC domain solved 
[198] 
TBC1D9B Rab22a Binds Rab22a (personal communication F. 
Barr; University of Liverpool, UK) 
siRNA mediated knock down of Rab22a 
inhibits autophagy in 2GL9 cells (unpublished 
N. McKnight et al.) 
Contains a single span transmembrane and two 
GRAM domains, which are similar to plekstrin 
homology (PH) domains involved in PI lipid 
binding [263] 
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TBC1D4 
AS160 
Rab2a, 
Rab8a, 
Rab10, 
Rab14 
Akt substrate, GLUT4 translocation [264] 
Rab8a, 10, and 14 are involved in endocytic 
recycling [194, 265, 266] 
RUTBC1 
KIAA0397 
SGSM2 
Rab4, 11 Interacts with Rab and Rap [267] 
TBC1D16 Rab36 Rab36 may regulate the spatial distribution of 
late endosomes and lysosomes and is found in 
the Golgi and TGN [258] 
TBC1D10A 
EPI64 
Rab27a Shiga toxin uptake [199] 
Microvillar structure [268] 
Exosome secretion [261] 
TBC1D10B  Shiga toxin uptake [199] 
Exosome secretion [199, 261] 
 
Over-expression of TBC1D14 inhibits autophagosome formation and leads to 
tubulation of a membrane compartment, which sequesters ULK1. It is able to bind 
directly to ULK1 as shown by a yeast-2-hybrid assay but this interaction may not be 
exclusive and ULK1 can bind other GAPs as well. A PSI blast revealed distant 
homology to the yeast protein Sbe22p, which binds Atg18, another essential autophagy 
protein. For all these reasons and since I was particularly interested in early events of 
autophagosome formation, which involve ULK1, I chose to investigate this TBC1D14 
further. 
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Chapter 4. Characterisation of TBC1D14 
 
4.1 Aim 
 
TBC1D14 is a 693 amino acid long protein with a C-terminal TBC domain and an N-
terminus containing no known motifs (Fig. 4-1). A structure of the TBC domain of 
TBC1D14 has been published by Tempel et al. [198] encompassing amino acids 357-
672, however, the entire TBC domain is predicted to be longer stretching from amino 
acids 223 to 669. The crystal structure revealed that a significant realignment of the two 
catalytic arginine and glutamine residues is necessary for TBC1D14 to act as a GAP. 
This is probably achieved by interaction with its target Rab causing conformational 
changes in the GAP domain so the catalytic residues can be aligned leading to GTP 
hydrolysis. However, the target Rab GTPase of TBC1D14 has not been reported, and 
the role of TBC1D14 in membrane traffic is not known. Therefore, I investigated the 
role of TBC1D14 in intracellular traffic and autophagy.  
 
 
Figure 4-1 Domain structure of TBC1D14 
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TBC1D14 is a 693 amino acid protein containing a C-terminal TBC domain and an N-terminus with no 
known motifs. The predicted molecular weight is around 80 kDa. The crystal structure of the TBC 
domain from amino acid 357 to 672 has been solved [198] but the functional TBC domain is predicted to 
stretch from amino acid 223 to 669 (yellow). The two catalytic residues necessary for GAP activity 
arginine R472 and glutamine Q508 are indicated.  
 
4.2 TBC1D14 inhibits long-lived protein degradation and 
endogenous LC3 lipidation in a GAP activity dependent 
manner 
 
To confirm that the effect of TBC1D14 over-expression on autophagy is not limited to 
the inhibition of LC3 lipidation, I performed a long-lived protein degradation assay 
[269, 270]. Whereas short-lived proteins are mostly degraded by the proteasome, more 
stable long-lived proteins are usually removed by autophagy. HEK293A cells were 
labelled with radioactive [
14
C]valine over-night to allow its incorporation into newly 
synthesised proteins. To allow degradation of radioactively labelled short-lived 
proteins, cells were then chased in cold medium for 24h. Autophagy was induced by 
starvation for 2h, during which degradation of labelled proteins leads to release of 
[
14
C]valine into the medium. Trichloroacetic acid (TCA)-soluble 
14
C counts were then 
measured from the medium of TBC1D14 transfected and renilla vector control 
transfected cells. Over-expression of TBC1D14 and the TBC1D14R472A mutant 
inhibit long-lived protein degradation to a similar extent as a kinase deficient mutant of 
ULK1, ULK1K46I, which is known to inhibit autophagy [21] (Fig. 4-2).  
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Figure 4-2 TBC1D14 over-expression inhibits long-lived protein degradation 
HEK293A cells were transfected with either renilla vector control, TBC1D14WT (WT), 
TBC1D14R472A (RA) or, kinase inactive ULK1K46I (ULK1 KI), which is known to inhibit autophagy. 
Cells were labelled with [
14
C]valine overnight and chased in cold medium for 24h to allow degradation of 
short-lived proteins. Cells were then starved for 2h in EBSS, and the acid-soluble 
14
C released into the 
medium was counted, the cells were harvested and the acid insoluble 
14
C from the cells was counted. 
Each condition was done in triplicate and the experiment was repeated twice. Long-lived protein 
degradation was calculated from the 
14
C cpm medium/
14
C cpm total (medium and cells), normalized to 
control starved samples, and presented as arbitrary units. Asterisks indicate results from unpaired 
Student’s t-test compared to starved control values. WT, p<0.0001; RA, p<0.0001; ULK1 KI, p=0.0021. 
 
As described above the crystal structure of TBC1D14 shows that its catalytic arginine 
and glutamine residues have an atypical conformation compared to the TBC domains of 
Gyp1p and TBC1D22A, which have also been crystallised. This may explain why the 
single mutant TBC1D14R472A fails to rescue the inhibition of autophagy when over-
expressed. Therefore, I tested a double mutant TBC1D14R472A/Q508A 
(TBC1D14RA/QA) protein and monitored endogenous LC3 lipidation as a read-out for 
autophagy. I also tested the other single mutant lacking the catalytic glutamine 
TBC1D14Q508A (TBC1D14QA). The RA/QA and QA mutant constructs were cloned 
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using a QuickChange Multi Site-directed mutagenesis kit using the myc-TBC1D14 wild 
type or RA mutant constructs as a template. Over-expression of TBC1D14RA/QA fails 
to inhibit LC3 lipidation in HEK293A cells suggesting that the double mutant protein 
lacks GAP activity (Fig. 4-3). The single mutant TBC1D14QA inhibits autophagy to a 
similar extent as TBC1D14RA and TBC1D14WT.  
 
 
Figure 4-3 Over-expression of the double mutant TBC1D14RA/QA does not 
inhibit autophagosome formation 
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HEK293A cells were transfected with TBC1D14WT (WT), control renilla vector, TBC1D14Q508A 
(QA), or TBC1D14R472A/Q508A (RA/QA) constructs and starved for 2h with or without leupeptin (leu) 
to measure autophagic flux. The mean result of 3 experiments with each condition done in duplicate 
except for the fed condition is shown. A representative western blot of the transfected cell lysates is 
shown below using the antibodies indicated and the LI-COR system. Asterisks indicate results of 
unpaired Student’s t-test compared to vector control EBSS with leupeptin: WT, p<0.0001; QA, p=0.0002; 
and WT EBSS vs. control EBSS: p=0.0432). Error bars indicate standard error of the mean (SEM). 
 
4.3 siRNA mediated knock down of TBC1D14 enhances 
autophagy 
 
To better study the role of TBC1D14 in autophagy an antibody was raised against a 
peptide from human TBC1D14. Rabbits were injected with three different peptides, two 
from the N-terminus (one rabbit each) of TBC1D14 and one from the C-terminus (two 
rabbits). Peptides were chosen based on calculations of antigenicity using the 
MacVector program. A cysteine residue was added to the N-terminus of the peptide to 
allow conjugation of the peptide to a sulfolink column for affinity purification of 
specific antibodies. The peptides were as follows: 
STO289 (amino acids 81-101): CSAVHVRRKQSDSDLIPERA 
STO290 (amino acids 116-136): CTEREQSVRKSSTFPRTGYD 
STO291 and STO292 (amino acids 671-691) CLTALQKDSREMEKGSPSLR 
 
I tested the rabbit sera by western blot for detection of endogenous TBC1D14 with 
lysates from HEK293A cells mock transfected, or after TBC1D14 was knocked down 
with a siRNA pool consisting of 4 different oligos (Fig. 4-4). Cells were transfected 
with 50nM of the siRNA pool twice over the course of 3 days to achieve efficient 
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protein depletion. Western blots were then done using the four different rabbit sera 
diluted 1:100 in 5% milk. TBC1D14 is a 78 kDa protein and a band of this size, which 
disappears upon siRNA knock down of TBC1D14 can be detected with both STO298 
and STO291 (Fig. 4-4, red asterisks). However, STO289 also detects many unspecific 
bands at around that size, therefore STO291 was used for all further experiments. 
STO291 was affinity purified using the peptide the rabbits were injected with covalently 
conjugated to a sulfolink column (Pierce) according to the manufacturers instructions. 
 
Figure 4-4 STO289 and STO291 rabbit sera detect endogenous TBC1D14 by 
western blot 
HEK293A cells were transfected with a siRNA pool consisting of 4 individual duplexes targeting 
different regions of TBC1D14 or mock transfected. Transfections were done on day 1 and 2 using 
Oligofectamine and 50nM pooled siRNA. On day 4 after a 72h knock down period cells were harvested 
for western blot analysis. The membrane was probed with the 4 different rabbit sera (STO289-292) 
diluted 1:100 in 5% milk and HRP-conjugated secondary antibodies specific for rabbit immunoglobulins. 
Chapter 4. Results 
 154 
Red asterisks indicate a band that is the right size to be TBC1D14 and is not present when TBC1D14 is 
depleted in the knocked down cells. Dashed lines indicate where the membrane was cut. The lower part 
of the membrane was stained for actin as a loading control. 
 
Next, I wanted to test whether siRNA mediated knock down of TBC1D14 could 
enhance autophagy in HEK293A cells. First, I deconvoluted the siRNA pool against 
TBC1D14 to determine which duplex would work most effectively when used alone 
instead of the pool. HEK293A cells were transfected as described above with either 
50nM siRNA pool or 50nM of one of the siRNA duplexes. The membrane was blotted 
with anti-TBC1D14 antibody and Ponceau staining served as a control for protein 
loading. Duplex 12 showed a good depletion of the TBC1D14 protein in two 
independent experiments and was chosen for all future siRNA knock-down assays. 
 
 
Figure 4-5 Deconvolution of a siRNA pool targeting TBC1D14 
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HEK293A cells were transfected with a siRNA pool against TBC1D14 as described in Figure 4-4 or with 
50nM of the individual siRNA duplexes. Shown are western blots using anti-TBC1D14 from two 
independent experiments. p = siRNA pool; number indicates the duplex number given by the 
manufacturer. Arrowhead indicates TBC1D14 band. Ponceau staining was performed before antibody 
staining (lower panel). 
 
To test whether TBC1D14 knock down has any effect on autophagy I chose to use 
endogenous LC3 lipidation as a readout. HEK293A cells were transfected with a siRNA 
oligo targeting TBC1D14 twice as described above and LC3 lipidation was measured 
by western blot using the LI-COR system. Knock down of TBC1D14 was confirmed by 
blotting with anti-TBC1D14 antibody using HRP-labelled secondary antibodies and 5% 
milk to block because the TBC1D14 antibody does not work with the LI-COR system.  
 
Knock down of TBC1D14 leads to a significant increase in autophagosome formation 
in starved conditions with or without leupeptin but has no effect on basal autophagy in 
fed cells (Fig. 4-6). This suggests that TBC1D14 controls autophagosome formation 
induced by starvation but not in basal homeostatic autophagy. Consistent with this 
notion, over-expressed TBC1D14 does not inhibit basal autophagosome formation (Fig. 
4-4). Alternatively, autolysosome formation could be inhibited leading to a block in 
LC3 turnover but this is highly unlikely since I have shown above that TBC1D14 over-
expression affects autophagosome formation and not maturation. 
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Figure 4-6 siRNA mediated knock down of TBC1D14 leads to increased 
autophagosome formation upon starvation 
HEK293A cells were transfected with a single duplex targeting TBC1D14 or mock transfected, left in fill 
medium, starved in EBSS with or without leupeptin (leu) for 2h and harvested. Endogenous LC3 
conversion was measured by western blot. The graph shows the mean of 5 independent experiments 
(n=5). A representative blot is shown. Asterisks indicate results of paired Student’s t-test, starved 
p=0.0323; starved with leupeptin p=0.0224. Error bars indicate standard error of the mean (SEM). 
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4.4 Endogenous TBC1D14 localises to the Golgi and 
endosomes 
 
Using the STO291 antibody against TBC1D14 I investigated the intracellular 
localisation of endogenous TBC1D14. I stained HEK293A cells using a standard PFA-
fixation based protocol and observed TBC1D14 in a juxta-nuclear position, a punctate 
pool, and in the nucleus. To further characterise the juxta-nuclear pool of TBC1D14 I 
then labelled the cells with antibodies recognising a marker of the cis and medial Golgi 
cisternae anti-GM130 and a marker of the trans-Golgi network (TGN) anti-TGN46. 
Indeed, TBC1D14 shows good co-localisation with the Golgi and TGN and this pool 
seems to increase upon nutrient starvation suggesting that TBC1D14 cycles between the 
Golgi/TGN and a peripheral pool and re-distributes to the Golgi/TGN upon starvation 
(Fig. 4-7). 
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Figure 4-7 Endogenous TBC1D14 localises to the Golgi and TGN, a peripheral 
punctate pool and the nucleus 
HEK293A cells were starved for 2h in EBSS or not, labelled with antibodies against TBC1D14 (green), 
GM130 (red) and TGN46 (blue) and, imaged using confocal microscopy. Note that the Golgi/TGN pool, 
and the extent of co-localisation with TGN46 and GM130 increase upon starvation. Merged box 1 (fed) 
and box 2 (starved) are shown below. 
 
To make sure that this antibody is specific in immunofluorescence, HEK293A cells 
were knocked down with siRNA against TBC1D14 or not and labelled with STO291. 
The Golgi/TGN fraction and part of the peripheral pool of TBC1D14 were strongly 
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depleted in the knocked down cells (Fig. 4-8b). The nuclear staining was not reduced 
upon TBC1D14 knock down suggesting that this signal is unspecific. Some of the 
peripheral staining may be unspecific as well as it didn’t disappear completely. 
Alternatively, the depletion of TBC1D14 may not be 100% although it does seem 
efficient as assessed by western blot analysis using post-nuclear supernatant of cells 
from the same knock-down experiment (Fig. 4-8d).  
 
In addition to TBC1D14 cells were labelled with anti-mAtg9 to investigate the 
possibility that TBC1D14 regulates mAtg9 trafficking. mAtg9 is a transmembrane 
protein that cycles between the TGN and endosomes re-distributing to the endosomal 
pool upon starvation [41]. This movement is dependent on the presence of ULK1 since 
knock down of ULK1 leads to an increase of mAtg9 in the TGN even in starved cells. 
However, mAtg9 traffic is not affected by TBC1D14 knock down (Fig. 4-8b). mAtg9 
disperses normally in cells lacking TBC1D14 and is found on the TGN in fed cells 
consistent with the observation that TBC1D14 depletion does not induce basal 
autophagy (Fig. 4-6). While knock-down of ULK1 leads to concentration of mAtg9 on 
the TGN it does not alter TBC1D14 trafficking as it appears to be more concentrated in 
the TGN area after starvation similarly to cells that were not depleted of ULK1 (Fig. 4-
8c). 
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Figure 4-8 siRNA mediated knock down of TBC1D14 does not alter mAtg9 
trafficking 
HEK293A cells were transfected for 72h with (a) mock transfected using Oligofectamine without RNA, 
or single siRNA duplexes against (b) TBC1D14 (50nm), or (c) ULK1 (50nm). Cells were incubated in 
full medium, or for 2 h with EBSS, and labelled with antibodies against endogenous TBC1D14 (green) 
and mAtg9 (red) followed by specific fluorescently tagged secondary antibodies. (d) In parallel, cells 
were harvested for western blot analysis to confirm the knock down efficiency. Post-nuclear supernatants 
were run on SDS-PAGE and membranes were labelled with anti-ULK1, anti-TBC1D14, and anti-actin. – 
indicates mock transfected, 14 indicates siTBC1D14, U1 indicates siULK1. Note: the nuclear staining of 
TBC1D14 is non-specific as siRNA mediated knockdown of TBC1D14 did not decrease it. ULK1 
knockdown prevents the starvation-induced dispersal of mAtg9 away from the TGN (lower panel in (c)) 
whereas knockdown of TBC1D14 does not. 
 
4.5 TBC1D14 binds ULK1 via its TBC domain 
 
TBC1D14 interacts with ULK1 in a yeast-2-hybrid assay and co-localises with it when 
over-expressed in HEK293A cells. Since both anti-ULK1 and anti-TBC1D14 antibodies 
were raised in rabbit it was not possible to look at whether the endogenous proteins co-
localise. However, I wanted to confirm the interaction of ULK1 with TBC1D14 by co-
immunoprecipitation. Therefore, HEK293A cells were transfected with human HA-
ULK1 and GFP-TBC1D14 as well as truncation mutants of TBC1D14 containing the 
TBC domain only (GFP-TBC1D14-TBC) or the N-terminal domain alone (GFP-
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TBC1D14-N) to determine where ULK1 binds. Unfortunately, neither the ULK1 nor 
TBC1D14 antibodies efficiently immuno-precipitate the endogenous proteins so I used 
anti-HA to pull down over-expressed HA-ULK1 and test whether GFP-TBC1D14 co-
immunoprecipitates with it. Anti-FLAG was used as a negative control. Co-
immunoprecipitation was carried out over night at 4ºC with antibodies bound to protein 
G-sepharose beads and post-nuclear whole cell lysates. GFP-TBC1D14 co-
immunoprecipitates with ULK1 via its TBC domain but not its N-terminal domain (Fig. 
4-9). To test the possibility that this interaction is regulated by starvation, and therefore 
the activation status of ULK1 (see Introduction and [83]), the cells were starved for 2h 
in EBSS before lysis. However, the interaction efficiency is the same in fed and starved 
cells suggesting that TBC1D14 binds ULK1 constitutively (Fig. 4-9a). 
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Figure 4-9 TBC1D14 binds ULK1 via its TBC domain 
(a, b) HEK293A cells were transfected with HA-ULK1 and the indicated GFP-TBC1D14 construct. 
Proteins were allowed to express for 24h and cells were starved in EBSS for 2h or not. Cell lysates were 
then immunoprecipitated with anti-HA or anti-FLAG antibodies. L=3% lysate; IP=immunoprecipitated 
pellet; S=3% supernatant, unbound fraction. Membranes were labelled with antibodies against HA and 
GFP using the LI-COR system. (a) Full length GFP-TBC1D14 co-immunoprecipitates with ULK1 in 
both fed and starved conditions and there is no difference in binding efficiency. No HA- or GFP-tagged 
protein was co-immunoprecipitated when an irrelevant antibody, anti-FLAG, was used. (b) The C-
terminal TBC domain (amino acids 224-669) but not the N-terminus (amino acids 1-223) of TBC1D14 
binds to ULK1. 
 
To assess the localisation of the fragments of GFP-TBC1D14 they were transfected into 
HEK293A cells and processed for confocal microscopy. As expected, full length GFP-
TBC1D14 forms tubules like the myc-TBC1D14 does and recruits ULK1. The N-
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terminal domain of TBC1D14 is diffusely cytosolic whereas the C-terminal TBC 
domain forms tubules (Fig. 4-10). However, the tubules formed by the TBC domain 
alone are mostly concentrated in the juxta-nuclear position suggesting that there is a 
signal in the N-terminus, or the last 24 amino acids of TBC1D14 that leads to transport 
of the protein away from the microtubule organising centre (MTOC), or prevents and 
regulates retrograde transport. As expected from my co-immunoprecipitation 
experiments the over-expressed TBC domain also recruits ULK1.  
 
Figure 4-10 Subcellular distribution of TBC1D14 truncation mutants 
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HEK293A cells were transfected with (a) full length GFP-TBC1D14, (b) GFP-TBC1D14-N, which 
comprises the N-terminus from amino acids 1-223, or (c) GFP-TBC1D14-TBC, which comprises the C-
terminal TBC domain from amino acids 224-669. Cells were then starved for 2h in EBSS and stained 
with anti-ULK1 (red). 
 
Preliminary data suggests that over-expression of either truncation mutant alone does 
not inhibit autophagosome formation (Fig. 4-11). HEK293A cells were transfected with 
the truncation mutants and full length GFP-TBC1D14 to assess their effect on LC3 
lipidation via western blot. As expected the full length GFP-TBC1D14 like myc-
TBC1D14 inhibits autophagosome formation. The two truncation mutants GFP-
TBC1D14-N and GFP-TBC1D14-TBC, however, do not. Although, this experiment 
would have to be repeated it seems that the TBC domain alone is not sufficient to 
inhibit autophagy but requires some signal or function of the N-terminus or very C-
terminal amino acids. 
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Figure 4-11 Over-expression of the TBC domain of TBC1D14 does not inhibit LC3 
lipidation 
HEK293A cells were transfected with full length GFP-TBC1D14 (TBC1D14FL), GFP-TBC1D14-N 
comprising the N-terminus of TBC1D14 (amino acids 1-223), or GFP-TBC1D14-TBC containing only 
the TBC domain (amino acids 224-669). Cells were left in DMEM (single well), starved (duplicate 
wells), or starved with leupeptin (duplicate wells) for 2h. Single wells were used for the full length 
protein. Membranes were revealed with anti-GFP, anti-actin and anti-LC3 using the LI-COR system. 
N=GFP-TBC1D14-N, TBC=GFP-TBC1D14-TBC, control=renilla vector control, FL=GFP-TBC1D14. 
Quantification done with Metamorph software is shown in the lower panel. Grey bars indicate values for 
each replicate, black bars indicate average of duplicates or single replicate. 
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4.6 In vitro GAP activity assay for TBC1D14 
 
The target Rab for TBC1D14 has not been identified. Therefore, I wanted to do an in 
vitro GAP assay using purified recombinant TBC1D14 protein to identify the target 
Rab. TBC1D14 was cloned into pBacPAKGST vector and N-terminally tagged GST-
TBC1D14 was purified by the protein purification facility at the London Research 
Institute (LRI) from insect cell lysates over-expressing it. The GST was cleaved off to 
elute untagged TBC1D14 using 3C-protease taking advantage of a 3C cleavage site, 
which is located C-terminally to the GST-protein in the vector. Insect cells were used 
for expression of GST-TBC1D14 because the protein cannot be expressed in bacteria 
(personal communication F. Barr; University of Liverpool, UK).  
 
Recombinant purified Rab GTPases were provided by Prof. F. Barr (University of 
Liverpool, UK), and loaded with a mixture of [32P]GTP and cold GTP. I tested a 
library of 48 Rab GTPases incubated with or without (buffer alone) TBC1D14 protein 
for 1 hour at 30ºC to allow GTP hydrolysis. The specific activity of each reaction was 
calculated as described in Materials and Methods and proteins were pelleted using 
activated charcoal slurry and 
32
P released into the supernatant buffer through GTP 
hydrolysis was measured. GAP activity was calculated by dividing the amount of GTP 
hydrolysed by the specific activity (see Materials and Methods for a detailed description 
of the calculations). As a positive control TBC1D20 was used, which is known to act on 
Rab1b and an increase in 
32
P counts in the supernatant can be seen [200] (Fig. 4-12). 
Unlike the other Rabs, Rab21 has very high intrinsic GTPase activity. TBC1D14 did 
not activate any of the Rab GTPases. This could be due to protein concentration being 
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too low, because the protein lost its GAP activity during purification, or due to 
TBC1D14 not having GAP activity at all. The assay was repeated by Dr. Shin-ichiro 
Yoshimura (University of Liverpool, UK) in a different buffer, with higher protein 
concentration using GST-TBC1D14 rather than untagged protein but still no GTPase 
activation by TBC1D14 was seen. 
 
 
Figure 4-12 In vitro GAP activity assay with TBC1D14 against the Rabome 
Recombinant TBC1D14 protein was purified from Sf9 and High5 insect cells (pooled) by the LRI protein 
purification service. 5g of each Rab GTPase was loaded with [32P]GTP and cold GTP (1:5). 200ng of 
TBC1D14 (black bars), or empty buffer (grey bars) was added to each Rab followed by 1h incubation at 
30ºC. 2.5l of each GAP reaction was counted to allow calculation of the specific activity of each 
reaction. 5l of each GAP reaction was added to 800l activated charcoal slurry, spun down and 400l of 
the supernatant buffer containing released free 
32
P, as a result of GTP hydrolysis, was counted. GAP 
activity was calculated by dividing the amount of GTP hydrolysed by the specific activity [251]. Control 
is TBC1D20 incubated with Rab1b, which is known to be its target [200]. All reactions were done in 
duplicate and shown is the average of the two. 
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4.7 Yeast-2-hybrid screen to identify Rab binding partners of 
TBC1D14 
 
In another approach to identify the Rab GTPase target of TBC1D14, a yeast-2-hybrid 
screen was done by Dr. Shin-ichiro Yoshimura (a collaborator at the University of 
Liverpool, UK). The screen was done in the same way as described in Figures 3-6 and 
3-8 using TBC1D14R472A as bait against a library of Rab GTPases. The RA mutant 
was used because the interaction between RabGAP and Rab is thought to be stabilised 
by removal of the arginine finger [204]. TBC1D14 binds specifically to Rab11a and 
Rab11b but no other Rabs tested (Fig. 4-13). It is particularly significant that Rab25, 
which is closely related to Rab11 and is sometimes called Rab11c, did not bind 
TBC1D14.  
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Figure 4-13 TBC1D14 binds to Rab11a and 11b 
(a) A yeast-two-hybrid screen to identify Rab binding partners of TBC1D14 was done by Shin-ichiro 
Yoshimura (University of Liverpool, UK). Cells were transfected with the indicated active (QA) Rab 
constructs (prey) and TBC1D14R472A (bait) and selected for double transfected cells on plates lacking 
leucine and tryptophan (-L/-W left). Each box shows five colonies streaked on both selective media. 
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Binding of the TBC1D14 to the Rab allows growth on quadruple drop out medium (QDO) lacking 
leucine, tryptophan, histidine and adenine (right panel). 
 
4.8 TBC1D14 co-localises with Rab11 in HEK293A cells 
 
To confirm the finding that TBC1D14 binds Rab11a and Rab11b (now called Rab11 
when both isoforms are meant) I looked at the endogenous proteins by indirect 
immunofluorescence in HEK293A cells. To that end, cells were stained with anti-
TBC1D14, and anti-Rab11 antibodies. Rab11 is found on recycling endosomes, the 
pericentriolar endocytic recycling compartment (ERC) and the TGN [271, 272]. I found 
some overlap of TBC1D14 with Rab11 in the MTOC region and also on peripheral 
recycling endosomes (Fig. 4-14). Note, not all recycling endosomes are TBC1D14 
positive and the co-localisation is often partial but this may be expected since a GAP 
only acts at a specific step during vesicle traffic, and endosomes are mosaic structures 
containing various subdomains [193]. 
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Figure 4-14 TBC1D14 co-localises with Rab11 in HEK293A cells 
HEK293A cells were labelled with anti-TBC1D14 (green) and anti-Rab11 (red) antibodies and were (a) 
left in DMEM for 2h (fed), or (b) starved for 2h in EBSS. Panels on the right show enlarged boxes 
indicated. Arrowheads point to Rab11-positive recycling endosomes that contain TBC1D14. 
 
This commercial Rab11 antibody probably recognises both isoforms of Rab11 as they 
are very similar and only differ in 19 amino acids in the C-terminus, although the 
immunogen used by the manufacturer contains some of the divergent amino acids. 
Unfortunately, it is not specified which isoform was used as a template to synthesise the 
antigenic peptide. Both isoforms are expressed in HEK293A cells as shown by western 
blot analysis with two different isoform specific antibodies (Fig. 4-15). However, the 
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isoform specific antibodies used for immuno-blotting only work for 
immunofluorescence analysis after permeabilisation of cells with saponin. As this leads 
to loss of TBC1D14 staining because its membrane association is not strong enough 
(data not shown) I could not do co-localisation experiments using these isoform specific 
antibodies. 
 
 
Figure 4-15 HEK293A cells express both Rab11 isoforms 
HEK293A cells were transfected with no siRNA, siRNA against Rab11a (25nM), Rab11b (25nM), or 
both (25nM each) twice and after 72h harvested for western blot analysis. Membranes were labelled with 
antibodies specific against Rab11a or Rab11b and actin. si11a=siRab11a, si11b=siRab11b, WB=western 
blot. 
 
4.9 Conclusion 
 
I have confirmed that TBC1D14 is a general inhibitor of autophagosome formation and 
its effect is not limited to an inhibition of LC3 lipidation. Using an antibody against 
TBC1D14 I found that it localises to the Golgi/TGN and recycling endosomes. 
TBC1D14 binds both Rab11 isoforms but no other Rab GTPases in yeast-2-hybrid 
experiments and co-localises with Rab11 in HEK293A cells. Mutation of the two 
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catalytic residues arginine 472 and glutamine 508 rescues inhibition of autophagy most 
likely by abolishing GAP activity. 
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Chapter 5. TBC1D14 regulates autophagosome 
formation via ULK1 and Rab11-positive recycling 
endosomes 
 
5.1 Aim 
 
TBC1D14 binds Rab11, which is involved in endocytic recycling of proteins such as the 
Transferrin receptor (TfnR) back to the plasma membrane via the endocytic recycling 
compartment (ERC). Recycling endosomes (REs) have never been implicated in 
autophagy. However, TBC1D14 co-localises with Rab11 on REs and negatively 
regulates autophagy. Therefore, I investigated the role of REs and Rab11 in 
autophagosome formation and how TBC1D14 regulates this process. 
 
5.2 TBC1D14 tubulates recycling endosomes 
 
Since endogenous TBC1D14 is localised to Rab11-positive REs I hypothesised that the 
tubules induced by TBC1D14 over-expression are tubulated REs. To test this, 
HEK293A cells were transfected with myc-TBC1D14 and stained with anti-TBC1D14 
and anti-Rab11 or anti-TfnR, which is a cargo of REs (Fig. 5-1). Transfected cells can 
easily be recognised by the appearance of tubules throughout the cells. These tubules 
contain the TfnR and are Rab11 positive confirming that they are REs. Interestingly, the 
TfnR completely disperses in untransfected starved cells (Fig. 5-1b) whereas Rab11 
does not. Endogenous TBC1D14 shows little overlap with the pericentriolar ERC 
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because it is mostly localised to the Golgi and TGN. It remains unclear why the over-
expressed protein preferentially localises to REs and the ERC and tubulates those two 
but not the Golgi or TGN. 
 
 
Figure 5-1 TBC1D14 over-expression tubulates recycling endosomes 
(a) HEK293 cells were transfected with myc-TBC1D14 and 24h later starved in EBSS or not, and 
labelled with antibodies against TBC1D14 (green) and Rab11 (red). (b) Same as in (a) but cells were 
labelled with anti-Transferrin receptor (TfnR) antibody. Small boxes on panel show enlarged TfnR-
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positive endosomes with endogenous TBC1D14 from untransfected cells. Asterisks indicate transfected 
cells. Boxes on transfected cells in merged panels are enlarged on the right. Scale bars are equal to 10m. 
 
I hypothesised that inactivation of Rab11 by TBC1D14 leads to tubulation of REs and 
the ERC either causing a defect in budding of vesicles, enhanced homotypic fusion 
between them or leading to a defect in vesicle transport. Furthermore, TBC1D14 may 
be recruited to REs by Rab11 as it does not seem to have any membrane association 
domains. To test this I transfected cells with siRNAs against Rab11a and Rab11b prior 
to transfection with GFP-TBC1D14. Indeed, knock down of Rab11 prevents TBC1D14 
from tubulating endosomes and leads to a cytosolic localisation of the over-expressed 
protein (Fig. 5-2a) strongly supporting the hypothesis that TBC1D14 is a Rab11-GAP. 
Over-expression of the TBC1D14RA/QA double mutant still leads to RE tubulation, as 
TBC1D14RA/QA is probably still able to bind Rab11, perhaps even more strongly 
[204]. Even though TBC1D14RA/QA may not inactivate Rab11, it may prevent binding 
of Rab11 effectors. Also, it is likely that Rab11 is part of a Rab cascade similar to the 
Rab5-Rab7 cascade in early to late endosome maturation [205, 206] and that failure to 
inactivate Rab11 stops this cascade still leading to endosome tubulation.  
 
Chapter 5. Results 
 178 
 
Figure 5-2 Depletion of Rab11 prior to TBC1D14 expression prevents tubulation 
of REs 
(a) Cells were transfected with siRNA duplexes against Rab11a and Rab11b (25nm each) on day 1 and 2 
and subsequently transfected with GFP-TBC1D14 on day 3. On day 4 (72h knock down, 24h expression) 
cells were labelled with anti-TBC1D14 and anti-Rab11 antibodies. Scale bar is equal to 10m. (b,c) 
HEK293A cells were transfected with (b) myc-TBC1D14R472A/Q508A or (c) myc-TBC1D14QA and 
labelled with anti-TBC1D14 and anti-TfnR antibodies. 
 
Lastly, if Rab11 inactivation is the cause of tubulation of REs by TBC1D14 then loss of 
Rab11 should have the same phenotype. Indeed knock down of Rab11 in HEK293A 
cells revealed that REs are more tubulated in the absence of Rab11 although the tubules 
are not as extreme as in the case of TBC1D14 over-expression (Fig. 5-3). Furthermore, 
the endosomal pool of TBC1D14 is greatly diminished and probably reduced to 
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background staining in the Rab11 depleted cells suggesting that RE association of 
TBC1D14 is dependent on binding to Rab11. The Golgi pool of TBC1D14 on the other 
hand remains the same in knocked down compared to control cells. 
 
 
Figure 5-3 siRNA mediated knock down of Rab11 tubulates TfnR-positive REs 
HEK293 cells were transfected with single siRNA duplexes against Rab11a and Rab11b (25nm each) for 
72h as described before. Cells were incubated in EBSS for 2 h, and stained with antibodies against 
endogenous TBC1D14 (green) and TfnR (red). While TfnR-positive endosomes are tubulated in the 
absence of Rab11, TBC1D14 seems to be present on the Golgi still.  
 
5.3 Transferrin but not epidermal growth factor is delivered to 
TBC1D14 tubules and Tfn recycling is delayed 
 
To test whether tubulated REs are functional I looked at uptake of the ligand Transferrin 
(Tfn) and another extracellular cargo, epidermal growth factor (EGF). EGF is taken up 
by receptor mediated endocytosis and delivered to early endosomes just like Tfn is but 
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from there the two ligands follow different trafficking routes. Tfn is sorted away to be 
recycled to the plasma membrane via the ERC while EGF follows the degradative route 
via MVBs to the lysosome.  
 
Serum starved HEK293A cells transfected with GFP-TBC1D14 were incubated in the 
presence of fluorescently labelled Tfn and EGF for 30 sec (this being the zero minute 
timepoint without chase) or 15 min, and then chased in serum free medium without 
fluorescent ligands for 5min, 45min, or 1h and 45min (Fig. 5-4). After 0min both Tfn 
and EGF can be seen in small vesicles just below the plasma membrane and some co-
localisation is observed, as expected. After a 15min pulse with the ligands, plus a 5min 
chase, Tfn is found in the ERC and REs as well as TBC1D14 tubules, whereas EGF is 
in endosomes separate from Tfn. After 45min chase most of the Tfn has been recycled 
back to the extracellular medium in the untransfected cells whereas it is retained in the 
GFP-TBC1D14 positive tubular REs. EGF degradation is much slower so that it can 
still be observed in endosomes after 45min and this is not affected in GFP-TBC1D14 
transfected cells. After 1h and 45min of chase all the Tfn is apparently recycled even in 
the transfected cells whereas some EGF is still located in what are probably late 
endosomes/MVBs. This finding that Tfn can be delivered to TBC1D14 tubules and is 
recycled eventually but with much delay supports my hypothesis that TBC1D14 
structures are tubulated REs. Also, EGF trafficking in transfected cells is 
indistinguishable from untransfected cells suggesting that other internalisation routes 
are not affected by TBC1D14 over-expression and, importantly, that late endosomes 
and lysosomes are intact.  
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Figure 5-4 Tfn recycling via TBC1D14 tubules is delayed whereas EGF trafficking 
is unaffected 
HEK293A cells were transfected with GFP-TBC1D14 and 24h later allowed to internalise fluorescently 
labelled Alexa647-Transferrin (Tfn, red) and Alexa555-epidermal growth factor (EGF, blue). Tfn and 
EGF were applied to the cells for 30 seconds at room temperature, and then cells were fixed (0min). Or 
cells were allowed to internalise Tfn and EGF for 15 minutes at 37˚C, washed and then chased for 5min, 
45min, or 1h 45min in serum free medium at 37˚C. Asterisks indicate transfected cells. Indicated boxes 
are enlarged in bottom panel. Scale bars are equal to 10m. 
 
To confirm these results I also performed a biochemical assay following the recycling 
of radioactively labelled [
125
I]Tfn in myc-TBC1D14, myc-TBC1D14RA/QA, renilla 
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vector, and Rab11aN124I  transfected cells. Rab11aN124I is a dominant negative 
mutant of Rab11a, which cannot bind nucleotides and is expected to impair Tfn 
recycling since another dominant negative mutant Rab11S25N was shown to delay Tfn 
recycling [272]. All [
125
I]Tfn handling was done by Dr. Minoo Razi (LRI).  
 
Serum starved transfected HEK293A cells were allowed to internalise [
125
I]Tfn for 
10min at 37ºC followed by two acid washes at 4ºC to remove plasma membrane bound 
[
125
I]Tfn. These washes were counted and added to the calculations. Cells were then 
chased at 37ºC for 20, 50, or 110 minutes in either serum free DMEM, which for this 
duration does not induce autophagy, or EBSS, which will induce autophagy quickly. 
The [
125
I]Tfn released at each time point was counted in the medium and at the end cells 
were lysed and the total lysate was also counted. The percent recycled [
125
I]Tfn was 
determined by dividing the cpm in the medium (adding all counts from previous time 
points if applicable) by the total cpm (lysate+medium). The amount of internalised 
versus bound (lysate/lysate+acid washes), which gives an indication of how efficient 
uptake was for each condition, was found to be approximately 65% for all conditions 
(data not shown) suggesting that endocytosis and surface receptor availability is not 
affected in |TBC1D14 transfected cells. 
 
Tfn recycling was delayed in Rab11aN124I expressing cells compared to control cells, 
as expected, and also in TBC1D14 expressing cells although not as strongly (Fig. 5-5). 
The mutant TBC1D14RA/QA impaired Tfn recycling as efficiently as the wild type. 
There may be a slight difference between fed and starved chase conditions but the 
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experiment would have to be repeated to confirm this. Although the RA/QA mutant 
protein is expected to have no GAP activity I have shown above that it still tubulates 
REs and may therefore still cause a delay in Tfn recycling.  
 
Figure 5-5 Tfn recycling is delayed in TBC1D14 over-expressing cells 
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HEK293A cells were transfected with renilla vector control, myc-TBC1D14, myc-
TBC1D14R472A/Q508A or Rab11aN124I. After 24h expression transfected cells were serum starved for 
2h and incubated with [
125
I]Tfn for 10min at 37ºC to allow uptake. Then, cells were put on ice and acid 
washed twice with the acid wash measured by gamma counting. Cells were chased in serum free medium 
(fed; top) or EBSS (starved; bottom) for 20, 50, or 110 min. At each time point the supernatant medium 
containing recycled [
125
I]Tfn was removed for gamma counting and the cells were lysed to count 
intracellular [
125
I]Tfn. All conditions were done in duplicates and the average was used for calculations. 
The percentage of recycled [
125
I]Tfn was calculated by dividing CPM
medium
 + CPM
medium
 of previous time 
points, if applicable, by CPM
medium all time points
 + CPM
cell lysate
. This number was multiplied by 100 to 
display % values. 
 
To further investigate the nature of the TBC1D14-induced tubules I performed electron 
microscopy (EM) with the help of Dr. Minoo Razi (LRI). HEK293A cells transfected 
with either GFP or GFP-TBC1D14 were incubated with HRP-Tfn, gold-labelled anti-
EGFR, and human EGF to stimulate uptake of the latter, for 2 hours continuously. This 
allows internalisation of labelled Tfn and EGFR and achieves a steady state distribution 
of the two markers. Fixed cells were then prepared for EM and the HRP reaction was 
done, which will cause HRP-Tfn to appear dark in the EM pictures. We did not observe 
any tubulation in the GFP transfected cells (not shown) but saw a tubulated endosome 
containing HRP-Tfn but not gold anti-EGFR in the GFP-TBC1D14 transfected cells 
(Fig. 5-6). I would hypothesise that this cell is transfected with GFP-TBC1D14 and that 
the tubule seen corresponds to the tubules seen by confocal microscopy but further 
experiments, including correlative light and EM, could confirm this. 
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Figure 5-6 Putative GFP-TBC1D14 tubular RE revealed by EM 
HEK293A cells were transfected with GPF-TBC1D14 and 24h later cells were serum-starved for an hour 
and stimulated with HRP conjugated Tfn and human EGF (Sigma) in the presence of gold-anti-EGFR 
(clone 108) for 2hrs. Cells were fixed in 0.1M cacodylate containing 2% paraformaldehyde and 2% 
glutaraldehyde. HRP-Transferrin stimulated cells were incubated with hydrogen peroxide and DAB as 
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described by Graham and Karnovsky (1966) [273, 274], and were then embedded by standard procedures 
[275]. Thin (70nm) sections were imaged using a transmission electron microscope. Top panel shows the 
whole cell with the marked box enlarged below. Scale bars represent top=2m, bottom=500nm. 
 
5.4 Over-expression of dominant negative Rab11 inhibits 
autophagosome formation 
 
TBC1D14 over-expression leads to tubulation of REs in a Rab11 dependent manner and 
causes inhibition of autophagosome formation. This implies that Rab11 itself must be 
involved in autophagosome formation. Therefore, I tested Rab11 mutants for their 
effect on autophagy. As mentioned above Rab11N124I is a dominant negative mutant, 
which is unable to bind nucleotides, and should essentially have the same effect as 
TBC1D14 when over-expressed. Rab11Q70A is a dominant active mutant that 
preferentially binds GTP rather than GDP. Rab7 has been shown to be essential for late 
endosome-autophagosome fusion [183, 184] and similarly it has been suggested that 
Rab11 mediates MVB-autophagosome fusion [216], therefore, I included a dominant 
negative form of Rab7 (Rab7T22N), which prevents autophagosome maturation leading 
to an accumulation of LC3-II because it is not degraded in autolysosomes. Indeed, over-
expression of Rab7T22N leads to accumulation of LC3-II even in fed cells as expected 
(Fig. 5-7). However, in my hands, the block of autophagosome-lysosome fusion 
induced by excess Rab7T22N seems to be incomplete as LC3-II accumulates even 
further when leupeptin is added to the starvation medium. 
 
Compared to Rab7T22N the dominant negative form of Rab11 has a very different 
effect on autophagy in HEK293A cells. Over-expression of Rab11aN124I and 
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Rab11bN124I robustly inhibits autophagosome formation and not maturation, as there 
is a strong reduction of LC3-II even in the presence of leupeptin. As seen with 
TBC1D14 over-expression there is no difference in basal autophagy between control 
and transfected fed cells. Over-expression of wild type Rab11 enhanced autophagy but 
the constitutively active mutant Rab11aQ70A had no effect on LC3 lipidation. 
 
Figure 5-7 Inactive over-expressed dominant negative Rab11 inhibits autophagy 
HEK293A cells were transfected with the indicated GFP-tagged Rab construct, Rab11a wild type 
(Rab11aWT), Rab11aQ70A (GTP-bound), Rab11aN124I, Rab11bN124I (nucleotide empty), or 
Rab7T22N (GDP-bound). 24h later cells were starved in EBSS with or without leupeptin (leu). 
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Endogenous LC3 conversion was measured by western blot using anti-LC3. The mean of at least 3 
independent experiments is shown with the starved and starved with leupeptin samples done in 
duplicates. Asterisks indicate results of unpaired Student’s t-test comparing to the vector control (fed vs. 
fed; starved vs. starved; etc.). Rab11aWT starved with leupeptin p=0.0096; Rab11aN124I starved 
p<0.0001; starved with leupeptin p<0.0001; Rab11bN124I starved p<0.0001; starved with leupeptin 
p<0.0001; Rab7T22N fed p=0.001; starved p=0.0443; starved with leupeptin p<0.0001. Error bars 
indicate SEM. A representative western blot is shown using anti-GFP antibody to detect transfected Rab 
proteins, anti-actin, and anti-LC3 antibodies to detect the respective endogenous proteins. 
 
The above result strongly suggests that Rab11 is a positive regulator of autophagosome 
formation. To investigate further whether it is essential for autophagy HEK293A cells 
were depleted of Rab11a and 11b by siRNA mediated knock down and LC3 lipidation 
was measured. However, biochemical analysis was not feasible because there was a 
significant amount of cell death in Rab11 knock down cells. This could be due to the 
role of Rab11 in cytokinesis [276, 277] as many multinucleated or apoptotic cells are 
observed by immunofluorescence (not shown). Indeed, when TBC1D14 is highly over-
expressed, some cells are also multi-nucleated (Fig. 3-4). Alternatively, redundancy 
between Rab11 and Rab25, which are very similar [196] may explain why knock down 
of the former has no effect. Rab11 and Rab25 may use the same effectors but, whereas 
these are sequestered by dominant negative Rab11, they are freely available to interact 
with Rab25 in Rab11 siRNA treated cells. Knock down of all three Rab proteins may be 
more effective or use of different RNA duplexes since many siRNAs have off target 
effects. Knock down over a shorter time period than the 3 days used for this experiment 
may allow biochemical analysis. 
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Figure 5-8 siRNA mediated knock down of Rab11 had no robust inhibitory effect 
on autophagy 
HEK293A cells were transfected with the indicated siRNA as described above and left in full medium, 
starved, or starved with leupeptin (leu) for 2h before lysis. Western blot analysis was performed using the 
LI-COR system for quantification of actin and LC3. HRP-conjugated secondary antibodies and d ECL 
reagent were used to detect anti-Rab11a and anti-Rab11b. si11a=siRab11a, si11b=siRab11b, 
si11a/b=siRab11a and 11b, mock=mock transfected. Data represents the mean of 6 independent 
experiments. Error bars represent SEM. Paired Student’s t-test detected no significance. Membrane 
blotted with anti-Rab11b on the left is one membrane but was partly flipped (last 3 lanes were loaded the 
other way round) for clarity. 
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5.5 Over-expression of constitutively active Rab11 can not 
rescue TBC1D14 induced inhibition of autophagosome 
formation 
 
I have shown that TBC1D14 inhibits autophagosome formation when over-expressed, 
and tubulates REs in a Rab11 dependent manner suggesting that it acts a Rab11-GAP. 
Therefore, I hypothesised that by-passing Rab11 inactivation by over-expressing a 
constitutively active mutant Rab11Q70A, which preferentially binds GTP rather than 
GDP, should rescue the inhibition of autophagosome formation induced by TBC1D14. 
Similarly, ULK1 sequestration may also be contributing to the phenotype and providing 
excess ULK1 by over-expressing it may rescue autophagy inhibition. To test these 
hypotheses, HEK293A cells were transfected with myc-TBC1D14 as before either 
alone or together with Rab11aQ70A, Rab11bQ70A, myc-ULK1, or HA-ULK1 and 
assayed for LC3 conversion as described above. Both ULK1 constructs were used 
because the myc-tagged one contains mouse ULK1 whereas the HA-tagged one 
contains the human homologue even though their amino acid sequences are very 
similar. 
 
Co-transfection of Rab11Q70A did not rescue inhibition of autophagosome formation, 
and the reduction in LC3 lipidation was comparable to TBC1D14 alone (Fig. 5-9). This 
may be due to sequestration of effectors of Rab11 and/or TBC1D14, so that a functional 
Rab11 effector platform cannot form. ULK1 co-transfection with TBC1D14 on the 
other hand was able to rescue autophagy inhibition and induced even higher rates of 
LC3 conversion than observed in control cells. Even under fed conditions basal 
Chapter 5. Results 
 191 
autophagy was enhanced in ULK1-TBC1D14 over-expressing cells, which is not seen 
when ULK1 alone is over-expressed [20, 21]. 
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Figure 5-9 Over-expression of constitutively active Rab11 does not rescue 
TBC1D14 induced inhibition of autophagosome formation by TBC1D14 but over-
expression of ULK1 does 
HEK293A cells were transfected with renilla vector (control), GFP-Rab11bQ70A and myc-TBC1D14 
together (11bQA+14), GFP-Rab11aQ70A and myc-TBC1D14 together (11aQA+14), myc-TBC1D14 
alone (14), human HA-ULK1 and myc-TBC1D14 together (hU1+14), or mouse myc-ULK1 and myc-
TBC1D14 together (mU1+14). Cells were processed as usual for LC3 western blotting. Membranes were 
incubated with antibodies against actin and LC3 as indicated, followed by antibodies against myc, GFP, 
and HA to detect over-expressed proteins using the LI-COR system. Secondary antibodies labelled with 
two different infrared fluorophores were used and polyclonal antibodies (myc and HA) were pseudo-
coloured magenta, monoclonal antibodies were pseudo-coloured cyan and the two pictures were overlaid 
showing the over-expressed proteins. The actin band is still visible in the top blot as membranes were not 
stripped after LC3 and actin quantification but labelled with anti-myc, anti-HA, and anti-GFP. (a) 
Representative western blot of TBC1D14 over-expression with constitutively active Rab11Q70A. (b) 
Representative western blot of TBC1D14 over-expression with either HA-ULK1 or myc-ULK1. Data 
represents mean of 3 independent experiments and error bars represent SEM. Asterisks indicate results 
from unpaired Student’s t-test comparing fed control to fed condition, starved with leupeptin (leu) control 
to starved with leupeptin condition, etc. GFP-Rab11bQ70A and myc-TBC1D14 starved with leupeptin 
p<0.0001; GFP-Rab11aQ70A and myc-TBC1D14 starved with leupeptin p<0.0001; TBC1D14wt starved 
with leupeptin p=0.0002; myc-ULK1 and myc-TBC1D14 fed p<0.0001; HA-ULK1 and myc-TBC1D14 
fed p=0.0046, starved p<0.0001, and starved with leupeptin p<0.0001. 
 
Despite the ability of excess ULK1 to rescue inhibition of autophagy induced by 
TBC1D14 it is unlikely that ULK1 sequestration is the sole reason for inhibition of 
autophagosome formation since over-expression of the TBC domain of TBC1D14, 
which still binds ULK1, does not inhibit autophagy (Fig. 4-11). This raises the question 
whether the TBC domain alone localises to the same compartment as full length 
TBC1D14 or whether it is found on a different organelle such as the Golgi apparatus. 
After all endogenous TBC1D14 localises to the Golgi and it is conceivable that the N or 
C-terminal domains of this protein, which are missing in the TBC construct, somehow 
regulate its localisation. Were this the case failure to tubulate REs may the reason that 
there is no inhibition on autophagosome formation when the TBC domain alone is over-
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expressed. Therefore, cells were transfected with GFP-TBC1D14-TBC and labelled 
with anti-TfnR to investigate whether the TBC domain localises to the pericentriolar 
ERC like the full length protein or to a different compartment. Indeed, the TBC domain 
alone localises to a TfnR-positive structure (Fig. 5-10). Interestingly, this juxta-nuclear 
pool appears larger than the normal ERC observed in untransfected cell suggesting that 
RE movement away from it is blocked or transport towards it enhanced.  
 
 
Figure 5-10 The TBC domain of TBC1D14 alone can tubulate REs 
HEK293A cells were transfected with GFP-TBC1D14-TBC (amino acids 224-669) (green), fixed and 
labelled with anti-TfnR antibody (red). The cell border and the nucleus (Nuc) are indicated by dotted 
lines. Note that there is an untransfected cell in the south east corner of the image. 
 
5.6 Over-expression of TBC1D14 does not affect other cellular 
trafficking pathways 
 
As shown in Figure 5-4 EGF uptake and trafficking was not affected by TBC1D14 
over-expression. To confirm that TBC1D14 acts in Rab11-dependent RE trafficking 
only I investigated the distribution of several markers of other intracellular trafficking 
pathways in TBC1D14 expressing cells. HEK293A cells were transfected with myc- or 
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GFP-TBC1D14, starved for 2 hours or not and fixed. Cells were then labelled with the 
corresponding antibody to a range of markers for subcellular compartments. With the 
exception of CI-MPR and LAMP2 only starved cells are shown for marker proteins that 
do not change distribution upon starvation (Fig. 5-11). 
The cation-independent mannose-6-phosphate (M6P) receptor (CI-MPR) shuttles 
between the TGN and endosomes to target M6P labelled lysosomal enzymes to the 
lysosome [278]. It is sorted in the early endosomes to be transported back to the TGN 
(see Introduction section 1.2.1) and unlike TfnR does not change its distribution upon 
starvation (Fig. 5-11a). TBC1D14 over-expression does not disturb the localisation of 
CI-MPR although these TBC1D14-positive tubules can often be found juxta-posed to 
CI-MPR-positive vesicles. TfnR and CI-MPR are both found in early endosomes but 
probably only the TfnR-positive endosomal subdomain is tubulated by TBC1D14. 
Another early endosomal protein early endosomal autoantigen 1 (EEA1) which is an 
effector of Rab5 [279] behaves similarly to CI-MPR in that it can be found in close 
proximity to TBC1D14-positive tubules but is not affected by its over-expression (Fig. 
5-11b). Finally, EGFR, which localises to both early and late endosomes/MVBs, can be 
found in some TBC1D14 tubules but this is probably because unlike CI-MPR it is not 
actively sorted to a subdomain of the early endosome but follows the degradative route 
passively as endosomes mature from early to late to lysosomes (Fig. 5-11c). However, 
this degradative route itself is not affected by TBC1D14 over-expression as the late 
endosomal protein Rab7 and the lysosomal associated membrane protein 2 (LAMP2) 
are distributed normally in transfected cells (Fig. 5-11d,e). Note, that LAMP2 shows a 
much more peripheral distribution after starvation due to autolysosome formation. 
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The Golgi and TGN were labelled with antibodies against Golgi matrix protein of 130 
kDa (GM130) and trans-Golgi network integral membrane protein 2 of 46 kDa 
(TGN46), respectively [280, 281] (Fig. 5-11f,g). Surprisingly, TBC1D14 tubules do not 
substantially co-localise with GM130 or TGN46, as is the case for endogenous 
TBC1D14. This preference of over-expressed TBC1D14 to localise to Rab11-positive 
compartments rather than the Golgi/TGN may be due to titration of an essential effector 
that keeps TBC1D14 on the Golgi/TGN or directs it there. However, this is purely 
speculative. Interestingly, the Golgi appears to be fragmented in some but not all 
TBC1D14 over-expressing cells but it is unclear what leads to this differential 
phenotype. It may possibly be cell cycle specific but this was not investigated. The 
other possibility is that TBC1D14 has a role in Golgi stability as has been reported 
before by Haas et al. [200], even though it did not bind any known Golgi localised Rabs 
in a yeast-2-hybrid assay (Fig. 4-13). 
 
Finally, TBC1D14 tubules do not overlap with the ER protein calreticulin suggesting 
that the secretory pathway is intact in TBC1D14 over-expressing cells (Fig. 5-11h). 
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Figure 5-11 TBC1D14 over-expression does not disturb several other intracellular 
trafficking pathways 
HEK293A cells were transfected with GFP or myc-TBC1D14 (green) and 24h later starved for 2h in 
EBSS where indicated. Cells were then labelled with antibodies against (red) the (a) CI-MPR (cation 
independent-mannose-6-phosphate receptor), (b) EEA1 (early endosomal autoantigen 1), (c) EGFR 
(epidermal growth factor receptor) (d) Rab7 (e) LAMP2 (lysosomal associated membrane protein 2), (f) 
GM130 (Golgi matrix protein of 130 kDa), (g) TGN46 (trans-Golgi network integral membrane protein 2 
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of 46 kDa), and (h) calreticulin. Asterisks indicate transfected cells, with enlarged inset on right indicated 
as boxes on the merged panel. Scale bars are equal to 10m. 
 
5.7 TBC1D14 tubules do not co-localise with early autophagic 
markers DFCP1 or WIPI2 
 
So far I have shown that over-expression of TBC1D14 tubulates Rab11-positive REs, 
sequesters ULK1 and leads to inhibition of autophagosome formation. However, this 
population of REs has not been previously linked to autophagy, so I investigated the 
role of REs in autophagosome formation. 
The phosphatidylinositol-3-kinase (PI3K) complex apart from the ULK1 kinase 
complex is also essential for initiation of autophagy (see Introduction section 1.1.3). 
This second complex contains the class III PI3K vps34, which creates 
phosphatidylinositol-3-phosphate (PI3P) on isolation membranes and autophagosomes. 
WIPI2 and DFCP1 are two PI3P-binding autophagy proteins, which localise to isolation 
membranes dependent on PI3K activity. The ULK1 and PI3K complexes most likely 
act somewhat in parallel [80], very early in autophagosome formation, so I investigated 
whether WIPI2 or DFCP1 would localise to TBC1D14 induced tubular REs together 
with ULK1. 
TBC1D14 was over-expressed in HEK293A cells, which were starved and labelled with 
antibodies against ULK1 and WIPI2. WIPI2 is mostly cytosolic and diffuse in fed cells 
but forms distinct puncta on isolation membranes upon starvation [57]. These WIPI2 
puncta co-localise with ULK1 in most cases, however, WIPI2 is not observed on 
TBC1D14 tubules suggesting that autophagosome formation is blocked by TBC1D14 
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over-expression before the two pathways converge (Fig. 5-12a). TBC1D14 was found 
to share some sequence similarity with a yeast protein sbe22p in a PSI blast. 
Interestingly, sbe22p was found in a yeast-2-hybrid assay to bind Atg18p, which is the 
yeast homologue of WIPI2 but I could not confirm this interaction by co-
immunoprecipitation in HEK293A cells. There is also no substantial co-localisation 
between endogenous TBC1D14 and WIPI2 although some WIPI2 puncta can be 
observed in close proximity to the Golgi/TGN pool of TBC1D14 (Fig. 5-12b, insets 1 
and 2). 
DFCP1 localises to the same structures as WIPI2 but because there is no antibody 
against DFCP1 available myc-TBC1D14 was over-expressed in HEK293A cells stably 
expressing GFP-DFCP1 [69]. Immunofluorescence staining with anti-myc and anti-
TBC1D14 specific antibodies revealed that DFCP1 does not localise to tubulated REs 
(Fig. 5-12c, inset 1) and does not co-localise with endogenous TBC1D14 endosomal 
puncta but the DFCP1 Golgi pool shows good overlap Golgi localised TBC1D14 (Fig. 
5-12c, inset 2). 
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Figure 5-12 PI3P binding proteins WIPI2 and DFCP1 do not localise to TBC1D14 
tubules 
(a) HEK293A cells were transfected with GFP-TBC1D14, starved for 2h in EBSS and labelled with anti-
ULK1 (red) and anti-WIPI2 antibody (blue in merge). WIPI2 co-localises with ULK1 in cytosolic puncta 
(arrowheads) but is not recruited to TBC1D14 induced ULK1-positive tubules (arrows). (b) HEK293A 
cells were starved for 2h in EBSS, fixed, and labelled with antibodies against WIPI2 and TBC1D14. 
Dotted boxes 1 and 2 are enlarged on the right. (c) Cells stably expressing GFP-DFCP1 (201 cells) were 
transfected with myc-TBC1D14, starved and stained with antibodies against myc (blue) and TBC1D14 
(red). Transfected myc-positive cells are marked with an asterisk. GFP-DFCP1 puncta do not co-localise 
with myc-TBC1D14 tubules (inset 1) but endogenous TBC1D14 shows overlap with GFP-DFCP1 in the 
Golgi/juxta-nuclear region in untransfected cells (inset 2, arrows). Scale bars are equal to 10m. 
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TBC1D14 over-expression does not seem to inhibit WIPI2 and DFCP1 puncta 
formation dramatically but appears to reduce the number of GFP-LC3 positive 
autophagosomes. This suggests that the PI3K pathway is unaffected and WIPI2 as well 
as DFCP1 can localise normally to IMs in TBC1D14 over-expressing cells. However, 
these isolation membranes may not be able to progress to become autophagosomes 
because TBC1D14 over-expression blocks other essential autophagic functions most 
likely involving the ULK1 kinase complex. To test this hypothesis TBC1D14 
transfected starved 2GL9 cells were labelled with anti-WIPI2 antibody and the number 
of WIPI2 positive isolation membranes was counted. Indeed preliminary data suggests 
that there are slightly more WIPI2 puncta in TBC1D14 over-expressing cells and that 
less of those have acquired GFP-LC3, which localises to autophagosomes at a later 
stage than WIPI2 (Fig. 5-13). Whereas in untransfected cells on average 64% of WIPI2 
spots were also positive for GFP-LC3, this was significantly reduced in transfected cells 
to 57%.  
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Figure 5-13 WIPI2 puncta accumulate in TBC1D14 over-expressing cells 
2GL9 cells were transfected with myc-TBC1D14 and starved for 2h in EBSS. Cells were labelled with 
anti-myc (red) to detect transfected cells (marked by a white asterisk) and anti-WIPI2 antibodies. A 
representative image used for spot counting is shown above with the transfected cell enlarged underneath. 
The number of WIPI2 spots were counted in 52 untransfected and 55 transfected cells on the same cover 
slip and classified as GFP-LC3-positive or negative. In untransfected cells 64.3% (±2.3% SEM) of WIPI2 
spots were GFP-LC3 positive compared to 56.9% (±1.6% SEM) in myc-TBC1D14 transfected cells. 
Black asterisks indicate result of unpaired Student’s t-test with p=0.0084. Scale bars are equal to 10m. A 
distribution of spot count per cell is shown below. Each data point represents the number of WIPI2 
puncta per cell. Red asterisk indicates significant accumulation of WIPI2 spots in TBC1D14 transfected 
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cells as calculated by an unpaired Student’s t-test. p=0.0247. Red line indicates mean number of WIPI2 
spots per cell. Mean untransfected=12.44 (±0.7427); mean transfected=14.82 (±0.7308). Error bars 
indicate SEM. 
 
5.8 mAtg9 and ULK1 localise to REs 
 
Another early acting autophagy protein is mAtg9. This transmembrane protein cycles 
between the TGN and an endosomal pool and disperses to endosomes upon starvation 
(see Introduction section 1.1.5.1). Although mAtg9 has been shown to localise to late 
endosomes it can also be found to co-localise extensively with REs labelled by TfnR 
(Fig. 5-14a). In starved HEK293A cells labelled with antibodies against endogenous 
ULK1, mAtg9, and TfnR, mAtg9 seems to be localised on subdomains of REs rather 
than cover the entire surface and almost every RE observed contains such a mAtg9 
subdomain (Fig. 5-14ii). ULK1 also localises to REs and can occupy the same area as 
mAtg9 or be on a different domain (Fig. 5-14i and iii). This localisation seems to be 
starvation-independent as both proteins are also found on REs in fed cells (data not 
shown), however, closer investigation and quantification of mAtg9 overlap on REs in 
fed versus starved cells may reveal subtle differences.  
 
When TBC1D14 is over-expressed REs are tubulated and sequester ULK1, however, 
mAtg9 is not localised to tubules (Fig. 5-14b). Interestingly, mAtg9 dispersal is not 
affected by TBC1D14 over-expression suggesting that its trafficking to other 
compartments such as late endosomes is intact but it cannot reach REs that are 
tubulated. I hypothesise that REs provide an autophagy signalling platform containing 
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both ULK1 and mAtg9, which can induce autophagosome formation upon nutrient 
deprivation. This signalling platform is disrupted by TBC1D14 over-expression and 
Rab11 inactivation leading to a block of autophagosome formation. 
 
Figure 5-14 mAtg9 and ULK1 localise to REs, but TBC1D14 tubules contain only 
ULK1 
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(a) HEK293A cells were starved for 2h in EBSS, fixed and labelled with antibodies against ULK1 
(green), mAtg9 (red) and TfnR (blue). Inset i) shows the triple-labelled merge. Insets ii) and iii) were 
pseudo-coloured for clarity so that TfnR (green) is shown with ii) mAtg9 (red), and iii) ULK1 (red). 
Arrowheads indicate i) TfnR, ii) mAtg9 and iii) ULK1 positive puncta. Two enlarged images of REs are 
shown (top inset corresponds to top box). (b) Same as in (a) but HEK293 cells were transfected with 
myc-TBC1D14, and labelled with anti-myc instead of TfnR. Inset iv) shows triple labelled merge. Inset 
v) shows mAtg9 (red) and myc-TBC1D14 (green) tubules, which do not overlap, and vi) shows ULK1 
(red) co-localised on myc-TBC1D14 (green) tubules. Enlarged images of a RE-tubule are shown as 
indicated. Asterisks in (b) indicate myc-TBC1D14 transfected cells. Scale bars are equal to 10m. 
 
5.9 TfnR and Rab11 show partial co-localisation with GFP-LC3 
 
Since REs contain two early autophagy proteins ULK1 and mAtg9 it is tempting to 
speculate that REs can not only act as a platform to activate downstream signalling to 
induce autophagosome formation but also provide membrane to expanding isolation 
membranes. To test this hypothesis 2GL9 cells were starved for two hours and labelled 
with anti-TfnR. Partial co-localisation of TfnR with GFP-LC3 positive autophagosomes 
can be observed in these cells (Fig. 5-15a). Likewise when 2GL9 cells were starved for 
2h, fixed, treated with saponin briefly to reduce cytosolic Rab11 background and 
labelled with isoform specific anti-Rab11a or anti-Rab11b and anti-TfnR antibodies, 
GFP-LC3 spots can be observed that contain all three markers (Fig. 5-15b). This 
suggests that REs may provide membrane to expanding IMs and/or autophagosomes 
directly but are probably not the sole membrane donors. Alternatively, the partial co-
localisation observed between RE markers and GFP-LC3 positive autophagosomes may 
be due to engulfment of REs by autophagosomes as this cannot be distinguished from 
membrane incorporation by immunofluorescence microscopy.  
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Myc-TBC1D14 shows no substantial co-localisation with GFP-LC3 but is sometimes 
observed in close proximity to GFP-LC3 puncta and endogenous TBC1D14 also shows 
very little overlap with GFP-LC3 (Fig. 5-15c). This may be due to TBC1D14 acting in a 
different step in RE trafficking and no longer associating with Rab11 on 
autophagosomes or because of the interaction with Rab11 is too transient to detect 
reliably.  
 
Furthermore, because GFP-LC3 is quenched in an acidic environment such as the 
autolysosome it can only reveal immature AVs. To investigate whether TBC1D14 can 
be found on mature autophagosomes I transfected HEK293A cells with an mRFP-
EGFP-LC3 tandem-fluorescent construct (tf-LC3). Because mRFP is not quenched in 
autolysosomes mature autophagosomes will appear red, whereas immature 
autophagosomes will appear yellow. Again, no co-localisation of endogenous 
TBC1D14 with either population of AVs was observed (Fig. 5-15d) 
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Figure 5-15 TfnR and Rab11 show partial co-localisation with GFP-LC3 
(a) 2GL9 cells were starved for 2h in EBSS, fixed, and labelled with anti-TfnR antibody (red). TfnR 
partially co-localises with GFP-LC3 positive autophagosomes (arrowheads). (b) 2GL9 cells were starved 
for 2h in EBSS, treated with 0.2% saponin/PIPES to reduce cytosolic staining, fixed and labelled with 
antibodies against Rab11a (red, top) or Rab11b (red, bottom) and TfnR (blue). Rab11 and TfnR partially 
co-localise with GFP-LC3 positive autophagosomes (arrowheads). Note that although the anti-Rab11a 
and anti-Rab11b antibodies are isoform specific by western blot (Fig. 4-15) I have not tested whether they 
also specifically recognise the native isoforms in immunofluorescence experiments. (c) 2GL9 cells were 
starved for 2h in EBSS, fixed, and labelled with anti-TBC1D14 (red). TBC1D14 shows very little co-
localisation with GFP-LC3 positive autophagosomes (arrowheads). (d) Cells were transfected with tfLC3, 
fixed, stained for TBC1D14 and starved for 2h in EBSS (bottom image) or not (top image). The tfLC3 is 
visualized in the green and red channel, which is shown merged. Enlarged insets (1) and (2) are from 
starved cells.  
 
5.10  Conclusions 
 
I have shown a role for REs in autophagy, which I propose act as signalling platforms to 
induce autophagy and may provide parts of the autophagosomal membrane. Two early 
autophagy proteins ULK1, and mAtg9, localise to Rab11-positive REs. The RabGAP 
protein TBC1D14, binds to Rab11, and tubulates TfnR/Rab11-positive REs when over-
expressed. Tubulated REs sequester ULK1 but not the other early autophagy proteins 
mAtg9, WIPI2, or DFCP1 nor the later acting protein LC3. Autophagy is inhibited by 
TBC1D14 over-expression at an early step during formation or expansion and not 
during maturation. In agreement with the data suggesting TBC1D14 is a GAP or an 
effector for Rab11, I have shown that a dominant negative mutant of Rab11 inhibits 
autophagosome formation. 
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I propose a model whereby a population of ULK1 and mAtg9 is resident on the REs in 
both fed and starved conditions. ULK1 is recruited to the REs by TBC1D14. Upon 
nutrient starvation ULK1 is activated and moves to the site of autophagosome formation 
or recruits Atg proteins to form IMs de novo. mAtg9, which localises to REs and other 
endosomal populations may be a nutrient sensor on these vesicles that can activate 
autophagy when cells are deprived of nutrients.  
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Chapter 6. ULK1 knock-out mice 
 
6.1 Aim 
 
ULK1 or its homologues is essential for autophagy in HEK293A and HeLa cells as well 
as S. cerevisiae, D. discoideum, C. elegans, and D. melanogaster [20, 22-26]. In mice 
ULK1 has been shown to regulate axon extension in primary neurons in culture, 
purified from mouse brain [90]. However, whereas invertebrates have one Atg1 
homologue there are at least two but possibly up to five Atg1 homologues in vertebrate 
organism, which in mice and humans are called ULK1, ULK2, ULK3, ULK4 and 
STK36. To investigate the specific functions of ULK1 in mice, animals lacking the 
ULK1 protein were created (ULK1KO) by Dr. Edmond Chan and I analysed whether 
they have any specific defects. 
 
6.2 ULK1 knock-out mice appear healthy, are fertile, and 
undergo autophagy 
 
ULK1KO mice were created by injecting 129 embryonic stem (ES) cells with a gene 
trap insertion in the ULK1 gene (clone AC0566, Sanger institute gene trap resource) 
into C57BL/6J blastocysts to create chimeric mice. Gene trapping is a method of 
creating embryonic stem cells with a random insertion of a well defined reporter 
cassette. This cassette contains a splice acceptor site from an engrailed 2 (En2) intron 
located 5 to a promoterless -gal/neo (or -geo) fusion construct, followed by a poly-
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adenylation signal from an SV40 virus gene. Once this cassette is inserted in an exon or 
more often an intron of a gene X this will lead to splicing events creating a fusion 
transcript consisting of the upstream 5’ exon(s) of gene X, followed by the -gal/neo 
reporter/resistance gene, followed by a poly-A stretch, which leads to translation 
termination. This transcript will be under the endogenous promoter of gene X and the -
gal product can then serve not only as a reporter to confirm insertion of the gene trap 
cassette but also as an indicator of the expression pattern of gene X. Trapped ES cells 
can be selected using neomycin as the neomycin transferase in the -geo fusion protein 
confers neomycin resistance but cells will be selected regardless of whether the 
insertion occurred intergenically or intragenically. Insertion of the gene trap at the 5’ 
end is more likely to lead to total loss of function of a gene but there is always a small 
possibility that inactivation is incomplete. In clone AC0566 that was used to create 
ULK1KO mice the gene trap cassette inserted at the beginning of the ULK1 gene 
intronically after exon 3 creating a fusion protein of the first 81 amino acids of ULK1, 
the -galactosidase and neomycin transferase (Fig. 6-1). This results in a short 
truncation of the kinase domain of ULK1 (spanning from amino acids 16-278) and is 
expected to lead to complete loss of function. However, both heterozygous and 
homozygous ULK1KO mice show no obvious phenotypes and are fertile. ULK1KO 
mice were backcrossed into the C57BL/6J strain for 10 generations (n=10), which 
should result in a 99.9% C57BL/6J background but still no phenotype was observed. 
Detailed post-mortem analysis by the histopathology laboratory at LRI (see Appendix) 
also revealed no abnormalities in ULK1KO mice. 
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There are several explanations for the lack of a severe phenotype in ULK1KO mice. 
Firstly, there is a small possibility that the gene was not completely inactivated by the 
gene trap insertion but this is unlikely given the upstream 5’ location of the reporter 
cassette and its location inside the kinase domain. Secondly, the only ES cells to survive 
the selection process may have carried a mutation or polymorphism that leads to 
enhanced ULK2 expression or another compensating mechanism. Thirdly, 
compensation may have occurred during development leading to an increase in ULK2 
levels. Lastly, ULK1 dependency for autophagic function may be a feature applying to 
immortalised cells in culture and not in vivo for unknown reasons but possibly linked to 
the immortalisation process. 
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Figure 6-1 ULK1 knock-out mice were created using gene trapped ES cells 
ES cells were obtained from the Sanger institute gene trap resource and injected into C57BL/6J 
blastocysts to create chimeric mice harbouring a disrupted ULK1 gene in the germ line. The gene trap 
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cassette has inserted in an intronic region after exon 3 in a very upstream 5’ region of the ULK1 gene, 
which is found on chromosome 5 in mice and contains 28 exons encoding a 1051 amino acid protein. In 
the ULK1 knock-out mice instead, a fusion protein containing the first 81 amino acids of ULK1 followed 
by the -galactosidase-neomycin transferase fusion protein is transcribed. Importantly, the ULK1 gene 
was interrupted at the N-terminal region of the kinase domain, which should essentially inactivate the 
protein. 
 
To investigate whether basal autophagy is impaired in ULK1KO mice several tissues 
were analysed for LC3 lipidation by western blotting. For this wild type, heterozygous 
and knock-out sex-matched littermates were sacrificed, and organs or tissues were 
removed and shock-frozen in liquid nitrogen. Tissues tested included: whole brain, 
heart, liver, lung, kidney, pancreas, and skeletal muscle from the thigh. Tissues were 
then lysed in 4 to 5 times their weight of TNTE and homogenised using a polytronic 
homogeniser. Protein content in cleared lysates was measured by Bradford assay and 
60g protein was loaded per lane. Membranes were blotted with antibodies against 
ULK1, actin as a loading control, and LC3. No differences in basal LC3 lipidation 
between wild type, heterozygous and knock-out mice could be observed in any of the 
tissues tested (Fig. 6-2). Ponceau staining of membranes revealed two thick bands 
running at roughly the same size as LC3, which probably represent haemoglobin. In 
tissues where haemoglobin is particularly high, the LC3 antibody bound inefficiently 
and the western blot staining could probably not reveal all LC3 bound to the membrane. 
In the liver, LC3-II is much more prevalent and no LC3-I could be detected. Actin 
staining for the pancreas was uneven and there may have been some degradation in the 
heterozygous and knock-out samples, which could be due to handling differences. 
ULK1 could not be visualised in all tissues even though it is reported to be expressed 
ubiquitously (Fig. 6-2). This may reflect different protein levels or be due to the 
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appearance of different background bands. However, this analysis was only done once 
and should be repeated optimising ULK1 blotting. 
 
Figure 6-2 Basal autophagy is not affected in ULK1KO mouse tissues 
A wild type, a heterozygous, and a knock-out mouse were sacrificed, and organs or tissues were removed 
and shock-frozen in liquid nitrogen. Tissues tested were: whole brain, heart, liver, lung, kidney, pancreas, 
and skeletal muscle from the thigh. Tissues were then lysed in 4 times their weight of TNTE containing 
protease and phosphatase inhibitors except for the liver with 5 times its weight in TNTE because of 
relatively high protein content. Tissue lysates were homogenised using a polytronic homogeniser and 
cleared by short centrifugation for 5 min. at 2500g. All these steps were done at 4ºC. Protein content in 
cleared lysates was measured by Bradford assay and samples were heated to 65ºC for 15min. in 5X 
sample buffer. 60g of protein was loaded in each lane and membranes were stained with ponceau 
(shown below) and afterwards labelled with anti-ULK1, anti-actin, and anti-LC3 antibodies. ULK1 band 
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where detectable is indicated by red arrowheads. In tissues with high haemoglobin content (marked by H 
and two arrows) the LC3 band was hard to visualise as the large haemoglobin band probably prevents 
efficient anti-LC3 binding. This analysis was done once with 3 littermate sex-matched mice. 
 
6.3 ULK1KO mice have reduced thymic cellularity but the T cell 
populations look normal 
 
Some post-mortem reports on ULK1KO mice that had died of old age stated that in 
several cases they had a small thymus, which was never reported for wild type mice. 
Furthermore, during the course of this investigation another group reported reticulocyte 
maturation defects in ULK1KO mice [81] although they only observed this in a mixed 
C57B/6, 129Sv, and FVB/N background mouse strain but not a pure C57BL/6J strain 
(personal communication). These findings prompted me to investigate the 
hematopoietic system of ULK1KO mice more closely. I first investigated the thymus, 
which is the site of T cell maturation in which autophagy plays an important role [244, 
282]. Thymi were removed from ULK1 wild type (WT), heterozygous (HET), and 
knock-out (KO) sex matched littermates and processed through a 70m mesh into fresh 
medium to obtain primary thymocytes. Red blood cells (RBCs) were removed by 
incubation in RBC lysis buffer for 5 min. This buffer is slightly hypotonic leading to 
RBC lysis with minimal effects on other cells. Some thymocytes were left in full 
medium or starved for 2.5 hours in EBSS with leupeptin lysed and analysed by anti-
LC3 western blotting. No difference in basal autophagy between WT, HET, or KO fed 
thymocytes could be observed (Fig. 6-3a). Autophagy seems to be slightly enhanced in 
all starved thymocytes with a slight increase in lipidated LC3 in ULK1KO cells 
compared to cells that have some ULK1. ULK1 staining revealed that HET thymocytes 
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have half as much ULK1 protein as WT cells with the band disappearing completely in 
the KO cells, as expected. However, this analysis should be optimised and repeated to 
allow quantification of LC3 conversion. 
 
For FACS analysis 10
6
 thymocytes from each mouse were labelled with anti-CD4 and 
anti-CD8 antibodies to reveal the major T cell populations and FACS profiles were 
acquired for 1min each with gates set on live single cells. The FACS profile of 
ULK1WT, HET, or KO thymi revealed no substantial differences in the percentage of 
mature CD4+ (~10%) and CD8+ T (~5%) cells or immature double positive (~77%) T 
cells (Fig. 6-3b). Since autophagy may also act as a type II programmed cell death 
pathway and enhanced autophagy in starved ULK1KO thymocytes may lead to 
enhanced apoptosis the cells were also labelled with AnnexinV and DAPI. Early 
apoptotic cells display phosphatidylserine (PS) on their surface, which is only located to 
the inner plasma membrane leaflet in healthy cells and AnnexinV binds PS therefore 
labelling early apoptotic cells specifically. DAPI binds DNA and reveals necrotic or late 
apoptotic bodies. However there was no difference in the percentage of apoptotic CD4+ 
or CD8+ T cells between ULK1WT, HET or KO thymi (Fig. 6-3c) nor in the double 
positive or double negative thymocyte populations (not shown). There do seem to be 
less T cells in total however in the ULK1KO thymus (137,464 cells) compared to the 
ULK1WT thymus (176,513 cells) with the HET thymus having an intermediate 
phenotype (154,715 cells).  
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Figure 6-3 ULK1KO thymocytes can undergo autophagy 
Thymi were removed from ULK1 wild type (WT), heterozygous (HET), and knock-out (KO) sex-
matched littermates and processed through a 70m mesh to harvest thymocytes. Cells were incubated for 
5min in red blood cell (RBC) lysis buffer to remove RBCs. (a) One group of thymocytes was starved for 
2.5h in EBSS with leupeptin (leu) or left in full medium, lysed and run on SDS-PAGE for western 
blotting with anti-LC3, anti-actin, and anti-ULK1 antibodies. (b,c) The other group was labelled with 
DAPI, AnnexinV, and antibodies against CD4 and CD8 for FACS analysis. 10
6
 cells were resuspended in 
FACS buffer and the FACS profile was acquired for 1 min each with gates set on single live cells. (b) 
FACS profiles of CD4 and CD8 positive T cell populations of ULK1WT, HET and KO thymi. (c) FACS 
analysis of T cell apoptosis for CD4+ gate (top) and CD8+ gate (bottom). 
 
As shown above there was no difference in basal autophagy in thymocytes lacking 
ULK1 as compared to the wild type cells. However, since the vast majority of 
thymocytes consist of T cells it would probably not be detectable by western blot 
analysis if there were a defect in autophagy in a small population of cells such as 
dendritic cells or thymic epithelial cells, which use autophagy to present endogenous 
antigens via MHC-II molecules to CD4+ T cells [244]. To look at different 
subpopulations of thymocytes cells were FACS sorted by the LRI sorting facility into 
CD4+, CD8+, double positive and double negative cells. Not enough cells could be 
harvested for LC3 western blot analysis but as in the previous experiment (and as noted 
in the post-mortem report) there seemed to be about 3 times less cells in the ULK1KO 
and HET thymi as compared to the WT thymus (Table 2). However, this data is 
preliminary and needs further confirmation. 
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Table 6-1 Thymocyte FACS sorting reveals lower total cellularity in ULK1HET 
and KO thymi 
Thymocytes from entire thymi of ULK1WT, HET, and KO mice were labelled with anti-CD4, and anti-
CD8 antibodies and FACS sorted into the four different populations. Cells were counted during sorting 
and the total numbers are shown in this table. 
 WT HET KO 
Double positive T cells 13.4x10
6
 (82%) 3.4 x10
6
 (67%) 3.2 x10
6
 (57%) 
CD4+ T cells 1.7 x10
6
 (10%) 895000 (17%) 1.02 x10
6
 (18%) 
CD8+ T cells 613000 (4%) 340000 (7%) 360000 (6%) 
Double negative cells 679000 (4%) 450000 (9%) 1.08 x10
6
 (19%) 
Total cellularity 16.4 x10
6
 5.1 x10
6
 5.7 x10
6
 
 
6.4 ULK1KO mice have less mature T cells 
 
It has been shown that T cells derived from Atg5 knock-out (Atg5KO) mice deficient in 
autophagy are reduced in number but develop normally and only when they reach the 
peripheral circulation and spleen show defects in survival and proliferation [283]. 
Therefore, I next investigated mature T cells from the spleen of ULK1KO mice. The 
ULK1 deficient mice had been reported to have mild splenomegaly [81] and indeed this 
is the case in our strain as well as observed repeatedly (Fig. 6-4a). Splenocytes from 
sex-matched littermates were FACS sorted into CD4, CD8, CD19 and triple negative 
cell populations. CD19 labels mostly B cells, which are practically absent in the thymus 
but abundant in the spleen where they act as co-activators of naïve T cells. The four 
subpopulations including whole splenocytes before sorting were harvested for western 
blot analysis to assess autophagic activity via LC3 lipidation. A Bradford assay was 
used to quantify protein concentration in each sample and 75g protein was loaded in 
each well unless the volume would have exceeded 60l (the maximum that can be 
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added to a well). All three cell types CD4+ and CD8+ T cells as well as B cells had 
mostly lipidated LC3-II indicating that they are undergoing basal autophagy (Fig. 6-4b). 
Starvation in culture did not seem to induce any more autophagy in these cells. Triple 
negative cells, which constitute a mixture of other cell types also showed basal 
autophagy in WT as well as ULK1KO cells and a two hour treatment with EBSS with 
leupeptin also did not increase autophagic activity dramatically. However, LC3 
lipidation measurements should be repeated for quantification and statistical analysis. 
 
 
Figure 6-4 ULK1KO mice have splenomegaly but mature T cells from the spleen 
of ULK1KO mice can undergo autophagy 
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(a) Spleens from ULK1WT and KO sex-matched littermates. (b) Western blot for LC3 and actin with 
splenocytes from ULK1WT and KO littermates. Splenocytes were FACS sorted using antibodies against 
CD4, CD8, and CD19 (B cells and follicular dendritic cells) and starved for 2h in EBSS with leupeptin or 
left in full RPMI for 2h as was done with a fraction of unsorted splenocytes (total). Equal protein was 
loaded (75g) except for samples with low protein concentration as assessed by a Bradford assay, in 
which case 60l were loaded onto the gel. All 3 subpopulations and the triple negative (TN) cells were 
run on SDS-PAGE and membranes were blotted with anti-LC3 and anti-actin. 
 
To investigate whether peripheral T cells are affected by the absence of ULK1 
splenocytes from wild type, heterozygous, and knock-out littermate mice were analysed 
by FACS. Cells were labelled for CD4 and CD8 T cell markers, for CD19 a B cell and 
follicular dendritic cell marker and for DAPI and AnnexinV to analyse apoptosis. The 
FACS profile of WT, HET, and KO splenocytes revealed that there are indeed less CD4 
(WT~15%, KO~10%) and CD8 (WT~8%, KO~5%) positive T cells in spleens of KO 
mice as they are reduced in percentage as well as number (Fig. 6-5). The HET 
splenocytes show an intermediate phenotype and these results are reproducible (n=2) 
suggesting that ULK1 may be involved in T cell development, selection, and/or 
survival. CD19 positive B cells and follicular dendritic cells, which assist in B cell 
maturation [284], were not affected by lack of ULK1. 
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Figure 6-5 Peripheral CD4 and CD8 positive T cell numbers are reduced in 
ULK1KO mice 
Spleens were removed from ULK1 wild type (WT), heterozygous (HET), and knock-out (KO) sex-
matched littermates and processed through a 70m mesh to harvest splenocytes. Cells were incubated for 
5min in RBC lysis buffer to remove RBCs. These cells were labelled with antibodies against CD4, CD8, 
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and CD19 for FACS analysis. 10
6
 cells were resuspended in FACS buffer and the FACS profile was 
acquired for 1 min each. The graph shows total numbers of CD4+ and CD8+ T cells, which are reduced 
in ULK1HET and KO mice compared to the WT as was seen repeatedly (n=2). 
 
6.4.1 ULK1KO splenocytes show enhanced apoptosis 
 
As mentioned above these splenocytes were also labelled with DAPI and AnnexinV to 
analyse the amount of apoptosis. When gated on CD4+, CD8+, or CD19+ cells more 
apoptotic CD4+, and CD8+ T cells are observed in the spleens of KO mice compared to 
WT animals with the HETs again showing an intermediate phenotype. CD19+ B cells 
show no substantial enhancement in apoptosis (Fig. 6-6). Both early apoptosis 
(AnnexinV positive) and late apoptosis or necrotic cell death (AnnexinV positive and 
high DAPI) are enhanced in the ULK1KO splenocytes, which could explain the reduced 
numbers of T cells in the KO spleen. However, it cannot be excluded that there is also a 
proliferation defect. 
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Figure 6-6 Peripheral T cells from ULK1KO mice show enhanced apoptosis 
The same splenocytes as in Figure 6-5 were labelled with AnnexinV and DAPI for FACS analysis. 10
6
 
cells were resuspended in FACS buffer and the FACS profile was acquired for 1min each. Gates were set 
on, CD4 positive T cells (top), CD8 positive T cells (middle), or CD19 positive B cells. 
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6.5 ULK1KO splenocytes show a significant deficit in response 
to TCR stimulation compared to WT cells 
 
To confirm these preliminary results, and obtain further insight into the ability of 
ULK1KO T cells to be activated, I investigated their response to T cell receptor (TCR) 
stimulation. TCR can be stimulated experimentally by activating anti-CD3 and co-
stimulatory signals, which are normally provided by antigen presenting cells (APCs) 
[285]. Anti-CD3 diluted in PBS was bound to 96-well plates over night in various 
concentrations via serial dilution. Splenocytes were harvested from ULK1WT or KO 
littermate mice and 0.5x10
6
 cells were added to each well in full medium. RBCs were 
not lysed by incubation in RBC-lysis buffer as in previous experiments to prevent even 
minimal damage to other splenocytes. Cells were incubated for 72 hours during which 
anti-CD3 will activate the TCR leading to T cell activation, proliferation, and cytokine 
secretion. Essential co-stimulatory signal are provided by APCs present in the 
splenocyte preparation. After 3 days the amount of metabolically active cells per well 
was measured using the CellTitre-Glo
®
 luminescent cell viability assay. This assay 
determines the amount of ATP in the sample, which is directly proportional to the 
amount to metabolically active live cells. Luminescence was measured using an 
Envision plate reader. Although activation of T cells may also lead to proliferation of 
co-stimulatory APCs through cytokine secretion the bulk of the proliferating cells are 
probably T cells.  
 
The response of ULK1KO splenocytes is significantly impaired compared to wild type 
cells (Fig. 6-7). In ULK1WT cultures an increase in cell number is first observed after 
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stimulation with about 0.5g/ml anti-CD3 peaking at 2.5g/ml. This is significantly 
delayed in ULK1KO cultures, whose number only peak at a concentration of 5-10g/ml 
anti-CD3 possibly due to a reduction in cell proliferation or enhancement of apoptosis 
or induction of anergy a state of non-responsiveness that can be induced in lymphocytes 
[286]. 
 
Figure 6-7 ULK1KO splenocytes show an impaired response to TCR stimulation 
with anti-CD3  
Spleens were removed from ULK1WT and KO sex-matched littermates and passed through a 70m mesh 
to obtain splenocytes. Red blood cells were not removed by lysis to avoid damage to other splenocytes. 
0.5x10
6
 cells were plated per well of a 96-well plate, which had been coated over night with the indicated 
concentration of anti-CD3 in PBS. Cells were incubated for 72h in normal growth conditions with each 
concentration done in triplicate. CellTitre-Glo reagent was added to each well according to the 
manufacturers instructions and luminescence was measured using an Envision plate reader. Y-axis shows 
luminescence intensity, which is directly proportional to live metabolically active cells. Shown is the 
mean of 4 independent experiments (n=4) and error bars represent SEM. Asterisks indicate result of two-
way ANOVA analysis with p=0.0429 overall, and Bonferroni posttests results for 1.25g/ml p<0.01; for 
2.5g/ml p<0.01. 
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6.5.1 The FACS profile of anti-CD3 stimulated splenocytes suggests that 
there is more apoptosis in ULK1KO cells 
 
The above result suggests that either ULK1KO splenocytes undergo more apoptosis or 
proliferate less upon anti-CD3 stimulation. To address this question the FACS profiles 
of various concentrations were analysed. Splenocytes were treated as described above 
and while 3 wells per condition were used for the CellTitre-Glo assay the remaining 
well was prepared for FACS analysis. The cells were labelled with antibodies against 
CD4, CD8, and with a nucleic acid binding dye TO-PRO3 to identify late apoptotic and 
necrotic cells. Reflecting the previous results, the percentage of both CD4 (WT~12%, 
KO~5% at 0.07g/ml anti-CD3) and CD8 (WT~7%, KO~2% at 0.07g/ml anti-CD3) 
positive T cells was lower in ULK1KO splenocytes. T cell populations are activated and 
proliferate upon anti-CD3 stimulation in KO cultures but at a lower rate than the in the 
WT and they never reach the same levels as ULK1WT cultures (CD4+: WT~20%, 
KO~11% at 10g/ml anti-CD3; CD8+: WT~24%, KO~18% at 10g/ml anti-CD3) 
(Fig. 6-8a). 
 
The late apoptotic/necrotic marker TO-PRO3 revealed that there are more dead cells in 
the ULK1KO wells than in the WT wells at low (WT~5%, KO~8% at 0.07g/ml anti-
CD3) as well as at high concentrations of anti-CD3 (WT~9%, KO~16% at 10g/ml 
anti-CD3; Fig. 6-8b). Only the CD4 positive T cell population is shown in Figure 6-8b 
but the CD8 positive population looks very similar (data not shown). Most dead cells 
are not CD4 positive but in any case I would expect late apoptotic or necrotic T cells 
revealed by this analysis not to display T cell markers anymore. This strongly suggests 
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that there is more apoptosis in ULK1KO spleens compared to the WT but does not 
exclude additional proliferation defects. 
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Figure 6-8 Anti-CD3 stimulated ULK1KO splenocytes show enhanced apoptosis 
Splenocytes were treated the same as in Figure 6-7 and while 3 wells were used for the CellTitre-Glo 
assay, one well per condition was prepared for FACS analysis, which was performed for the indicated 
anti-CD3 concentrations. Cells were labelled with antibodies against CD4, CD8, and a nucleic acid 
binding dye TO-PRO3, which stains late apoptotic and necrotic cells. (a) FACS profile of splenocytes 
illustrating CD4 and CD8 cell populations. (b) FACS profile of cells illustrating CD4 and TOPRO 
positive cells. 
 
6.6 CFSE proliferation assay shows impairment in ULK1KO 
cells 
 
Another way to measure cell proliferation and survival is by incorporation of the 
fluorescent dye carboxyfluorescein succinimidyl ester (CFSE), which is retained in the 
cytosol [287]. Therefore, fluorescence intensity is reduced by half after every cell 
division and this can easily be measured by FACS analysis.  
Splenocytes from ULK1WT and KO littermates were labelled with CFSE and cultured 
in various conditions for 4 days. The different conditions were: no treatment (no cell 
divisions are expected without stimulus); anti-CD3; anti-CD3 with co-stimulatory 
anti-CD28; anti-CD3 with growth factor IL-2; phorbol 12-myristate 13-acetate (PMA) 
with ionomycin. As described above anti-CD3 leads to activation of TCR signalling 
together with its co-activator anti-CD28. CD28 on antigen presenting cells (APCs) 
present in the culture can provide this co-stimulatory signal but exogenous addition of 
anti-CD28 should enhance the stimulatory signal. IL-2 is an important cytokine that is 
massively produced by T cells and other cells after activation leading to T cell 
proliferation and survival. PMA activates protein kinase C (PKC) due to its similarity to 
diacylglycerol (DAG) and ionomycin is an ionophore leading to enhanced intracellular 
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calcium levels. These last two events are usually the downstream signalling events of 
TCR activation but PMA/ionomycin addition can by-pass these signalling events to 
elucidate whether any block in T cell activation is downstream or upstream of kinase 
signalling. 
The response of ULK1KO CD4-positive T cells to anti-CD3 and anti-CD3/anti-CD28 
is dramatically impaired compared to control cells as the peaks of the dividing cells are 
much reduced (Fig. 6-9a). This seems to be rescued by supplementing IL-2 or by 
addition of PMA/ionomycin suggesting that ULK1KO splenocytes have a defect in IL-2 
signalling or production. Interestingly, when the total cell number is calculated it seems 
that IL-2 administration could not really rescue CD4+ T cell expansion, as T cell 
numbers were not increased in IL-2 treated wells compared to untreated wells (Fig. 6-
9b). However, the proliferative ability of ULK1KO CD4+ T was rescued by IL-2 
addition since there is a large peak of dividing cells in the CFSE assay suggesting that 
cells underwent cell division but died or became anergic and therefore could not 
expand. The ULK1HET cells again show an intermediate phenotype to the ULK1KO 
(not shown). Note also that in the anti-CD3, or anti-CD3/anti-CD28 treated wells 
small peaks can be observed but no T cell expansion is taking place suggesting that they 
may be able to proliferate but may undergo apoptosis or anergy much more than 
ULK1WT cells.  
 
Chapter 6. Results 
 234 
 
Figure 6-9 ULK1KO CD4 positive T cells show an impaired response to TCR 
stimulation 
Spleens were removed from WT and KO sex-matched littermates and processed through a 70m mesh to 
obtain primary splenocytes. Cells were labelled with CFSE and anti-CD4 and 0.2x10
6
 cells per well were 
cultured for 4 days under the following conditions in duplicates: no treatment (NT); 5g/ml plate bound 
anti-CD3 alone, or with 1g/ml plate-bound anti-CD28, or with 100U/ml recombinant IL-2; 10ng/ml 
PMA with 300ng/ml of ionomycin. Shown is the number of cells with diluted CFSE staining gated on the 
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CD4+ population (top) and in the graph below the total number of CD4+ T cells pooled from 2 wells after 
the treatment. Total CD4+ T cells were calculated using small beads that were added to the cells (see 
Material and Methods).  
 
6.7 ULK1KO mice show normal thymic morphology but may 
have less autophagosomes in thymic cells of non-T cell 
origin 
 
Thymic epithelial cells (TECs) have been shown to be important in presentation of 
endogenous antigens to CD4+ T cells leading to negative selection and apoptosis if its T 
cell receptor recognises the auto-antigen [244, 282]. TECs use autophagy to process 
endogenous antigens to be loaded on MHC-II molecules for T cell presentation. 
Therefore, if there were a specific defect of autophagy in TECs of ULK1KO mice this 
would not be detectable by LC3 western blotting as they make up less than 5% of cells 
in the thymus but it would lead to auto-reactive T cells leaving the thymus and reaching 
the peripheral T cell pool. This may lead to autoimmune disease or, more likely [244], 
to induction of apoptosis in the auto-reactive T cells by cells such as regulatory T cells. 
This could explain the above results and therefore I wanted to investigate autophagy in 
TECs. 
 
As seen in Figure 6-3b about 95% of cells in the thymus are mature (CD4 or CD8 
positive) or immature (CD4 and CD8 double positive) T cells. The other 5% contain 
among other cell types the TEC and dendritic cells. Because the population of TECs is 
so small and GFP-LC3/ULK1KO mice were not yet available electron microscopic 
(EM) analysis of ULK1WT and KO thymi was performed to obtain preliminary results. 
Chapter 6. Results 
 236 
Thymi were removed from sex-matched littermate mice and fixed immediately in 
PFA/glutaraldehyde. All further processing for EM and image acquisition was done by 
Ken Blight in the electron microscopy unit at LRI and standard procedures were used. 
Figure 6-10 shows representative EM images of sections of ULK1WT (Fig. 6-10a) and 
ULK1KO (Fig. 6-10b) thymi. The over-all structure of the ULK1KO thymus looks 
normal mostly consisting of small spheroid T cells interspersed by TECs and other cells 
with dendritic morphology. Because TECs and dendritic cells extend branch like 
structures in between the immature T cells to make contact with as many cells as 
possible the nucleus of these cells is usually not in the plane of section and only 
cytoplasmic regions are easily seen. In the ULK1WT thymus the areas of cytoplasm 
between T cells, which are hypothesised to be TECs or dendritic cells (DCs), contain 
many autophagosomes, and one case of an autophagosome engulfing a mitochondrion 
can be seen (Fig. 6-10a, iii). Autophagosomes were identified by having diverse 
contents of similar electron density as the cytoplasm, even though the double membrane 
cannot always be resolved. Also, considering that there are professional phagocytes 
such as DCs and macrophages present in the thymus, it is hard to distinguish an 
autophagosome from a phagosome if the double membrane is not resolved, except when 
structures such as mitochondria are engulfed, as they are not expected to be released to 
the extracellular space. In this preliminary experiment, many fewer autophagosomes 
were seen in ULK1KO thymus sections suggesting that ULK1 may be more essential in 
TEC autophagy than in other cells. The cell in panel vi may contain numerous 
autolysosomes although normally autolysosomes have more homogenous contents than 
in this example. Alternatively, these organelles could be secretory lysosomes found in 
natural killer cells and cytotoxic T lymphocytes [288]. 
Chapter 6. Results
 237 
Chapter 6. Results
 238 
 
Chapter 6. Results 
 239 
Figure 6-10 EM analysis of a ULK1KO thymus suggests a reduction in 
autophagosomes in TECs 
Thymi were removed from ULK1WT and KO sex-matched littermates and fixed immediately in 
PFA/glutaraldehyde according to standard procedures. (a) Section of ULK1WT thymus with 3 enlarged 
images i-iii. The area enlarged in image i is indicated by a dashed box in the zoomed out picture (b) 
Section of a ULK1KO thymus. The area enlarged in image iv is indicated by a dashed box in the low 
magnification picture. T indicates putative T cells (based on morphology) but only two examples are 
labelled in (a) and (b); asterisks indicate interspersed cells with dendritic morphology, which at least in 
part represent TECs; Nuc indicates nuclei; AV indicates autophagosomes; AVd indicates autolysosomes; 
M indicates mitochondria. Note an autophagosome engulfing a mitochondrion in image iii. 
 
6.8 Conclusion 
 
ULK1KO mice appear healthy under conventional laboratory conditions, they are fertile 
and can undergo basal autophagy. This is surprising because ULK1 is essential in all 
invertebrate organisms and vertebrate cells in culture tested so far. This discrepancy 
may be explained by the presence of several ULK1 homologues in mammalian 
genomes especially ULK2, which shares more than 50% homology with ULK1 
although ULK2 does not seem to be essential for autophagy in HEK293A cells. This 
observation is, however, consistent with results from independently created ULK1KO 
mice [81]. ULK1 mice show mild splenomegaly as reported previously and seem to 
have reduced thymic cellularity as was reported for mice with an Atg5 deficient thymus 
although thymic T cell populations appear to undergo normal development. 
Interestingly though, peripheral CD4+ and CD8+ T cells in the spleen of ULK1KO 
mice are reduced compared to wild type animals and show a significantly impaired 
response to TCR stimulation, which may be due to reduced survival or proliferation of 
ULK1KO T cells. 
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Based on my data on T cell apoptosis, survival, proliferation, and EM analysis of a 
ULK1KO thymus I propose three hypotheses that may explain this phenotype: 1) 
Thymic epithelial cells are autophagy compromised leading to inefficient removal of 
auto-reactive T cells and subsequent induction of apoptosis or anergy in these cells 
upon auto-antigen encounter in the periphery, 2) IL-2 signalling or production are 
impaired in ULK1KO T cells or other IL-2 producing cells leading to inefficient 
activation and proliferation of T lymphocytes, 3) ULK1 has been proposed to play a 
role primarily in mitophagy and it may be that the presence of damaged mitochondria in 
cells with a high metabolic rate such as activated T cells leads to cellular damage and 
apoptosis [81] although this remains to be tested. 
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Chapter 7. Discussion 
 
In this study I aimed to further elucidate the membrane trafficking events involved in 
autophagosome formation. As a main approach to answer these questions an over-
expression screen with all putative human RabGAPs was performed to identify those 
that inhibit autophagosome formation through Rab GTPase inactivation and one GAP 
TBC1D14 was studied in detail. 
 
I have shown that 11 out of 38 putative human RabGAPs inhibit starvation induced 
autophagy by 40% or more when over-expressed in 2GL9 cells. One of those TBC 
domain containing proteins is TBC1D14, whose function was previously unknown. 
Over-expression of TBC1D14 inhibits autophagosome formation, long lived protein 
degradation, and depletion of the protein enhances autophagy. TBC1D14 binds Rab11 
and tubulates recycling endosomes (REs) in a Rab11 dependent manner. The 
endogenous protein localises to the Golgi/TGN and endosomes. ULK1 is sequestered 
by TBC1D14 induced tubulated REs but is also found on REs normally together with 
mAtg9. I hypothesise that mAtg9 and ULK1 coordinate autophagosome formation 
using REs as a signalling platform and/or as a membrane source for phagophores. 
 
To study the role of the important autophagy kinase ULK1 in vivo, mice with a 
disrupted ULK1 gene were created by Dr. E. Chan. Despite ULK1 being essential for 
autophagy in HeLa and HEK293A cells, mice lacking ULK1 appear healthy and are 
fertile. However, I’ve shown that ULK1KO mice have less CD4 and CD8-positive T 
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cells and show defects in mature T cell proliferation upon TCR stimulation and/or 
survival whereas B cell numbers are unaffected. 
 
In conclusion, I have performed a comprehensive analysis revealing RabGAPs involved 
in autophagosome formation. One of those TBC1D14 is a novel effector of Rab11 and I 
show for the first time an essential role of Rab11 and REs in autophagosome formation. 
Further analysis is necessary to elucidate whether REs are novel membrane donors for 
IM expansion or whether they serve as a signalling platform for the ULK1 kinase 
complex. In vivo ULK1 seems to have an especially important role in the adaptive 
immune system that ULK1KO mice cannot compensate for. 
 
7.1 Identification of 11 RabGAPs that inhibit autophagy when 
over-expressed in 2GL9 cells 
 
The screen I performed identified 11 RabGAPs that inhibit autophagy as assessed by 
GFP-LC3 lipidation when over-expressed in 2GL9 cells (Fig. 3-1). To confirm that the 
reduction in autophagosome formation observed was due to Rab GTPase inactivation 
eight mutants, which should lack catalytic GAP activity, were tested for their ability to 
rescue this inhibition. Indeed, seven out of these eight no longer reduced LC3-II 
formation confirming that they act on a Rab GTPase involved in autophagosome 
formation. The remaining three inhibitory RabGAPs were not tested as the catalytic 
residues could not be easily distinguished and the mutant construct was not available. I 
believe that the large number of RabGAPs (~30%) inhibiting LC3 lipidation highlights 
the important point that autophagosome formation is a complex, multi-step process that 
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may well require the activity of several Rab proteins. Phylogenetic analysis of the TBC 
proteins that inhibit autophagosome formation revealed that they do not fall into a 
specific subfamily of RabGAPs, and share no common domains other than the TBC 
domain. 
 
Within the group of 11 RabGAPs classified as having a substantial effect on GFP-LC3 
lipidation, the role of TBC1D14 in autophagosome formation was studied in detail and 
will be discussed below. TBC1D14 was chosen because it binds and co-localises with 
ULK1, whose activation is the most upstream event in autophagosome formation [98]. 
Out of the other ten RabGAPs a few show partial co-localisation with GFP-LC3 and 
published data supports my findings that some of these may have a role in autophagy.  
 
TBC1D7 was shown to inhibit the TSC1 complex, which in turn controls mTOR 
activity [75]. It is not entirely clear what the molecular mechanism for this inhibition is 
but it may be through regulation of Rab17 activity. Rab17 was shown to be the target of 
TBC1D7 regulating cilia formation [201] but I have also shown that over-expression of 
a dominant negative mutant Rab17N132I inhibits autophagosome formation (Fig. 3-9). 
Also, TBC1D7 shows some juxta position with GFP-LC3 (Fig. 3-2a). Taken together 
this suggests that TBC1D7 and Rab17 may also be involved in induction of autophagy 
possibly through regulating mTOR activity via the TSC1/2 complex. 
 
TBC1D17 shows partial co-localisation with GFP-LC3 puncta (Fig. 3-2b) and has been 
shown to bind Rab5 [196], which has been previously shown to have a role in the 
removal of aggregated mutant huntingtin (Htt) by selective autophagy [217]. In 
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accordance with Rab5 binding, myc-TBC1D17 can be seen on the plasma membrane 
and a punctate pool (Fig. 3-2b and 3-3b). However, two other Rab5 GAPs, RN-tre and 
RabGAP5 [197, 289] had only a mild inhibitory effect and were not amongst the top 11 
candidates (Fig. 3-1). Interestingly, Htt has been shown to be important for activation of 
Rab11 [290], as in Huntington’s disease patient fibroblasts, Rab11 activity was 
diminished and Tfn recycling was inhibited.  
 
The RabGAPs TBC1D10A, B and, C were all shown to act on Rab35 [199], which was 
shown to regulate TfnR recycling [202]. It is possible that Rab35-positive REs have a 
similar function in autophagy as Rab11-positive REs, which I have shown to be 
involved in autophagosome formation. However, over-expression of inactive 
Rab35N120I did not inhibit LC3 lipidation, on the contrary, it slightly enhanced it (Fig. 
3-9). Further experiments would be necessary to clarify the role of the TBC1D10 family 
and Rab35 in autophagosome formation such as siRNA mediated knock down of Rab35 
or over-expression of different mutants. 
 
The target Rab GTPase of TBC1D9 is not known and its function remains unknown. It 
seems to localise to a juxta-nuclear compartment (Fig. 3-2d and 3-3d) but was not found 
to be involved in Golgi maintenance [200]. TBC1D9 contains two GRAM domains, 
which are PI lipid binding domains. 
 
TBC1D9B shows partial co-localisation with GFP-LC3 (Fig. 3-2f) positive 
autophagosomes and like TBC1D9 has two GRAM domains, which could enable it to 
bind to PI3P on the phagophore although this needs to be confirmed. The target Rab of 
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TBC1D9B is not known but it binds Rab22a indicating that it may act on this Rab 
GTPase (personal communication F. Barr; University of Liverpool, UK). Interestingly, 
Rab22a was found to be necessary for autophagosome formation as siRNA mediated 
knock down inhibited GFP-LC3 spot formation in 2GL9 cells (N. McKnight, LRI, 
unpublished data). Rab22a was shown to be involved in recycling of proteins 
endocytosed by clathrin independent mechanisms [291]. This particular recycling route 
does not affect TfnR and acts independently of Rab11. However, a dominant negative 
mutant Rab22aS19N had no effect on LC3 lipidation when over-expressed in 
HEK293A cells but closer investigation or use of a different mutant, which is unable to 
bind nucleotides may confirm a role for TBC1D9B and Rab22a in autophagosome 
formation. 
 
TBC1D4 (also called AS160) is involved in glucose transporter 4 (GLUT4) trafficking 
and was shown to act on Rab2a, Rab8a, Rab10 and Rab14 [264]. Rab2a and Rab14 are 
closely related to Rab11 [196, 292], and Rab8a and Rab10 also have roles in endocytic 
recycling [194, 265, 266] further suggesting a more general role of REs in 
autophagosome formation, which is not limited to Rab11 alone. Interestingly, a closely 
related GAP TBC1D1 similarly regulates GLUT4 trafficking but had no effect on LC3 
lipidation when over-expressed but this may be due to complementary regulation of 
TBC1D4 and TBC1D1 by growth factors [293] with a specialised role for TBC1D4 in 
autophagy. 
 
RUTBC1/SGSM2 was reported to bind to Rab11 and Rab4, which are involved in 
endocytic protein recycling [267], and I observed partial co-localisation of RUTBC1 
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with GFP-LC3 puncta (Fig. 3-2h), suggesting that similarly to TBC1D14 it is involved 
in RE traffic and autophagy. However, unlike TBC1D14, RUTBC1 did not induce 
tubule formation or co-localise with ULK1 (Fig. 3-3g). Further investigation and 
identification of the target Rab for RUTBC1 are necessary to confirm its exact role in 
autophagosome formation. 
 
Lastly, TBC1D16 shows GAP activity towards Rab36  (personal communication F. 
Barr, University of Liverpool, UK). This small GTPase was shown to localise to the 
Golgi/TGN and cause juxta-nuclear accumulation of late endosomes and lysosomes 
when over-expressed [258]. However, my experiments using over-expressed TBC1D16 
or constitutively active Rab36Q182A suggest that both are also involved in 
autophagosome formation (Fig. 3-1 and 3-9). I did not see an accumulation of myc-
TBC1D16 in the Golgi area but further analysis is required to determine its localisation 
and confirm its target Rab (Fig. 3-2i and 3-3h). 
 
In summary, none of the TBC proteins tested co-localise dramatically with GFP-LC3 or 
ULK1-positive autophagosomes except for TBC1D14. However, TBC1D7 and 
TBC1D14 show some juxta-position to GFP-LC3 puncta and TBC1D17, TBC1D4, 
TBC1D9B and RUTBC1 show partial co-localisation with GFP-LC3 positive 
autophagosomes (Fig. 3-2). Co-localisation may be partial due to the transient 
interaction of the GAPs with their cognate Rab GTPases or because they act at a 
different step during autophagosome formation and do not localise permanently to the 
phagophore. 
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7.2 A yeast-2-hybrid screen identifies 17 RabGAPs interacting 
with ULK1 
 
In primary cultured cerebellar granule neurons ULK1 was shown to form a protein 
complex with Syntenin1, SynGAP, and Rab5 in which SynGAP acts as a Rab5-GAP 
[90]. However, SynGAP does not have a classical RabGAP TBC domain but a RasGAP 
domain and it can also act on Ras. While, SynGAP seems to be brain specific, I could 
confirm the interaction of ULK1 with Syntenin1 in HEK293A cells via co-
immunoprecipitation (Fig. 3-5). Therefore, I hypothesised that ULK1 may form a 
similar complex with a Rab and RabGAP in other cell types to regulate autophagy.  
 
Interestingly, in a yeast-2-hybrid screen ULK1 was found to interact with 17 out of 35 
human RabGAPs tested (Fig. 3-6). The large number of interactors could partly be due 
to the possibility that ULK1 can regulate other membrane trafficking events by binding 
to different RabGAPs, such as regulating neuronal vesicular traffic during axon 
extension as mentioned above. Alternatively, it is possible that ULK1 binds to TBC 
domains directly, which have a high similarity in their tertiary structure. This binding 
may normally be prevented in mammalian cells by compartmentalisation or 
inaccessibility due to binding of other co-factors. Indeed, I have shown that ULK1 binds 
to the TBC domain of TBC1D14 (Fig. 4-9), which I have also shown to be the only 
TBC protein that shows substantial co-localisation with ULK1 (Fig. 3-3 and 3-4). 
 
Another yeast-2-hybrid analysis I performed (Fig. 3-8), revealed that Syntenin1 binds 
Rab5, as has been reported previously [90], and Rab33, both of which have been shown 
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to be involved in autophagy [217, 222]. ULK1 does indeed bind the RabGAPs RN-tre 
and TBC1D22B, suggested to act on Rab 5 and Rab33, respectively ([289] and personal 
communication F. Barr, University of Liverpool, UK), and I speculate that such Rab-
RabGAP-ULK1 complexes may exists in HEK293A cells. However, neither of these 
RabGAPs, nor the corresponding inactive Rab GTPases, inhibit LC3 lipidation when 
over-expressed in HEK 293A or 2GL9 cells (Fig. 3-1 and 3-9), and therefore these Rab-
RabGAP pairs may regulate other membrane trafficking steps such as endocytosis in 
which ULK1 also plays a role in neurons [93]. 
 
Finally, as not all the TBC proteins that bind ULK1 inhibit autophagosome formation 
(Fig. 3-7) I suggest that ULK1 sequestration by over-expressed RabGAPs is not the 
main mechanism for this inhibition. This is supported by the fact that the RA mutant 
proteins, and the RA/QA mutant in case of TBC1D14, do not inhibit LC3 lipidation 
confirming that Rab inactivation rather than ULK1 sequestration is causing impaired 
autophagosome formation (Fig. 3-1 and 4-3). 
 
7.3 The function of TBC1D14 
 
Previous to this study the function of TBC1D14 was not known even though its TBC 
domain has been crystallised and solved [198]. I have shown that over expression of 
TBC1D14 leads to an inhibition of autophagosome formation as assessed by two robust 
autophagy readouts (Fig. 3-1 and 4-2); LC3 lipidation and long lived protein 
degradation. Furthermore, siRNA knock down leads to an increase in autophagosome 
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formation (Fig. 4-6) supporting the role of TBC1D14 as a negative regulator of 
autophagy 
 
By yeast-2-hybrid, and co-immunoprecipitation assays I show that TBC1D14 binds 
ULK1 directly via its C-terminal TBC domain (Fig. 3-6 and 4-9). However, 
sequestration of the ULK1 kinase complex alone is unlikely to be the sole mechanism 
for inhibition of autophagosome formation by TBC1D14. The over-expressed TBC 
domain is localised predominantly in a juxta-nuclear pool and sequesters ULK1 but it 
does not seem to be sufficient for inhibition of autophagosome formation as over-
expression of the TBC domain does not inhibit LC3 lipidation (Fig. 4-11). I hypothesise 
that TBC1D14 exhibits its autophagy inhibitory function on peripheral endosomes or 
tubules and the mislocalisation of the TBC domain on the juxta-nuclear ERC prevents 
this. 
 
Inhibition of autophagosome formation by TBC1D14 is likely due to inhibition of 
Rab11 functions, as I have shown that Rab11 inactivation itself leads to inhibition of 
autophagosome formation (Fig. 5-7), and TBC1D14 is a negative regulator of Rab11. 
There are two main possibilities as to how TBC1D14 inhibits Rab11 and the trafficking 
steps regulated by Rab11: As a Rab11-GAP or as a Rab11 effector. 
 
The target Rab GTPase of TBC1D14 is not known and attempts to purify recombinant 
TBC1D14 from bacteria for in vitro GAP assays have failed due to aggregation of the 
protein (personal communication F. Barr, University of Liverpool, UK). Therefore, I 
performed an in vitro GAP assay with TBC1D14 purified from insect cells using the 
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baculovirus expression system (Fig. 4-12). However, no GAP activity could be detected 
against any of the 47 Rabs tested, either because the purified TBC1D14 was not active, 
because there was not enough GAP protein per reaction, or because it does not have 
GAP activity in vivo. 
 
My findings that mutation of both the arginine finger and glutamine thumb in the TBC 
domain of TBC1D14 abolished its ability to inhibit LC3 lipidation suggest that it does 
have GAP activity, which is dependent on these conserved catalytic residues (Fig. 4-3). 
For all the other GAPs tested mutation of a single one of those residues was sufficient to 
inactivate the protein (Fig. 3-1). However, It is likely that TBC1D14 has a slightly 
different catalytic domain than other TBC proteins as its arginine and glutamine 
residues are oriented at a different angle than the other two TBC domains so far 
crystallised [198] although more TBC domain structures would have to be solved and 
analysed accordingly to confirm this hypothesis. 
 
Even though I could not show in vitro GAP activity of TBC1D14 against Rab11, 
indirect evidence supports the hypothesis that it could be a Rab11-GAP.  
Firstly, yeast-2-hybrid analysis undertaken by one of our collaborators S. Yoshimura 
(University of Liverpool, UK), revealed that TBC1D14 binds specifically to Rab11a 
and Rab11b but not to any other Rabs including Rab25 (also called Rab11c) the most 
closely related GTPase (Fig. 4-13). 
Secondly, over-expressed TBC1D14 tubulates TfnR- and Rab11-positive REs and is 
also localised to these tubules but is diffusely cytosolic in cells that have previously 
been depleted of Rab11 using siRNAs (Fig. 5-2). I hypothesise that TBC1D14 localises 
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to REs by binding to Rab11 and inactivates Rab11 leading to impaired vesicle budding 
or a block of vesicle transport away and tubulation of REs. This is supported by the fact 
that Rab11 depletion by siRNA also leads to tubulation of REs in the absence of excess 
inhibitory TBC1D14 (Fig. 5-3). 
Therefore I have confirmed that Rab11 depletion and its inactivation by over-expressing 
TBC1D14, which I hypothesise to be a putative Rab11-GAP, both lead to tubulation of 
TfnR positive REs. However, the double mutant TBC1D14RA/QA, which I speculate to 
lack GAP activity, still tubulates TfnR-positive REs when over-expressed although it 
does not inhibit autophagosome formation (Fig. 4-3 and 5-2). This may be explained by 
the fact that the double mutant protein is expected to bind Rab11 even more strongly 
than the wild type due to the absence of the two protruding A and Q catalytic residues 
[204]. Binding of TBC1D14, therefore, could prevent specific effector binding to the 
Rab11 GTP bound form still leading to an inhibition of RE trafficking. 
 
On the other hand, it has been shown that another TBC protein TBC1D15 exhibits in 
vitro GAP activity towards Rab11a and Rab11b (F. Barr unpublished, University of 
Liverpool, UK). If the hypothesis that one RabGAP acts on one Rab family were true, 
then this would suggest that TBC1D14 is not the Rab11-GAP. However, this hypothesis 
remains to be proven, as there are several cases where multiple TBC proteins have been 
suggested to act on the same Rab. For example, RN-tre and RabGAP-5 in mammals, 
and TBC-2 in C. elegans, were shown to have GAP activity against Rab5 [197, 289, 
294]. Similarly, TBC1D15, TBC1D2, and TBC1D5 have been suggested to be Rab7-
GAPs [295-297]. There may be differences between cell types and organisms involved 
in these discrepancies but it may also be that the one GAP for one Rab hypothesis needs 
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to be revised and adjusted to the possibility that there may be regulatory mechanisms 
allowing different GAPs to act on the same Rab. 
 
An alternative possibility is that TBC1D14 is an effector of active GTP-bound Rab11 
and is recruited by it to inactivate a Rab immediately upstream of it. Such Rab cascades 
have been described for example in yeast where Ypt32 (the homologue of Rab11) 
recruits Gyp1 (homologous to TBC1D22A/B) to inactivate the upstream Ypt1 
(homologous to Rab1) [207]. Intriguingly, Ypt1 has been shown to be recruited to the 
yeast phagophore and functions in autophagy [74]. The same study also found that 
Trs85, a subunit of the TRAPPIII complex, which acts as a Ypt1 GEF is recruited to the 
yeast phagophore assembly site (PAS). Interestingly, TBC1D14 was found to bind the 
human homologue of Trs85 and another subunit of the TRAPP complex TPPC3 in a 
GST pull down assay done by Sharon Tooze (LRI). The heavy chain subunit of 
cytoplasmic dynein was also pulled down suggesting that TBC1D14 may act as an 
adaptor linking Rab11 to the microtubule cytoskeleton similarly to Rab11FIP2, which 
links it to the motor protein myosin V [298]. Another protein that was pulled down by 
GST-TBC1D14 is Annexin2, which is involved in positioning of TfnR/Rab11-positive 
REs [299]. However, this experiment should be repeated to confirm these interactions. 
 
In conclusion, I have shown that TBC1D14 is a negative regulator of Rab11 either by 
acting as a Rab11-GAP or an effector of Rab11. Both over-expression of TBC1D14 and 
dominant negative Rab11 lead to inhibition of autophagosome formation. Therefore, I 
speculate that the main cause for inhibition of autophagosome formation by TBC1D14 
is perturbation of Rab11 function and REs. Endogenous TBC1D14 localises to REs and 
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the Golgi complex. The role of TBC1D14 on the Golgi complex is unknown but 
TBC1D14 redistribution to the Golgi complex upon starvation may be important for 
initiation of autophagy possibly because this allows Rab11 to function in 
autophagosome formation when TBC1D14 is not inhibiting it on the peripheral REs. 
 
7.4 The role of TBC1D14 and REs in autophagy 
 
My results showing a perturbation of REs raised the question about whether other 
trafficking pathways are disturbed by TBC1D14 over-expression. Immunofluorescence 
staining against markers of several intracellular compartments showed that their 
distribution is unperturbed in TBC1D14 transfected cells with the exception of the 
Golgi apparatus, which seemed to be fragmented in some cells as has been reported 
previously [200]. It would therefore be interesting to investigate whether TBC1D14 also 
has a role in Golgi stability or the secretory pathway in addition to its function in 
endocytic recycling. 
 
I have shown that TBC1D14 is an effector of Rab11 and impairs endosomal recycling 
and autophagy when over-expressed (Fig. 5-4 and 5-5). In accordance with this I found 
that over-expression of dominant negative constructs of Rab11 (Rab11N124I) also 
inhibits autophagosome formation (Fig. 5-7). Rab11 was previously shown to be 
involved in fusion of MVBs with autophagosomes in human leukemic K562 cells [216]. 
However, this is clearly not the case in HEK293A cells as addition of leupeptin to block 
autophagic flux did not lead to accumulation of LC3-II in Rab11N124I expressing cells 
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unlike in cells expressing inactive Rab7T22N, which blocks late endosome-
autophagosome fusion [183, 184]. 
 
In agreement with my hypothesis that Rab11 functions in autophagosome formation 
over-expression of wild type Rab11 increased LC3-II levels (Fig. 5-7). However, over-
expression of a constitutively active protein Rab11Q70A had no effect on LC3 
lipidation. This may be due to the fact that Rab11 probably does not act alone but in a 
Rab cascade as described above and failure of Rab11 to be deactivated leading to 
disruption of this cascade could prevent it from acting in autophagosome formation. 
Furthermore, excess active Rab11 may lead to depletion of essential effectors that 
specifically bind to GTP-bound form of Rab11 and perturb the pathway. 
 
No significant inhibitory effect on autophagy could be observed after siRNA mediated 
knock down of Rab11a, Rab11b, or both (Fig. 5-8). However, biochemical analysis was 
hampered by the fact that the 72 hour knock down caused cell death leaving many 
multinucleated cells among the surviving population. This is probably due to the role of 
Rab11 in cytokinesis [277], which is not so pronounced during the relatively short 24 
hour over-expression of dominant negative Rab11N124I or TBC1D14. 
 
I hypothesised that TBC1D14 inhibits autophagosome formation through inactivating 
Rab11 and therefore performed rescue experiments on TBC1D14 over-expressing cells 
with constitutively active Rab11: The excess active Rab11Q70A may then overcome 
TBC1D14 inactivation. However, this was not the case, and it is likely that depletion of 
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effectors by active Rab11Q70A prevented rescue of autophagosome formation (Fig. 5-
9). 
 
Since ULK1 is sequestered by TBC1D14-induced tubular REs, I also tested whether 
over-expression of ULK1 together with TBC1D14 could prevent inhibition of LC3 
lipidation, which indeed seems to be the case. Interestingly, simultaneous expression of 
ULK1 and TBC1D14 significantly increased basal autophagy under fed conditions (Fig. 
5-9), which is not observed when ULK1 alone is over-expressed [20, 21]. Perhaps 
TBC1D14 sequesters inhibitory factors allowing ULK1 to induce autophagosome 
formation in fed conditions or TBC1D14 interferes with a negative feedback loop that 
may be normally induced by ULK1 over-expression. However, the signalling events 
downstream of the ULK1 kinase complex are poorly understood making it difficult to 
test these hypotheses. In this experiment I tested both HA-tagged human ULK1 and 
myc-tagged murine ULK1, firstly, because the TBC1D14 construct contains the human 
protein sequence, and secondly, to confirm that the newly cloned HA-ULK1 behaves 
similarly to the previously studied myc-ULK1. As expected, since these proteins are 
highly conserved between mouse and human (90% amino acid sequence identity) the 
phenotypes observed were comparable. These results would suggest that ULK1 
sequestration is one of the major factors leading to inhibition of autophagy by 
TBC1D14 but the situation seems to be more complex as the TBC domain alone does 
not seem to inhibit autophagy even though it is able to sequester ULK1. Since the TBC 
domain localises exclusively to the pericentriolar ERC and not peripheral TfnR-positive 
REs, which seem to be reduced or absent, I speculate that the peripheral distribution of 
TBC1D14-tubules and ULK1 sequestration on these peripheral tubules leads to a block 
in autophagosome formation (Fig. 4-10). 
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The autophagy specific PI3K pathway, which is required for autophagosome induction 
in addition to the ULK1 kinase complex, did not seem to be affected by TBC1D14 
over-expression, as the two autophagy specific PI3P effector proteins DFCP1 and 
WIPI2 respond normally to starvation by localising to punctate phagophores. However, 
my preliminary data shows that there are more WIPI2 puncta in TBC1D14 over-
expressing cells, and that compared to the control significantly fewer of these WIPI2 
puncta have acquired LC3 (Fig. 5-13). This implies that in the TBC1D14 expressing 
cells WIPI2 puncta accumulate because formation into LC3-positive autophagosomes is 
blocked, or halted at an early stage after WIPI2 acquisition but before LC3 recruitment. 
This result is strengthened by the notion that TBC1D14 over-expression disrupts the 
ULK1 kinase complex, but not PI3K signalling and that these two pathways act partly 
in parallel, perhaps independently of each other. At some point however, the two must 
converge for IMs to mature into autophagosomes.  
 
Another early acting autophagy protein is mAtg9, which localises to the IM from the 
beginning but remains transiently associated with the autophagosome throughout 
formation. I show that mAtg9 localises to REs in HEK293A cells together with ULK1 
but often occupying different subdomains of the RE membrane (Fig. 5-14). Since both 
ULK1 and mAtg9 act early in autophagosome formation and are essential for autophagy 
in HEK293A cells, this suggest that REs are important for phagophore formation and 
initiation of autophagosome formation through Atg protein assembly. mAtg9 and ULK1 
are associated with TfnR-positive REs in the periphery but less so on the ERC in both 
fed and starved conditions. An important question is whether ULK1 is able to recruit 
REs from the ERC upon starvation as TfnR dispersal is observed after EBSS treatment. 
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Or alternatively, whether ULK1, which becomes active upon nutrient deprivation 
causes retention of REs in the periphery blocking retrograde traffic to the ERC so that 
the REs can function in autophagosome formation. Similar questions can be asked for 
the role of mAtg9 on REs but it is striking that while ULK1 is sequestered by TBC1D14 
induced tubulated REs mAtg9 is not. 
 
From my thesis work the most important question remaining concerns the exact 
function of REs in autophagosome formation and I could envisage two scenarios, which 
incorporate my data and recent advances. 
 
The first possible scenario is that REs provide membrane to the phagophore and 
autophagosomes directly. This is supported by recent findings that plasma membrane 
derived endocytic vesicles provide membrane for autophagosome precursors [127]. In 
this study they also show that the clathrin coat machinery is necessary for 
autophagosome formation and since clathrin coated vesicles can also form on recycling 
endosomes and recruit Tfn [300] it is possible that similar mechanisms are involved in 
the supply of both endosomal and plasma membranes to IMs. Indeed I show that some 
Rab11/TfnR-positive REs co-localise with GFP-LC3 upon starvation (Fig. 5-15). As is 
the case with plasma membrane derived vesicles not all autophagosomes contain the RE 
markers Rab11 and TfnR.  
 
Accumulating evidence suggest autophagosomal membranes can be recruited from 
different sources and that not one single compartment provides the membrane for all 
autophagosomes. I speculate that REs may be an additional source of autophagosomal 
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membrane. If this were the case it raises the question as to whether REs provide 
membrane just for phagophore precursor formation where early Atg proteins assemble, 
or also for phagophore expansion, or both. If indeed REs were to provide a substantial 
amount of membrane to autophagosomes this raises the question of whether 
mechanisms exist to specifically exclude RE resident proteins from the autophagosome 
membrane as has been shown for ER and mitochondrial membrane proteins [123, 124, 
130]. 
 
The second possibility is that REs act as nutrient sensors that can activate autophagy 
proteins such as ULK1 and mAtg9 upon starvation and provide a signalling platform for 
the assembly of Atg protein complexes. REs and other endosomal vesicles that 
continuously shuttle between intracellular compartments and the plasma membrane are 
well equipped to monitor nutrient status. Since the transmembrane protein mAtg9 
localises to Rab7, Rab9, CI-MPR, and Rab11 positive endosomal populations it is an 
ideal candidate to be the prime nutrient sensor, which activates autophagy upon 
starvation. This is supported by my data suggesting that Rab11 and TBC1D14 are 
involved in starvation-induced autophagy but not basal autophagosome formation. 
However, further work is needed to confirm or reject these hypotheses and it is also 
possible that a combination of both theories is true. Interestingly, a recent study showed 
a functional connection between the REs and the intermediate compartment between the 
ER and cis-Golgi [301] raising the possibility that TBC1D14 may be involved in 
membrane traffic between these compartments. 
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In conclusion, I have shown for the first time a role for REs in autophagy, which I 
propose act as a signalling platforms to induce autophagy by regulating the localisation 
of ULK1 and/or providing membrane to the phagophore. TBC1D14 is a novel effector 
of Rab11 and inhibits autophagosome formation when over-expressed in HEK293A 
cells, as does dominant negative Rab11N124I. Over-expression of TBC1D14 leads to 
tubulation of REs and sequestration of ULK1 to subdomains of these tubules. No other 
autophagy proteins tested localise to tubulated REs but both ULK1 and mAtg9 can be 
found on REs normally. A model, which summarises my data is depicted in Figure 7-1. 
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Figure 7-1 Model for the role of REs in autophagosome formation 
I propose the following model: a population of ULK1 and mAtg9 is resident on REs in both fed and 
starved conditions. ULK1 is recruited to the REs by TBC1D14, whereas TBC1D14 is recruited by Rab11. 
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Upon nutrient starvation ULK1 is activated and moves to the site of autophagosome formation or recruits 
other Atg proteins to REs, which then contribute membrane to IM formation and expansion. Over-
expression of TBC1D14 in both fed and starved conditions tubulates REs and sequesters ULK1 on these 
tubules. Furthermore, the association of mAtg9 with this compartment is disrupted. The exact activation 
state of ULK1 on the tubulated REs remains to be elucidated but none of the other early Atg proteins 
tested localise to tubulated REs.  
 
7.5 ULK1 knock-out mice 
 
To better understand the role of ULK1 in autophagy in vivo, mice lacking a functional 
ULK1 gene (ULK1KO) were created by E. Chan (LRI) using gene trapped embryonic 
(ES) stem cells (Fig. 6-1). These mice appear healthy, are fertile and able to undergo 
basal autophagy in various tissues analysed (Fig. 6-2). This is surprising since acute 
knock down of ULK1 using siRNA leads to a loss of autophagy in HEK293A and HeLa 
cell lines [20]. Various mouse models with deletions of essential autophagy genes 
indicate that complete loss of autophagy leads to post-natal fatality for example in Atg5 
and Atg7 knock-out mice [8, 9], or death during early embryogenesis such as in the 
Beclin1 deficient animals and mice with an oocyte specific Atg5 deletion [102, 137, 
138]. Therefore, it was unexpected that ULK1 knock-out mice show no obvious 
phenotypes. This may be due to the presence of ULK2, which is highly homologous to 
ULK1 (51% overall, 78% in the kinase domain). Even though siRNA mediated knock 
down of ULK2 in HEK293A cells does not lead to an impairment of autophagy, ULK1 
and ULK2 may be partially redundant in vivo. A possible explanation for this is that 
acute knock down of ULK1 does not allow enough time for cultured cells to adapt and 
up-regulate the ULK2 gene or that they simply lack the ability to do so. Alternatively, 
the ES cells used to create chimeric mice may have been inadvertently selected for 
those that had up-regulated ULK2 functions because the others were not viable. 
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The only phenotype that has been reported for ULK1 knock-out in mice is a defect in 
reticulocyte maturation specifically the failure to remove mitochondria through 
mitophagy [81]. I did not investigate whether our mice show the same phenotype but I 
also observed a similar degree of splenomegaly as reported by Kundu and colleagues. 
Note however, that they can only observe these phenotypes in a mixed genetic 
background but not in a pure C57BL/6J background. Our ULK1 mice were back-
crossed for ten generations (n=10), which should lead to a >99% pure C57BL/6J genetic 
background. Certain phenotypes, especially neurological phenotypes, are only 
manifested consistently in a pure genetic background. However, even after ten 
generations no obvious phenotype was observed even though ULK1 was shown to be 
essential for axon extension in primary cerebellar granule neurons [90]. 
 
However, post-mortem reports on mice that died of old age were done by the scientific 
officer in the mouse facility and suggested that ULK1KO animals have a small thymus. 
This was reported exclusively for knock-out and some heterozygous mice, while no 
other abnormalities were consistently observed. Splenomegaly was not observed 
probably because this phenotype seems to be much reduced in older mice (my personal 
observations). The histopathology unit at LRI also reported no major abnormalities in 
ULK1KO mice but this analysis did not include thymus and spleen as I had removed 
them for FACS analysis (see Appendix). Tissue sections should be done however to 
determine if there are histopathological abnormalities. Splenomegaly in young mice 
may be due to stress-induced erythropoiesis caused by the presence of damaged 
mitochondria, which subsides at an older age when the erythropoietic system can no 
longer cope. However, this was not further investigated. On the other hand FACS 
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analysis did confirm reduced thymic cellularity although this experiment was only done 
once. Despite the reduced cell number the percentages of CD4+, CD8+ and double 
positive (immature) T cells in the thymus of ULK1KO mice is comparable to wild type 
animals (Fig. 6-3) suggesting that T cell development is normal. Basal and starvation-
induced autophagy are both readily observed in ULK1WT and KO thymocytes and 
there may even be an increase in the starvation response of the latter. However, this 
experiment would have to be repeated and quantified for statistical analysis to draw a 
final conclusion. 
 
While immature T cell populations in the ULK1KO thymus were similar in percentage 
to the WT, a decrease in percentage and number of mature T cells in the spleen of 
ULK1KO mice was observed. Like thymocytes, splenocytes of ULK1KO mice can 
undergo basal autophagy as LC3-II is observed in these cells (Fig. 6-4). Treatment with 
EBSS did not seem to induce autophagy in total splenocytes or FACS purified CD4+, or 
CD8+ T cells. In fact, both these T cell populations seemed to have mostly LC3-II and 
little or no LC3-I suggesting rapid autophagic turn-over. However, this experiment 
should be repeated to enable statistical analysis. A high percentage of splenocytes 
consists of CD19+ B cells but this population was not altered in number or percentage 
in ULK1KO spleens compared to the wild type. Enhanced apoptosis was observed in 
ULK1KO T cells (both CD4+, and CD8+) compared to WT cells but not in B cells, 
indicating that the reduction in number is due to cells dying rather than a defective 
proliferation. 
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These results were reproducible but to investigate whether these changes were 
statistically significant and whether ULK1KO T cells could respond normally to 
activating stimuli I performed anti-CD3-titration experiments. Anti-CD3 is an 
antibody that cross-links the T cell receptor (TCR) and induces T cell activation and 
proliferation. Indeed, cell proliferation can be observed with rising anti-CD3 
concentrations administered to splenocytes in culture over 3 days. That the majority of 
proliferating cells in these cultures are T cells was confirmed by FACS analysis, but 
cytokine and growth factor secretion by T cells will also induce proliferation of other 
splenocytes such as B cells and fibroblasts. The response in ULK1WT splenocytes 
peaks at 2.5g/ml anti-CD3 compared to ULK1KO splenocytes, which peak at a 
concentration of 10g/ml suggesting a considerable impairment in the response to TCR 
stimulation (Fig. 6-7). This assay measures the number of live cells after 3 days in 
culture but cannot distinguish whether ULK1KO have proliferated less or whether they 
have undergone more apoptosis. However, FACS analysis of the same cells again 
indicates enhanced cell death although an additional proliferative defect cannot be 
excluded (Fig. 6-8). 
 
To further analyse the response of ULK1KO T cells to TCR stimulation a CFSE 
proliferation assay was performed showing again that the response of ULK1KO cells is 
impaired (Fig. 6-9). Individual CFSE peaks indicate that some T cells were able to 
divide but no expansion of cell number took place. This could not be rescued by 
addition of anti-CD28 co-stimulatory signal, which is provided by APCs in the culture. 
Exogenous IL-2 addition, which is the major T cell growth factor also failed to rescue T 
cell expansion. Bypassing TCR/CD3 signalling with PMA/ionomycin largely rescued 
the T cell responses suggesting that mitogen-activated protein (MAP) kinase activation 
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and Ca
2+
 mobilisation can overcome the defects observed in ULK1KO cells. These 
findings are similar to results from Atg5 deficient T lymphocytes [283] but while it is 
likely that Atg5KO cells cannot undergo classical autophagy this was not shown by the 
authors and would be in contrast to ULK1KO T cells, which are autophagy competent. 
 
In summary I have shown, that T but not B lymphocytes from ULK1KO mice have 
impaired responses to TCR/CD3 stimulation and undergo more apoptosis both when 
activated and at steady state. Similar defects have been reported in Atg5KO T cells but 
it has been unclear whether this represents a specialised function of Atg5 or is 
applicable to the process of classical autophagy. My results would support the latter but 
more autophagy genes should be analysed to confirm this. On the other hand ULK1KO 
T cells seem to be able to form LC3-II positive autophagosomes as efficiently as wild 
type cells but it is still possible that they fail to respond to autophagy inducing, but 
presently unknown, stimuli leading to enhanced cell death and/or proliferation defects 
or anergy.  
 
Another possibility is that the differences observed between ULK1KO and ULK1WT T 
cells are due to impaired negative selection in the ULK1KO thymus leading to release 
of auto-reactive T cells into the peripheral lymphoid organs. Negative selection is 
mediated by thymic epithelial cells (TECs), which rely partly at least on autophagy to 
present self-antigens to immature T cells. T lymphocytes recognising such auto-antigens 
undergo apoptosis to prevent auto-immune disease. Autophagy defects in TECs could 
therefore lead to an increase in auto-reactive T cells in the periphery but these would be 
induced to undergo apoptosis or anergy by regulatory T cells, which are another line of 
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defence to prevent autoimmune disease. In support of this hypothesis, I observed less 
autophagosomes in EM images of an ULK1KO thymus than in the wild type thymus 
when looking specifically at TECs and other APCs in the thymus. However, this 
experiment has only been done once and the data remains preliminary. ULK1KO mice 
do not show autoimmune disease but this may be explained by the fact that there are 
other mechanisms to prevent this such as the regulatory T cells or lack of co-stimulatory 
B cells. Furthermore, CD8-positive T cells are also reduced in number and show 
impaired responses to TCR stimulation in ULK1KO mice but these cells do not rely on 
MHC class II presented antigen recognition as do the CD4-positive T cells (Fig. 6-5 and 
6-7). This could be explained by a lack of co-stimulation by CD4-positive helper T 
cells, which are necessary for CD8-T cell responses. It would be interesting to challenge 
ULK1KO mice with an infectious agent or a vaccine and study the immune response in 
vivo but under clean laboratory conditions they do not seem to succumb to infection 
more than wild type mice. 
 
In conclusion, I have shown that ULK1KO CD4 and CD8-positive mature T cells have 
an impaired response to TCR stimulation and are reduced in number. This suggests that 
ULK1 plays a critical role in the adaptive immune system, which ULK1KO mice 
cannot compensate for even though they can compensate for loss of ULK1 in most 
tissues and remain capable to undergo autophagy. It remains to be elucidated what the 
exact role of ULK1 in T cell biology is and whether it involves classical autophagy or 
represents a separate function of the ULK1 protein. 
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